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Thesis Abstract 
In cases of compromised bone remodeling like osteoporosis, insufficient osseointegration 
occurs and results in implant failure. Implant retention relies on proper secondary fixation, which 
is developed during bone remodeling. This process is disrupted in metastatic bone diseases like 
osteoporosis. Osteoporosis is characterized low bone mass and bone strength resulting from 
either accelerated osteoclast-mediated bone resorption or impaired osteoblast-mediated bone 
formation. These two processes are not independent phenomena. In fact, osteoporosis can be 
viewed as a breakdown of the cellular communication connecting bone resorption to bone 
formation. Because bone remodeling occurs at temporally generated specific anatomical sites 
and at different times, local regulators that control cross-talk among the cells of the BRU are 
important. Previous studies show Ti implant surface characteristics like roughness, 
hydrophilicity, and chemistry influence the osteoblastic differentiation of human MSCs and 
maturation of OBs. Furthermore, microstructured Ti surfaces modulate the production of factors 
shown to be important in the reciprocal communication necessary for the maintenance of healthy 
bone remodeling. Semaphorin signaling proteins are known to couple the communication of 
osteoblasts to osteoclasts and are capable of stimulating bone formation or bone resorption 
depending on certain cues. Implant surface properties can be optimized to exploit these effects 
to favor rapid osseointegration in patients with osteoporosis. 
  
Osseointegration in Metabolically Compromised Conditions • Spring 2019 
Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 11 
Chapter 1. Introduction 
Specific Aims 
Successful osseointegration of dental and orthopaedic implants is determined by the degree 
of bone apposition to the surface of the implant material. This complex cascade of biological 
events involves primary bone formation, ultimately leading to the development of mature lamellar 
bone via bone remodeling. In cases of compromised bone remodeling, like osteoporosis, 
insufficient osseointegration occurs, which can result in implant failure. 
In addition to its role in osseointegration, bone remodeling provides the mechanism for 
adaptation to mechanical stress and repair of micro-damage. The versatility of bone remodeling 
implies its ubiquity within the skeleton and its initiation highlights the importance of locally 
generated and regulated factors ensuring appropriate coupling mechanisms among bone 
forming osteoblasts (OBs), bone resorbing osteoclasts (OCs), and their respective 
mesenchymal (MSC) or hematopoietic (HSC) stem cell lineage precursors. These cells comprise 
the bone remodeling unit (BRU), and their contemporaneous and multidirectional communication 
balances bone formation with bone resorption. Any defects in this coupling process may lead to 
the dysregulation of bone homeostasis leading to low bone mass and strength resulting in 
osteoporosis. Thus, the continuous loss of bone that occurs in osteoporosis implies a defect in 
the coupling process. Although age-related mechanisms contributing to osteoporosis may 
originate from accelerated bone resorption or impaired bone formation, these processes are not 
independent phenomena. Therapeutic interventions targeting either half of this process will 
inevitably affect its counterpart. 
Implant surfaces made from titanium (Ti) or its alloys, including commercially pure Ti (cpTi), 
titanium – aluminum – vanadium (Ti6Al4V), and titanium – zirconium (TiZr), can be modified to 
stimulate osteogenesis, resulting in enhanced osseointegration, eliminating the need for 
exogenous biologics such as bone morphogenetic proteins (BMPs). Surface microroughness, 
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hydrophilicity, and chemistry influence the osteoblastic differentiation of human mesenchymal 
stem cells (MSCs). When grown on Ti surfaces that are microstructured and hydrophilic, these 
cells produce factors that create an osteogenic environment by: stimulating osteoblastic 
differentiation in progenitor cells distal to the implant; promoting vasculogenesis; reducing 
inflammation; and regulating osteoclastic resorption to achieve net new bone formation. These 
in vitro findings are correlated with preclinical studies in animal models and with human clinical 
studies. However, this research was limited to healthy animals and did not focus on 
compromised conditions. 
The overall goal of this research project addresses the clinical need for materials that enable 
rapid and sufficient implant osseointegration for patients with osteoporosis. The central 
hypothesis is that microstructured Ti and TiZr surfaces regulate the remodeling phase of 
osseointegration through direct actions on the coupling of cells in the BRU. Furthermore, we can 
tailor Ti implant design to exploit these effects to favor rapid osseointegration in patients with 
osteoporosis. However, to optimize osteoporotic osseointegration, we need a more complete 
understanding of cellular and molecular coupling events within the BRU and how modified Ti 
implants exert their regulatory control on bone remodeling. The objectives of this research 
project were completed by pursuing the following three specific aims. 
Aim 1: Determine the effects of microstructured titanium and titanium-zirconium 
surfaces on production of factors that regulate OC activity by cells of the osteoblast 
lineage. We will investigate how Ti and TiZr surface properties control local factor production 
responsible for the communication occurring within the BRU. The working hypothesis is that 
the microtopography and hydrophilicity of Ti and TiZr surfaces regulate production of factors 
associated with the reciprocal communication between MSCs, OBs, and OCs, specifically 
factors associated with Eph/Ephrin and semaphorin signaling. Smooth, rough, and hydrophilic-
rough Ti and TiZr disks will be used to assess changes in MSC and OB gene expression and 
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protein production of this signaling pathway. 
Aim 2: Determine the mechanisms through which implant surface properties influence 
cellular communication in bone remodeling. We have established that MSC differentiation 
and OB maturation are very different when cultured on microstructured surfaces vs. TCPS. 
MSCs and OBs primarily express the α5β1 integrin complex when grown on TCPS but shift to 
α1β1 and α2β1 when grown on microstructured substrates. Furthermore, microstructured 
implant surfaces facilitate osteogenesis through the non-canonical Wnt5a pathway, in contrast 
to the canonical Wnt3a pathway seen on TCPS. Semaphorins not only mediate BRU crosstalk 
but also stimulate osteoblastic differentiation and bone growth through β-catenin, bypassing 
canonical Wnt3a signaling, suggesting they are involved. The working hypothesis is that 
microstructured, hydrophilic surfaces regulate the BRU through semaphorin signaling inducing 
OB differentiation. We have developed a system that allows us to focus on surface-dependent 
mechanisms that control BRU reciprocal communication. 
Aim 3: Examine whether Ti implant surface properties can impact osseointegration in 
an in vivo model of compromised bone remodeling. Using an osteoporotic aged rat model, 
the in vivo effectiveness of surface modified Ti implants to influence bone formation will be 
examined as a function of surface-dependent regulation of OB/OC coupling mechanisms. The 
working hypothesis is that modified Ti implants can reinvigorate locally compromised bone 
remodeling without use of additional therapeutics. Osseointegration of modified Ti implants will 
be compared between aged osteoporotic rats with or without medications commonly used to 
combat osteoporosis. MSCs and OBs isolated from these rats will be used to correlate in vitro 
and in vivo results. 
Significance 
Aging of the population is currently a topic of public health concern. The number of people 
aged 60 or older is projected to grow to nearly 2 billion by 2050, with most of the increase seen 
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in developing countries.1 Consequently, the increasing occurrence of disorders and morbidities 
associated with aging is driving the necessity to develop technologies addressing the needs of 
this demographic. 
Currently, 18.1% of American adults over the age of 65 are completely edentulous and an 
estimated 37.9 million adults in the United States will have no natural teeth by 2020.2 Historically, 
edentulous patients have been treated with removable dentures. However, decreased dietary 
adequacy has been observed in these patients compared to dentate patients. Implant-supported 
dentures significantly improve quality of life in comparison to removable dentures, but many 
prosthetic and surgical problems and complications are still present. In a systematic review of 
data pooled from maxillary and mandibular fixed implant prostheses, only 29% of prostheses 
remained complication free after 5 years, which decreased to 9% after 10 years.3 These 
complications were attributed to the effects of aging on metabolic and endocrine processes, 
making implant osseointegration difficult to predict accurately. 
Sufficient bone volume (BV) and bone mineral density (BMD) are two of the most important 
patient factors for predicting implant success. These factors significantly diminish with age and 
their reduction is exacerbated by menopause. Patients experiencing excessive decreases in 
BMD are at risk of developing osteoporosis. Osteoporosis is a metabolic bone disease 
characterized by low BMD and BV, impairing bone strength and healing. An estimated 53.6 
million U.S. adults over the age of 50 were affected by osteoporosis or osteopenia in 2010.4 By 
2030, its prevalence is projected to increase to 71.4 million people.4 Furthermore, 80% of those 
affected by osteoporosis were postmenopausal women.4 
Countless research efforts have focused on developing new methods of altering biomaterial 
surfaces and characterizing their effects on early stage osteogenesis. No efforts, however, have 
sought to investigate how implant surfaces modulate the bone remodeling phase of 
osseointegration. By investigating the extent to which microstructured surfaces orchestrate the 
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dynamic cellular interplay of the BRU, this research shifts the paradigm of contemporary 
biomaterial surface research. An understanding of bone remodeling regulation will allow us to 
address the clinical need for implants capable of osseointegration in patients with a multitude of 
disorders compromising bone remodeling. The aim is not to cure these disorders, but rather 
determine whether microstructured implant surfaces can locally mitigate their effects and 
reinvigorate bone remodeling to promote rapid and sufficient osseointegration. 
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Chapter 2. Background 
Implants are used in orthopaedics and dentistry to improve the quality of life for patients who 
suffer from chronic back pain, degenerative joints, or edentulism. Titanium (Ti) and its alloys, 
including commercially pure Ti (cpTi), titanium–aluminum–vanadium (Ti6Al4V), and titanium–
zirconium (TiZr), are commonly used to restore structure and function of musculoskeletal tissues 
because of their high biocompatibility, corrosion resistance, and favorable weight-to-strength 
ratio. These attributes of Ti are due to its ability to form a passive oxide layer making it stable in 
biological systems. Since bone has a high composition of inorganic calcium phosphates, many 
have speculated that the passive oxide layer of Ti mimics the ceramic nature of bone. Ti and Ti 
alloy implants support stable osseointegration, the biological phenomenon providing a direct 
structural and functional connection between surfaces of load-bearing implant and living bone.  
The modern use of metallic implants for orthopaedic and dental applications has been 
evolving over the last 60 years.5–7 Early efforts in biomaterial design were primarily concerned 
with the biocompatibility of the material with the host tissue. Materials that limited the 
development of foreign body giant cells, provided no evidence of local toxicity, and mitigated 
fibrous encapsulation were deemed acceptable. Implants made from these materials were 
viewed as biologically inert fixtures, anchored in place either using cement or via mechanical 
interlocking between the implant and the surrounding bone tissue. However, failure to achieve 
mechanical stability led to micromotion of the implant and localized inflammation, and frequently 
ending with osteolysis and implant failure. 
Over the last few decades, research has made it clear that implant materials should go 
beyond compatibility and actively promote bone formation. One approach has been to induce 
peri-implant bone formation through the use of osteoinductive agents like demineralized bone 
matrix (DBM)8,9 and bone morphogenetic protein-2 (BMP2).10,11 Alternative approaches have 
included the use of bone graft substitutes that are designed to be osteogenic via the use of a 
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variety of factors, including platelet rich plasma (PRP),12–14 platelet derived growth factor 
(PDGF),15,16 and insulin-like growth factor-1 (IGF1),17,18 as well as vasculogenic factors like 
vascular endothelial growth factor (VEGF),17,19 and fibroblast growth factor-2 (FGF2).20,21 
However, many of these biologics are temporary solutions designed to stimulate initial bone 
formation. Long-term stability of an implant requires solutions that not only result in net bone 
formation but also provide continued osteogenic signals throughout the entire process of 
osseointegration. Physical modifications to the implant material surface, which will be present 
long after the exogenous bioactive agents are gone, provide the best options to achieve this. 
Stages of Osseointegration 
Bone is a dynamic tissue making it obvious that coordinated and sequentially organized 
cellular communication and biomechanical cues are needed to initiate and maintain the events 
responsible for osseointegration (Fig.1). Osseointegration begins with surgical trauma followed 
by the insertion of an implant. After implant insertion, blood vessels rupture and release proteins, 
ions, sugars, and lipids, important for blood clot formation (Fig.1A). Following formation of the 
blood clot, initial inflammatory response is controlled via immunomodulatory cells such as 
neutrophils, dendritic cells, and macrophages (Fig.1B). These immune cells produce 
chemokines that clean and disinfect the microenvironment, guide MSC recruitment or additional 
immune cells, and initiate tissue repair. 
The blood clot spans the gap between the injured bone and the implant. Formation of the 
blood clot is an important step in implant osseointegration, as it serves as a provisional matrix 
and scaffold for the migration of MSCs to the implant surface (Fig.1B). Surface design that 
facilitates this contact osteogenesis has been shown to control the fundamental processes that 
drive the osteoblastic differentiation of MSCs.22,23 Differentiating MSCs and mature OBs produce 
factors that create an osteogenic microenvironment, promote angiogenesis, reduce 
inflammation, and regulate osteoclast-mediated bone resorption. A cell-rich, immature bone 
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(primary bone) forms in direct contact with the surface of the Ti implant (Fig.1C). Following the 
formation of the primary bone, OCs begin to form (Fig.1D). Their formation marks the beginning 
of the bone remodeling phase of osseointegration and with it comes the progressive removal of 
the primary bone, creating space for new lamellar bone formation and replacing passive primary 
stability with active secondary fixation through biological bonding (Fig.1E). 
In vivo, bone is formed by OBs on areas of the bone surfaces that have been prepared by 
OCs. It is unclear as to how resorption sites are selected, but the process is initiated by the 
retraction of bone-lining cells to uncover osteoid. After removal of the osteoid, the OC attaches 
to the mineralized surface and forms a sealing zone. Beneath the OC, the formation of a closed 
compartment called the resorption lacunae occurs where the OC membrane is folded forming 
the ruffled border. The OC is able to release hydrogen ions through the ruffled border via activity 
Figure 1. Schematic illustrating the steps of implant osteointegration. Osteointegration involves formation 
of a fibrin clot (A), recruitment of monocytes, macrophages and MSCs (B); osteoblastic differentiation of MSCs 
and primary bone formation as well as vasculogenesis (C); and ultimately osteoclast-mediated bone remodeling 
(D); leading to mature bone (E). 
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of carbonic anhydrase, thereby reducing the pH and dissolving the mineralized portion of the 
extracellular matrix.24,25 Other enzymes like lysosomal cysteine proteinases and matrix 
metalloproteinases are then secreted to degrade the organic matrix.26,27 
The resorption pit created by the osteoclast has been shown to be chemotactic for 
osteoprogenitor cells,28 which migrate onto the surface and differentiate into mature osteoblasts. 
These cells produce growth factors like BMPs together with their regulatory apparatus, which 
induce osteoblast differentiation of MSCs and osteoprogenitor cells. The secretory osteoblasts 
produce osteoid consisting of extracellular matrix proteins such as type I collagen as well as 
osteocalcin and osteonectin. Mineralization of the osteoid is then promoted through the 
regulation of local concentrations of calcium and phosphate and tailoring of the extracellular 
matrix components. 
Biomimetic Implant Surfaces: Lessons from Bone Remodeling 
Based on the research from our group and others,29 biologically inspired dental and 
orthopaedic implant surfaces are now being produced that mimic the features of an OC 
resorption pit. Studies using model Ti surfaces fabricated using photolithography and 
micromachining show that 30 – 100μm diameter craters are preferentially colonized by 
osteoblasts,30,31 which are similar in size to OC resorption pits.32,33 Moreover, OCs do not 
uniformly degrade the mineralized portion of bone and are unable to completely degrade all the 
extracellular matrix components leaving debris such as collagen and hydroxyapatite fragments 
in the wake of their resorption. Hydroxyl ions also remain in the resorption pit as a result of the 
dissolution of hydroxyapatite crystals.34 Once the OC detaches from the bone, a resorption pit 
remains that has a unique surface with a particular chemistry and complex hierarchical structure 
that contains micro-, meso-, and nano features. Thus, native bone has physical features capable 
of altering the mechanical environment experienced by osteoblast lineage cells, and the inherent 
chemistry, roughness, and hydrophilicity of the bone surface can influence cell attachment and 
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cell shape, which can dictate cell proliferation and differentiation in vitro as well as 
osseointegration in vivo.  
Surface Chemistry 
Surface chemistry of an implant is determined by the properties of the bulk material as well 
as its method of fabrication. As stated previously, Ti is the choice material for both dental and 
orthopedic implant materials because of favorable bulk properties its high biocompatibility, 
increased resistance to corrosion, and favorable weight-to-strength ratio. Ti-based alloys, like 
Ti-6Al-4V and TiZr, are also used because of their improved material properties, particularly 
mechanical strength. Because of the altered bone turnover, many osteoporotic/osteopenic 
patients have severely limited bucco-lingual and/or mesiodistal dimensions, which further 
complicate dental implant interventions. Reduced diameter implants (1.8 – 3.0mm) have become 
a common alternative for these patients.35 Although Ti is the dominant material for dental implant 
applications, its mechanical properties can be inadequate following reductions in its diameter, 
increasing incidences of fatigue fracture and deformation from masticatory forces. Research 
investigating TiZr and Ti-6Al-4V substrates has shown increasing support for their use as an 
alternative biomaterial. 
Traditionally, Ti implants are produced by machining Ti or alloyed rods. The machining 
process results in a smooth surface with some microscopic irregularities;36–38 however, these 
irregularities have not been shown to be clinically significant.37 Using this machined surface as 
a base, additive or subtractive post-processing methods are employed to further alter the surface 
of the implant to generate a surface topography with features similar to OC resorption pits. 
Additive layering of Ti particles onto existing machined surfaces is frequently used to create 
bulk structures from computer aided designs.39 Ti plasma spraying applies layers of Ti particles 
onto the surface of machined rod implants using a plasma torch. Local melting typically occurs 
during this process, which can generate a patchwork surface containing irregular regions of 
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depressions and protrusions as well as relatively smooth areas. Bulk structures can also be 
produced by additive manufacturing reducing cost, time, and material waste. Metallic implants 
fabricated bottom-up can possess irregular geometries. Selective laser melting and electron 
beam melting are two methods in which powder layers of micron sized metallic particles are 
fused using a high energy beam, in a layer-by-layer fashion following a computer aided design.  
Surface Topography 
The positive influence of surface topography on osseointegration, achieved through 
subtractive methods like grit-blasting and acid-etching, has been a topic of investigation for 
several decades. It has been understood for some time that macro- and micro-rough implants 
outperform their smooth counterparts.40–44 Today, microrough surfaces dominate the market as 
they have been shown to achieve faster bone integration, a higher percentage of bone to implant 
contact (BIC), and a higher resistance to shear, as determined by removal torque values (RTVs), 
when compared to smooth implant surfaces.35 
Recently, studies have suggested features at the submicron and nanoscale have a direct 
effect on the biological response of bone.45–48 Type I collagen, the primary organic component 
of bone, consists of fibers ~300nm in length and ~0.5nm in width while the hydroxyapatite 
crystals in bone are generally ~50nm in length and ~5nm in diameter.49 In order to mimic these 
features, nanomodifications have been developed to directly restructure the oxide layer formed 
on the implant surface using coatings,50 hydrothermal reactions treatments,51 and surface 
oxidation.52,53 Reorganization of the oxide layer leads to a disordered nanostructure orientation, 
which has been shown to be more favorable compared to a highly ordered pattern.54 
Hydrophilicity 
Hydrophilicity is related to the wettability of the implant surface and is generally regarded as 
a result of the surface chemistry.55 The hydrophilicity of an osteoclast resorption pit surface is 
not known, making it difficult to mimic this property, but hydrophilic surfaces are known to 
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promote an environment conducive for bone formation.56,57 This has been attributed to rapid 
spreading of serum on the surface providing an overall coating of bioactive factors58 that can 
influence early cell adhesion,59 proliferation,60 and differentiation23,61 by modulating the bonding 
strength, total amount, and conformation of adsorbed proteins.62 One method commonly used 
to retain surface hydrophilicity of a biomaterial is to reduce atmospheric hydrocarbon 
contamination.63 Post-processing saline storage or plasma cleaning before implantation are two 
commonly used methods to either prevent the deposition of hydrocarbons or rid the surface of 
deposited hydrocarbons. Both processes indirectly increase the presence of hydroxyl ions on 
the implant surface, which could be the reason for the increased performance of hydrophilic 
compared to hydrophobic implants. 
Coupling of Bone Resorption to Formation: Implications for Osteoporosis 
In a healthy adult skeleton, the amount of resorbed bone is generally equal to the amount of 
new bone formation, thus maintaining skeletal integrity. This coordination, referred to as 
coupling, could play a significant role in the pathophysiology of osteoporosis. If the acceleration 
of bone resorption were matched by an equal or greater increase in bone formation there might 
be transient bone loss, but ultimately the removed bone would be replaced by new bone. Hence, 
the continuous loss of bone that occurs in osteoporosis implies a defect in the coupling process. 
Thus, it is of great importance to determine which factors regulate coupling and the influence 
implant surfaces have on these mechanisms. 
Regulation of Estrogen 
The rate at which bone remodeling occurs varies when an implant is present and depends 
on the type of implant used and its surface properties.64–66 Cells on microstructured surfaces 
exhibit and osteoblastic phenotype within the first 4 days of culture and produce factors that act 
via autocrine/paracrine signaling to regulate peri-implant bone remodeling.61 On TCPS, MSC 
differentiation occurs through the canonical Wnt3A pathway, causing an accumulation of β-
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catenin in the cytoplasm and its translocation into the nucleus to serve as a transcriptional 
activator.67–69 Previous studies have demonstrated surface mediated MSC differentiation 
downregulates genes associated with the Wnt3A pathway while upregulating genes of the 
Wnt11 and non-canonical calcium-dependent Wnt5a pathway.70–72 Expression of Wnt5a and 
Wnt11 signaling pathway components are also induced in mature female OBs when treated with 
17β-estradiol (E2),73,74 the primary sex hormone responsible for the development of post-
menopausal osteoporosis. Moreover, sensitivity to E2 treatment is increased when these cells 
are cultured on microrough and/or hydrophilic Ti implant surfaces compared to smooth Ti or 
TCPS.74–76 Estrogen deficiency may play a role in the impaired formation response during 
remodeling, because animals lacking ERα showed decreased formation responses to 
mechanical loading by a mechanisms that involves the Wnt signaling pathway. 
Estrogen is an osteoprotective hormone, and its deficiency leads to an elevated rate of bone 
turnover culminating in osteoporosis in females and, in some cases, older males. A hallmark of 
E2 deficiency is an elevated rate of bone turnover in which the rate of OC-mediated bone 
resorption increases and, secondarily, OB-mediated bone formation decreases. In osteoporotic 
patients, MSCs and OBs produce factors favoring osteoclastogenesis unfettered by any 
regulatory feedback mechanisms. Increased levels of pro-inflammatory IL-6 and decreased 
levels of TGFβ1 are produced by bone cells isolated from osteoporotic patients compared to 
healthy patients.77–79 Interestingly, both E2 treatment and microstructured Ti substrates are 
known to inhibit IL-6 production while enhancing production of TGFβ1 and OPG.75,80,81  
Communication from Osteoblasts 
Many of the factors produced by osteoblasts cultured on microrough Ti surfaces regulate 
bone remodeling by favoring osteogenesis over osteoclastic resorption, promoting net new bone 
formation (Fig.2). TGFβ1-dependent regulation of OPG production is one of the classic 
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mechanisms controlling localized bone remodeling.80 TGFβ1 enhances the proliferation of MSCs 
and OBs and stimulates extracellular matrix production of proteins like type I collagen. Latent 
TGFβ1 and latent TGFβ binding protein are synthesized and stored in the extracellular matrix. 
Most of the TGFβ1 produced by OBs cultured on Ti is in latent form,82 and the amount 
incorporated into the matrix is increased on rougher surfaces. Once the bone remodeling phase 
of osseointegration begins, the OCs degrade the newly synthesized matrix releasing the stored, 
latent TGFβ1 and convert it into active TGFβ1. Once activated, TGFβ1 acts on osteoclasts and 
downregulate their activity, in part by regulating production of OPG.80 
OPG serves as a decoy receptor for receptor activator of NFκB ligand (RANKL).83 By binding 
to RANKL, it prevents osteoclast differentiation by preventing its interaction with receptor 
activator of NFκB (RANK) on the OCP surface, an interaction required for the fusion and 
subsequent maturation of differentiated OCs. A feedback mechanism is in place that allows 
Figure 2. Cell signaling mechanisms among osteoblast lineage cells and osteoclasts involved in osseointegration, 
lead to release of local regulatory factors in the peri-implant space. Abbreviations: Transforming growth factor 
beta-1 (TGFβ1); receptor activator of NFκB ligand (RANKL); osteoprotegerin (OPG); 1α,25-Dihydroxy vitamin D3 
(1,25(OH)2D3). 
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osteoblasts to produce soluble RANKL in order to deplete excess OPG if the regulatory stimulus 
favors new osteoclast formation. Microrough Ti substrates facilitate increased production of OPG 
by osteoblasts; however, levels of RANKL do not change.84 Thus, the net effect is bone formation 
without bone resorption. 
Local regulatory factor production has also been shown to be sensitive to microstructured Ti 
implants. In addition to the high production of negative regulators of osteoclast activity, cells 
produce high levels of osteocalcin and osteopontin.22,53,85 Osteocalcin has been shown to 
promote the chemotaxis, adhesion, and spreading of osteoclasts86,87 while osteopontin plays a 
role in anchoring osteoclasts to the mineralized bone matrix.88 The sequential production of 
these factors suggests microstructured Ti facilitates the production of a cascade of factors by 
MSCs and osteoblasts to mediate osteoclast recruitment while preventing their premature fusion 
and activity. Although PGE2 stimulates osteoclastic activity at high levels, it is required at low 
levels for osteoblast activity.89,90 Osteoblast production of PGE1 and PGE2 is markedly increased 
when cells are cultured on microrough surfaces.82 Blocking the production of prostaglandins by 
the cyclooxygenase (Cox) inhibitor, indomethacin, also blocks the increase in other osteoblastic 
markers when cells are cultured on these surfaces, suggesting that they are necessary for 
enhanced osteogenesis.91,92 
BMP signaling is also tightly regulated during surface mediated osteogenesis, and that 
modulation of these signals can enhance or inhibit bone remodeling.93 Autocrine and paracrine 
actions of BMPs are known to be involved in cell proliferation, differentiation, and apoptosis.94 
Among these proteins, BMPs 2, 4, and 7 have shown to be the most important in bone formation 
and healing.95,96 Modulation of these osteogenic factors by implant surfaces provide molecular 
evidence of the increased osteoblastogenesis seen in vitro and increased healing times seen 
clinically. MSCs cultured on microstructured Ti substrates, display temporal upregulation of 
BMPs with increases of BMP2 and BMP4 occurring as early as 4 days, suggesting that they are 
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early regulators of surface-mediated osteogenesis.93 Their presence could also serve as the 
impetus for the commitment of MSCs to the osteoblast lineage when cultured on microstructured 
Ti, as they are known to regulate embryonic skeletal development.11 Furthermore, they also 
provide a mechanism for the differentiation of MSCs distal to the implant surface, as they are 
capable of multidirectional signaling. When MSCs were silenced for BMP2, production of OPG 
decreased suggesting that BMP2 effects impacts bone remodeling.93 
Axon Guidance Molecules 
Axon guidance molecules were originally identified as instructive cues for the navigation of 
axons, allowing axons to migrate to their targets during nervous system development. These 
molecules that guide growing axons towards and away from specific brain regions have been 
classified as attractive and repulsive, respectively.97 Besides their roles in neural circuit 
formation, axon guidance molecules have been implicated in various other biological processes, 
including cell motility, proliferation, differentiation, angiogenesis, cardiogenesis, tumor growth, 
tissue development, immune response, and, more recently, the coupling of osteoblasts and 
osteoclasts during bone remodeling.98–104 
Interactions of Eph family proteins with membrane bound Ephrin ligands on adjacent cells 
activate Eph receptor kinase-dependent pathways. Interestingly, the ephrins can also trigger 
tyrosine phosphorylation-dependent and independent signals, making bidirectional cell contact-
dependent communications possible.100 Loss- and gain-of-function experiments showed that 
osteoclast-derived EphrinB2 can act through a contact-dependent mechanism through its 
receptor, EphB4, expressed on the surface of osteoblasts.105,106 Forward signaling of EphrinB2 
through EphB4 has been shown to enhance osteogenic differentiation, while reverse signaling 
of EphB4 through EphrinB2 into OCPs can inhibit osteoclastogenesis by suppressing the c-Fos-
NFATc1 cascade.105,106 Overexpression of EphB4 in osteoblasts increases bone mass in 
transgenic mice, while high levels of EphrinB2 over-expression induce the committal of MSCs 
Osseointegration in Metabolically Compromised Conditions • Spring 2019 
Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 27 
to an osteoblastic lineage.106–108 Another possible ephrin/Eph mechanism within the osteoblast 
lineage arises from the finding that PTH and PTHrP promote production by osteoblasts of 
ephrinB2, and that blockade of the interaction between EphrinB2 and receptor EphB4 impairs 
late-stage differentiation of osteoblasts, indicating a role for this pathway in promoting osteoblast 
differentiation and bone formation.109 
Control of bone remodeling can also occur through the semaphorin signaling system, 
including their receptors, PLXNs and NRPs. Of the eight classes of semaphorin family proteins 
categorized by structure and sequence similarities, SEMA4D and SEMA3A have shown 
particularly convincing and intriguing control over bone remodeling.110 Sema4D is a 
transmembrane protein that is highly expressed at the cell membrane of both OCPs and mature 
OCs, whereas its expression in OBs is undetectable.111,112 Of the three receptors to which 
SEMA4D can bind, its highest affinity is for the PLXNB1 receptor, which is strongly increased 
during OB differentiation but not osteoclastogenesis.113 The binding of SEMA4D to PLXNB1 
impairs bone formation by inhibiting IGF-1 signals.112 Treatment of OBs with recombinant 
SEMA4D enhances motility and impairs cell – cell interaction, suggesting that OC-derived 
SEMA4D is required for the proper positioning of OBs within the bone microenvironment.112 
Genetic deletion of SEMA4D or PLXNB1 or blocking SEMA4D signaling with neutralizing 
antibodies in mice causes increased trabecular bone volume.112 Moreover, when SEMA4D was 
neutralized in OVX mice, bone formation was promoted without affecting bone resorption. 
Similar results were observed in a preclinical osteoporotic model when SEMA4D-targeting 
siRNA interfering molecules were specifically delivered to the bone using polymeric 
nanoparticles.114 Potent increases in trabecular bone volume are seen with SEMA4D silencing 
by enhancing OB number and activity, as indicated by the elevated mineral apposition rate.114 
Interestingly, the number of OCs are unchanged suggesting SEMA4D regulates the activity of 
mature OCs rather than their maturation.114 
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The class III semaphorin, SEMA3A, is a secreted protein which exerts its biological activity 
through interactions with NRP1 and its subsequent complex formation with PLXNA1.115,116 NRP1 
deficient mice display features of osteoporosis, which was reflected by both an increase in OC 
number and decrease in OB number.116 Interestingly, SEMA3A binding to NRP1 also disrupts 
the interaction between PLXNA1 and TREM2-DAP12, which is responsible for RANKL-induced 
osteoclastogenesis.116 Therefore, NRP1 is thought to compete with TREM2 for the PLXNA1 
complex formation. When NRP1 expression is low, binding of PLXNA1 to TREM2 is favored, 
stimulating osteoclastogenesis; however, in the presence of SEMA3A, generation of the 
SEMA3A-NRP1-PLXNA1 complex is favored, inhibiting osteoclastogenesis. These findings 
suggested that SEM3A secreted by osteoblast lineage cells synchronously affects both 
osteoclasts and osteoblasts in paracrine and autocrine manners, respectively. 
Like the effects of estrogen, SEMA3A is osteoprotective. The osteoprotective potential of 
SEMA3A is supported by some in vitro and preclinical studies. Treatment of OBs with 
recombinant SEMA3A activates Rac1 through FARP2, which facilitates the translocation of β-
catenin into the nucleus bypassing the need for any canonical Wnt3A initiating signals.116–118 
SEMA3A was also able to enhance bone regeneration in a cortical defect mouse model. 
Moreover, in a postmenopausal osteoporosis mouse model, SEMA3A treatment decreases 
bone loss after ovariectomy. These observations demonstrate that SEMA3A plays a crucial role 
in bone protection, yet no clear evidence that SEMA3A has similar bone protective effects in 
humans exists. To date, one cross-sectional study among postmenopausal women indicates 
that serum SEMA3A levels are positively with bone turnover as determined by serum osteocalcin 
levels. However, this association did not exist with BMD.119 
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Chapter 3. Comparable Responses of Osteoblast 
Lineage Cells to Microstructured Hydrophilic 
Titanium-Zirconium and Microstructured Hydrophilic 
Titanium 
Abstract 
Although titanium (Ti) is commonly used for dental implants, Ti alloy materials are being 
developed in order to improve their physical material properties. Studies indicate that osteoblast 
differentiation and maturation of human mesenchymal stem cells (MSCs) and normal human 
osteoblasts (NHOsts) respond to microstructured Ti and titanium-aluminum-vanadium (Ti6Al4V) 
surfaces in a similar manner. The goal of this study was to determine whether this is the case 
for osteoblast lineage cells grown on microstructured TiZr surfaces and whether their response 
is affected by surface nanotexture and hydrophilicity. Grade 4 Ti and TiZr (13-17% Zr) discs 
were modified by large grit sand-blasting and acid-etching with storage in saline solution, 
resulting in a complex microstructured and hydrophilic surface corresponding to the 
commercially available implants SLActive® and Roxolid® SLActive® (Institut Straumann AG, 
Basel, Switzerland). The subsequent Ti modSLA and TiZr modSLA surfaces were characterized 
and osteogenic markers were measured. Evaluation of physical parameters revealed that the 
fabrication method was capable of inducing a microstructured and hydrophilic surface on both 
the Ti and TiZr discs. Overall the surfaces were similar, but differences in nanostructure 
morphology/density and surface chemistry were detected. On Ti modSLA and TiZr modSLA, 
osteoblastic differentiation and maturation markers were enhanced in both MSCs and NHOsts 
while inflammatory markers decreased compared to TCPS. These results indicate a similar 
positive cell response of MSCs and NHOsts when cultured on Ti modSLA and TiZr modSLA. 
Both surfaces were hydrophilic, indicating the importance of this property to osteoblast lineage 
cells. 
Osseointegration in Metabolically Compromised Conditions • Spring 2019 
Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 30 
Introduction 
For the past two decades, titanium (Ti) has been the dominant material for dental implant 
applications due to its ability to form a passive oxide layer that makes it stable in biological 
systems.120 Ti exhibits superior biocompatibility and corrosion resistance as a result of this 
passive layer when compared to other implant materials and contributes to its functional 
osseointegration with the surrounding bone tissue.121 
Despite their high success rate, significant bone resorption in patients with Ti implants placed 
in close proximity to adjacent teeth as well as insufficient formation of peri-implant bone have 
been observed, particularly in patients with reduced or limited bucco-lingual and/or mesiodistal 
dimensions.122 Implants with reduced diameter (1.8 – 3.0 mm) have been used to prevent bone 
loss in these patients.122 While reduced diameter implants have reported retention rates of up to 
100%, reducing the diameter of grade 4, commercially pure Ti (cpTi) implants compromises their 
mechanical properties, thereby increasing incidences of fatigue fracture and deformation from 
masticatory forces.123–128 
Alloying titanium is a common method used to increase the inherent strength of the implant 
material; however, the corrosion characteristics and toxicity of certain alloying components must 
be considered when selecting the appropriate material for surgical applications. Titanium-
aluminum-vanadium alloy (Ti6Al4V) is frequently used for dental and orthopaedic implants and 
has shown good biocompatibility, stability, corrosion resistance, and mechanical properties. 
Recent studies have reported that components of Ti6Al4V may be gradually released over 
time.129–131 These ions, particularly vanadium, have been shown to cause adverse cells 
responses in vitro,131–137 although it is unclear whether a sufficient quantity of these ions will 
leach from an implant and cause a similar adverse reaction in vivo. 
Using other alloying components that have elicited no adverse reactions in vitro, like 
zirconium (Zr), would avoid this outcome entirely.138 An implant consisting of Ti alloyed with 13 
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to 17% Zr was developed by Institut Straumann AG (Basel, Switzerland). An analysis of the 
material properties of the TiZr alloy demonstrated a 40% increase in tensile strength and a 60% 
greater yield strength compared to the lower limit of the standard for cold worked grade 4 Ti, and 
13 to 42% higher endurance levels when compared to cpTi of similar dimensions, while retaining 
superior corrosion resistance.35,139 The enhanced mechanical properties of the TiZr alloy make 
it an excellent candidate for small diameter implants. 
Surface modifications that produce a complex micro-topography and increase hydrophilicity 
of dental implants have been shown to increase osteoblast differentiation, suggesting that they 
might also improve osseointegration, stability and retention of TiZr dental implants.23,29,55,61,140–
145 One such surface modification involves sand-blasting and acid-etching cpTi with immediate 
storage in saline solution, used by Straumann for fabrication of their commercially available Ti 
SLActive® and Roxolid® (13 – 17% TiZr alloy) SLActive implants. Clinical studies have shown 
that the Roxolid® implant meets established dental implant survival criteria and has a high 
success rate in patients (ranging from 95.2 to 100%), acceptable bone-level changes, probing 
pocket depth, plaque and sulcus bleeding.146–148 Although both preclinical in vivo and clinical 
studies have concluded that cpTi and TiZr dental implants behave similarly,146,149–151 there are 
few in vitro data supporting these findings. Additionally, the available in vitro studies have been 
limited to characterizing the molecular level cellular response of the osteoblast-like MG63 cell 
line.35 No study has directly compared the biological response of two key cell types important for 
osseointegration (progenitor cells and cells committed to an osteoblast phenotype) to cpTi and 
TiZr. 
The method used to modify the surface of the SLActive® and Roxolid® implants is the same, 
but the differences in chemical composition result in varying surface characteristics, potentially 
influencing cell response in different ways.52 Therefore, the purpose of this study was to assess 
the osteoblastic differentiation and maturation of human mesenchymal stem cells (MSCs) and 
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normal human osteoblast (NHOst) cells in response to grit-blasted, acid-etched and hydrophilic 
titanium-zirconium (TiZr modSLA) surfaces, and determine the similarity of these responses to 
those seen on grit-blasted, acid-etched, hydrophilic Ti (Ti modSLA). 
Materials and Methods 
Surfaces and Modifications 
Grade 4 Ti and TiZr (13 – 17wt% Zr) discs, 5mm in diameter and 1mm in thickness, were 
provided by Institut Straumann AG (Basel, Switzerland). Discs were modified by the same 
protocol used to produce commercially available Ti SLActive® and Roxolid® SLActive® 
implants. Disc surfaces were first treated by large grit sand-blasting (250 – 500µm) followed by 
acid-etching in a boiling mixture of HCl and H2SO4 with immediate storage in 0.9% NaCl solution. 
The subsequent Ti modSLA and TiZr modSLA discs were sterilized using γ-irradiation. 
Surface Characterization 
Scanning Electron Microscopy (SEM) 
Qualitative and quantitative characterization of the disc surface topography was evaluated 
using SEM (Ultra 60 FEG-SEM, Carl Zeiss SMT Ltd., Cambridge, UK). Secondary electron 
images were recorded at varying magnifications using an acceleration voltage of 5kV for three 
different samples (n=3). Morphometric quantification of nanostructure size and peak-to-peak 
distance was measured using ImageJ software (National Institutes of Health, USA). A grid 
composed of 20 evenly spaced squares arranged into a 4x5 matrix was superimposed onto the 
highest magnification SEM images. The diameter and peak distance to its closest neighbor were 
obtained for the centermost nanostructure within each square for a total of 60 measurements 
per material. 
X-Ray Photoelectron Spectroscopy (XPS) 
Chemical composition of the surface of the samples (n=3) was obtained by XPS (Thermo K-
Alpha XPS, Thermo Fisher Scientific, Waltham, Massachusetts). Spectra were collected using 
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a 400µm X-ray spot size at three different locations on each individual sample. 
Contact Angle Measurement 
Measurements were obtained using a goniometer (CAM 250, Ramé-Hart, Mountain Lakes, 
NJ). Samples (n=3) were measured in three different locations and dried with nitrogen between 
each measurement. A drop size of 2µL was used per individual measurement and a contact 
angle was calculated every 5s for 20s. The four measurements were then averaged to obtain 
one of the three measurements per disc. 
Confocal Laser Microscopy 
Surface roughness of the samples (n=3) was evaluated using a confocal laser microscope 
(Lext, Olympus, Shinjuku, Tokyo, Japan). Three measurements per sample were taken over an 
area of 644µm x 644µm with a 20x objective and a scanning pitch of 50nm. A cutoff wavelength 
of 100µm was used when calculating surface roughness (Sa) and peak-to-valley height (Sz). 
Cell Culture 
We used two different cell cultured models to examine cell response. Normal human 
osteoblasts (NHOst cells) (Lonza Biosciences, Walkersville, MD), a non-transformed cell line 
obtained from normal human bone, were cultured using Dulbecco’s modified Eagle medium 
(DMEM CellGro®, Mediatech, Inc., VA) supplemented with 10% fetal bovine serum (FBS, Life 
Technologies, Carlsbad, CA) and 1% penicillin-streptomycin (Life Technologies). Human MSCs 
(Lonza Biosciences), originally isolated from normal human bone marrow and demonstrated to 
be multipotent, were cultured in MSC growth medium (Lonza Biosciences). All cells were 
cultured at 37°C in 5% CO2 and 100% humidity. NHOst cells and MSCs were cultured on tissue 
culture polystyrene (TCPS) to facilitate determination of confluence. Test surfaces were Ti 
modSLA or TiZr modSLA. Cells were seeded on all groups at a density of 10,000 cells/cm2 in a 
96-well plate. After 24h, discs were transferred to a new 96-well plate with fresh medium and 
subsequently fed every 48h until confluence. 
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Cell Morphology 
MSCs or NHOst cells were plated on Ti modSLA or TiZr modSLA at a density of 5,000 
cells/cm2 in a 96-well plate and media were changed after 24h. Cells were cultured for 72h, 
washed in PBS, and then fixed in 3.7% paraformaldehyde. After a 10min fixation, surfaces were 
washed with PBS, and permeabilized with 0.05% Triton X-100 for 10min. Surfaces were washed 
again with PBS, and incubated in a staining solution consisting of 0.165 µM AlexaFluor 488 
phalloidin (Life Technologies) and 2 µg/mL Hoechst 33342 (Life Technologies) to visualize actin 
filaments and nucleic acids respectively. After staining, surfaces were mounted on glass cover 
slips using SlowFade (Life Technologies) and images were captured with a laser scanning 
microscope (Zeiss LSM 710, Carl Zeiss SMT Ltd., Cambridge, UK) at an excitation of 488nm for 
actin filaments and an excitation of 405nm for nucleic acids using a 40x objective. 
Biological Response 
At confluence, cells were incubated with fresh media for 24h. Media were collected and 
ELISAs used to measure levels of osteocalcin (Biomedical Technologies Inc., Stoughton, MA) 
osteoprotegerin (OPG, R&D Systems, Minneapolis, MN), vascular endothelial growth factor 
(VEGF, R&D Systems), bone morphogenetic protein-2 (BMP2, PeproTech, Rocky Hill, NJ), 
interleukin-6 (IL6, R&D Systems), and interleukin-10 (IL10, R&D Systems) following 
manufacturer’s instructions. Cells attached to surfaces were washed twice with 0.2ml PBS. 
Three discs were combined in 0.5ml of 0.05% TritonX-100 for each individual sample in a total 
sample size of six (n=6). Cells were lysed by sonication at amplitude 40 using an ultrasonicator 
(Vibra-Cell, Sonics, Newtown, CT). 
DNA content in the cell lysate was measured (QuantiFluor™ dsDNA system, Promega, 
Madison, WI) using a fluorescence detector (Synergy H1 Hybrid Reader, BioTek, Winooski, VT) 
at an excitation of 485nm and emission of 538nm. Immunoassay levels were normalized to DNA 
content. Cell lysate was also analyzed for alkaline phosphatase specific activity as the release 
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of p-nitrophenol from p-nitrophenylphosphate (Sigma-Aldrich, St. Louis, MO) at a pH of 10.25 
and a temperature of 37°C. Absorbance was measured at 405nm and alkaline phosphatase 
activity was quantified using a standard curve. Activity was normalized to total protein content in 
the cell lysates, as determined by bicinchoninic acid protein assay kit (Thermo Fisher Scientific). 
To quantify mRNA, cells were plated as described above. At confluence on TCPS, cells on 
all surfaces were incubated with fresh media for 12h. Samples were harvested using a TRIzol® 
(Invitrogen, Carlsbad, CA) extraction method. Six 5mm discs were combined in TRIzol® for each 
individual sample in a total sample size of six (n=6). RNA was quantified using a NanoDrop 
spectrophotometer (Thermo Fisher Scientific) and then reverse transcribed into 250 ng/µL 
cDNA. Real-time PCR was performed using a fluorescent dye (Power SYBR Green, Applied 
Biosystems, Foster City, CA) to quantify starting mRNA levels for integrin subunits alpha-1, 
alpha-2, alpha-5 and beta-1 (ITGA1, ITGA2, ITGA5, and ITGB1) and members of the bone 
morphogenetic protein (BMP) family: BMP4 and BMP7, BMP receptor-2 (BMPR2) and the BMP 
inhibitor Noggin (Nog). Levels of mRNA are normalized to glyceraldehyde phosphate 
dehydrogenase (GAPDH). Primer sequences are listed in Table 1. 
Statistical Analysis 
Surface characterization 
experiments and assessments 
of cell morphology were done 
using 3 discs per material. Data 
for surface analysis represent 3 
measurements per disc, 
resulting in an n=9 per variable. 
Data are presented as the 
mean ± standard error (SE). 
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For cell morphology, no quantitative analyses were performed. In vitro assays (n=6 cultures per 
variable) are presented as the mean ± SE. All cell culture experiments were repeated at least 
three times to ensure validity of the results. Data shown in the figures are from representative 
experiments. Expression of mRNAs for BMPs, receptors, inhibitors and integrins are 
represented as treatment over control using the fold increase of Ti modSLA and TiZr modSLA 
compared to TCPS as an internal control for the experiment. QQ-plots (not reported) showed 
the data were normally distributed, and the Brown-Forsythe test indicated the data were 
homoscedastic. A parametric one–way analysis of variance was performed with a Bonferroni 
post-hoc correction and α = 0.05 for the analysis of protein production. A Student’s t-test was 
used to compare gene expression on the two test surfaces using an alpha of 0.05. All statistical 
analyses were performed using JMP statistical software (SAS, Cary, NC). 
Results 
Material Characterization 
At low magnification, SEM images showed that the macroscale and microscale topography 
were similar for both surfaces (data not shown). However, SEM imaging at high magnification 
(Fig.3A, B, C) revealed larger and more exaggerated micro-scale surface features on Ti 
modSLA compared to TiZr modSLA (Fig.3D, E, F). Small, high density nanostructures were 
detected on Ti modSLA while large nanostructures at a lower density were observed on TiZr 
modSLA. Mean surface roughness (Sa) was greater on Ti modSLA compared to TiZr modSLA 
with no significant differences detected in mean peak-to-valley height (Sz) (Fig.3G). 
Morphometric analysis of the surface nanostructures (Fig.3H) reinforced the qualitative 
observations indicated by the SEM images. The mean nanostructure separation distance and 
nanostructure diameter were greater on TiZr modSLA when compared to Ti modSLA. 
XPS (Table 2) indicated similar oxygen and carbon levels between Ti modSLA and TiZr 
modSLA. Unalloyed Ti modSLA had only Ti while TiZr modSLA displayed appreciable 
Osseointegration in Metabolically Compromised Conditions • Spring 2019 
Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 37 
percentages of Ti and Zr. Contact angle measured 0° for both surfaces. 
 
Figure 3. Qualitative and quantitative characterization of the micro- and nano-scale parameters of the Ti modSLA 
and TiZr modSLA surfaces. SEM images of the Ti modSLA surface at 20Kx (A), 100Kx (B), and 200Kx (C). SEM 
images of the TiZr modSLA surface at 20Kx (D), 100Kx (E), and 200Kx (F). (G) Mean ± standard error (SE) of 
surface roughness (Sa) and peak-to-valley height (Sz). For each parameter, mean values of three measurements 
per three samples per modification are presented. (H) Mean ± standard error (SE) of nanostructure separation 
(peak-to-peak distance) and diameter associated with Ti modSLA and TiZr modSLA. For each parameter, 20 
measurements for three SEM images samples per modification are presented. 
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Cell Morphology 
Figure 4 shows MSCs and NHOst cells superimposed on the rough metallic surfaces of Ti 
modSLA or TiZr modSLA (actin – green, DNA – blue). Parallel striations of the actin filaments 
could be seen surrounding the nucleus of each cell. The nuclei and actin filaments around the 
nucleus were localized to area of the cell that did not overlay the valleys (dark regions) of the 
substrate. In contrast, distal actin filaments spanned valleys, and many appeared to associate 
with rough peaks (light areas) of the surface.  
Figure 4. Cell staining of MSCs (left) and NHOst cells (right) on Ti modSLA or TiZr modSLA 72h after 
cell seeding. Actin filaments are stained green and nucleic acids are stained blue. Each image was taken 
using a 40x objective. 
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Biological Response 
Cells grown on TiZr modSLA exhibited similar responses to those grown on Ti modSLA when 
compared to behavior on TCPS. DNA content was significantly lower on Ti modSLA and TiZr 
modSLA compared to TCPS for both MSCs (Fig.5A) and NHOst cells (Fig.5B), but DNA content 
of both MSC and NHOst cultures was greater on TiZr modSLA compared to Ti modSLA. Alkaline 
phosphatase specific activity was significantly higher on Ti modSLA and TiZr modSLA when 
compared to TCPS for both MSCs (Fig.5C) and NHOst cells (Fig.5D) (MSCs: Ti modSLA < TiZr 
modSLA; NHOst cells: Ti modSLA = TiZr modSLA). Production of osteocalcin (Fig.5E, F), 
osteoprotegerin (Fig.5G, H), VEGF (Fig.6A, B), and BMP2 (Fig.6C, D) was comparable in MSC 
and NHOst cultures grown on both Ti modSLA and TiZr modSLA and was greater than 
production on TCPS. IL6 production by MSCs (Fig.6E) and NHOst cells (Fig.6F) was 
significantly lower on Ti modSLA and TiZr modSLA compared to TCPS. No significant difference 
in MSC production of IL6 was detected between Ti modSLA and TiZr modSLA; however, IL6 
production by NHOst cells was significantly lower on TiZr modSLA compared to Ti modSLA. 
IL10 was produced in greater amounts by both MSCs (Fig.6G) and NHOst cells (Fig.6H) on Ti 
modSLA and TiZr modSLA compared to TCPS. MSCs produced less IL10 on TiZr modSLA 
compared to Ti modSLA, but no significant difference was detected in NHOst cell IL10 production 
on these surfaces. 
Compared to TCPS, significantly higher mRNA for BMP4, BMP7, BMPR2, and NOG were 
detected for MSCs and NHOst cells on Ti modSLA and TiZr modSLA (data not shown). There 
were some differences noted in gene expression in MSCs (Fig.7A) and NHOst cells (Fig.7B) 
grown on the test surfaces. BMP4 mRNA levels were higher for MSCs on TiZr modSLA 
compared to Ti modSLA; however, BMP4 mRNA levels were significantly lower for NHOSt cells 
on TiZr modSLA compared to Ti modSLA. No significant differences were detected in MSC or 
NHOst cell BMP7, BMPR2, and NOG expression for cells cultured on either Ti modSLA or TiZr 
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Figure 5. Effects of Ti modSLA and TiZr modSLA on the maturation of MSCs (left) and NHOst cells (right). MSCs 
and NHOst cells were plated separately on TCPS, Ti modSLA, or TiZr modSLA. At confluence on TCPS, cells 
were incubated in fresh media for 24h, collected, and measured for (A, B) DNA content, (C, D) alkaline 
phosphatase specific activity, (E, F) osteocalcin, and (G, H) osteoprotegerin. Data shown are the mean ± standard 
error (SE) of six independent samples. *p < 0.05 vs. TCPS; #p < 0.05 vs. Ti modSLA. 
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modSLA. mRNA levels of ITGα1, ITGα2, and ITGβ1 were significantly higher on Ti modSLA and 
TiZr modSLA compared to TCPS, while mRNA levels of ITGα5 were significantly lower for both 
MSCs and NHOst cells (data not shown). No significant differences in integrin expression were 
detected between MSCs plated on Ti modSLA or TiZr modSLA (Fig.8A); however, NHOst cell 
expression of ITGα2 was significantly lower on TiZr modSLA compared to Ti modSLA (Fig.8B). 
Discussion 
This study examined the response of cells involved in implant osseointegration of clinically 
available TiZr implant surfaces in order to assess whether there are differences with their 
response to commercially pure Ti surfaces processed in an identical manner. This is important 
because TiZr alloy provides the mechanical strength needed for small diameter implants that 
are designed for patients with limited mandibular bone dimensions,35 but less is known 
concerning the biological responses of osteoblast lineage cells to TiZr modSLA surfaces than is 
known concerning cell responses to Ti modSLA. Our results show that the surfaces are similar 
at the microscale but differ at the nanoscale. Cell number was higher on the hydrophilic TiZr 
surface than on hydrophilic cpTi, but osteoblastic differentiation of MSCs and osteoblastic 
maturation of NHOst cells were comparable. Moreover, production of factors that promote 
osteogenesis and vasculogenesis were comparable. MSCs and NHOst cells on both surfaces 
produced increased levels of the anti-inflammatory cytokine IL10 and reduced levels of the pro-
inflammatory cytokine IL6. While responses to both surfaces were similar, the expression of 
mRNAs for BMP4, BMP7, and the BMP-inhibitor Noggin differed between the two cell types. 
MSCs expressed higher levels of BMP4 whereas NHOst cells expressed higher BMP7. 
The morphology of the Ti modSLA and TiZr modSLA surfaces was not identical. Average 
roughness (Sa) of Ti modSLA was greater than was achieved on TiZr modSLA, although peak-
to-valley height (Sz) was identical. SEM revealed the formation of nanostructures on the Ti 
modSLA and TiZr modSLA surfaces similar to those described in previous studies.52,63 There 
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Figure 6. Effects of Ti modSLA and TiZr modSLA on the soluble factor production of MSCs (left) and NHOst cells 
(right). MSCs and NHOst cells were plated separately on TCPS, Ti modSLA, or TiZr modSLA. At confluence on 
TCPS, cells were incubated in fresh media for 24h, collected, and measured for (A, B) VEGF, (C, D) BMP2, (E, 
F) interleukin 6, and (G, H) interleukin 10. Data shown are the mean ± standard error (SE) of six independent 
samples. *p < 0.05 vs. TCPS; #p < 0.05 vs. Ti modSLA. 
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were distinct differences in the size and distribution of the nanostructures, with diameters and 
distances between nanostructures being greater on TiZr modSLA. 
The exact mechanism by which these nanostructures spontaneously generate is not known. 
Differences in the micro and nanoscale features of the Ti modSLA and TiZr modSLA surfaces 
following grit-blasting, acid-etching and storage in saline solution probably reflect differences in 
the Ti oxidation layer due to the underlying bulk material. The nanostructure is part of the oxide 
layer and grows as a result of the storage in saline solution (aqueous solution). The underlying 
bulk directly influences the oxide layer and thus the nanostructures depend on the bulk material. 
Wennerberg et al. speculated that the different corrosion properties and thus different diffusion 
energies/behavior are responsible for the 
differences in nanostructures.52 Furthermore, 
they suggest that the hydride layer resulting 
from acid-etching might act as nucleation 
centers. We did not examine the underlying 
mechanisms that resulted in the differences in 
nanostructures, but our data indicate that they 
contributed to the overall biological response of 
the MSCs and NHOst cells. That nanoscale 
features can impact cell response has been 
noted by us as well as others.51,142,152–154  
The surface energy of the two metals used 
in this study was indirectly measured using 
contact angle measurements to assess the 
surface hydrophilicity and XPS to determine the 
amount of surface carbon contamination. 
Figure 7. Effects of Ti modSLA and TiZr modSLA on 
BMP mRNA levels of (A) MSCs and (B) NHOst cells. 
MSCs and NHOst cells were plated separately on 
TCPS, Ti modSLA, or TiZr modSLA. At confluence on 
TCPS, cells were incubated in fresh media for 12h, 
collected, and measured mRNA levels of BMP4, 
BMP7, BMPR2, and NOG. Data is represented as fold 
change compared to TCPS. *p < 0.05 vs. Ti modSLA. 
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These measurements confirmed that the sand-blasting/acid-etching procedure with subsequent 
storage in saline solution induced a comparable surface energy between the two metals. In 
addition to detecting differences in bulk material using the presence or absence of zirconium, 
XPS showed increased oxygen and decreased carbon content and thus low level of carbon 
contamination. Contact angles measured 0°, demonstrating the surfaces of Ti modSLA and TiZr 
modSLA to be super-hydrophilic, consistent with the results of XPS and previous studies.52,71,155  
These results also suggest that the retention of a clean surface via prevention of hydrocarbon 
adsorption was a critical processing step. Variations in surface topography at the microscale and 
nanoscale can cause patterning of hydrophobic and hydrophilic regions,156 which can impact 
protein adsorption and ultimately integrin signaling. We did not compare dry microstructured Ti 
and TiZr to determine if such patterning had occurred, but our results indicate that the aqueous 
storage mitigated this occurring. Moreover, there were no visible differences in cell morphology 
or actin filament alignment to indicate a difference in attachment by either cell type on either 
surface. Our results indicate that both surfaces supported osteoblast differentiation of MSCs. 
The cells adopted a branched and elongated phenotype on the surface consistent with 
commitment to an osteogenic lineage rather than to adipogenic differentiation. As noted 
previously the cells tended to attach to the peaks via filopodia and suspend the cell body over 
valleys.157 
The qualitative capacity for Ti modSLA and TiZr modSLA to support a healthy osteoblastic 
phenotype is supported quantitatively using measurements of osteoblastic markers of 
differentiation and maturation. For both cell types, DNA content was decreased on both surfaces 
compared to TCPS, a trend described previously in studies comparing TCPS to Ti 
modSLA61,144,158 and TiZr modSLA.35 DNA content was greater on TiZr modSLA compared to Ti 
modSLA supporting the report that MC3T3-E1 osteoblasts exhibited greater attachment to a 
smooth TiZr (50% Zr) alloy compared to smooth cpTi.145 Together, these results suggest the 
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possibility that cells can attach or proliferate 
more readily on the surface of a TiZr alloy 
compared to cpTi. Overall, however, osteoblast 
differentiation on the two surfaces was 
comparable with respect to alkaline 
phosphatase specific activity and production of 
osteocalcin, osteoprotegerin, VEGF, and 
BMP2. Moreover, MSCs and NHOst cells 
exhibited comparable production of immune 
mediators on both surfaces. As noted 
previously for cells grown on Ti modSLA,158 
production of the pro-inflammatory cytokine IL6 
was reduced and production of the anti-
inflammatory cytokine IL10 was increased by 
cells grown on TiZr modSLA.  
Expression of genes encoding for additional 
osteoblastic proteins by MSCs and NHOst cells 
were similarly enhanced on Ti modSLA and TiZr modSLA. mRNA levels of BMPs (BMP4, 
BMP7), BMPR2 receptor, and NOG antagonist were increased to comparable levels by both cell 
types on modified surfaces compared to TCPS. Studies have demonstrated that BMPs are 
important factors for stimulating an osteogenic environment, which facilitates osteoblastic 
differentiation and maturation,159,160 and the signaling of BMPs is mediated by activation of their 
receptors and modulated by their antagonists. Promotion of the optimal osteogenic environment 
requires a delicate balance among these factors. As seen previously, the expression of BMP 
complexes was sensitive to microrough, nanostructured, and hydrophilic Ti;71,158 a result that 
Figure 8. Effects of Ti modSLA and TiZr modSLA on 
integrin mRNA levels of (A) MSCs and (B) NHOst 
cells. MSCs and NHOst cells were plated separately 
on TCPS, Ti modSLA, or TiZr modSLA. At confluence 
on TCPS, cells were incubated in fresh media for 12h, 
collected, and measured mRNA levels of ITGα1, 
ITGα2, ITGα5, and ITGβ1. Data is represented as fold 
change compared to TCPS. *p < 0.05 vs. Ti modSLA. 
Osseointegration in Metabolically Compromised Conditions • Spring 2019 
Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 46 
was not altered on TiZr modSLA. The small differences detected in BMP4 production were 
attributed to the intricate nature of the BMP system and do not reflect a preference toward either 
surface material.  
A similar result was also observed for the expression of integrin subunits. The α and β integrin 
subunit combinations determine which extracellular matrix proteins will be recognized by a cell, 
thus dictating cellular interactions with implanted materials by sending important information to 
the cell in order to maintain a healthy osteoblastic phenotype.161 Ti modSLA and TiZr modSLA 
were able to similarly enhance the expression of osteoblastic integrin subunits ITGα1, ITGα2, 
and ITGβ1 while decreasing the expression of ITGα5 by both MSCs and NHOst cells when 
compared to TCPS. Osteoblasts primarily express α5β1 when grown on TCPS but shift to the 
production of α1β1 and α2β1 when grown on rough Ti substrates.161 α2β1 is further increased 
on surfaces exhibiting high surface energy in the presence of nanostructures,155,161–163 a trend 
that remains consistent when the bulk material of the surface is altered. 
It is evident that MSC and NHOst osteoblastic differentiation and maturation have no 
significant preference to either Ti modSLA or TiZr modSLA, confirming the results observed both 
in vivo and clinically.146,149–151 Interestingly, this result was achieved despite differences in bulk 
material composition and surface roughnesses at both the micro- and nanoscale. This alludes 
to the possibility that a super-hydrophilic surface can conceal any modulatory effects the surface 
nanostructures may have had on the osteoblastic differentiation and maturation of MSCs and 
NHOst cells. Previous studies have reported the positive effects nanostructures have on 
osteoblastic differentiation and maturation over a range of varying morphologies.51,142,164 
However, these surfaces were not considered to be super-hydrophilic leaving unanswered 
questions regarding the degree to which a super-hydrophilic surface is able to overpower the 
effects of nanostructures. Because of the similar cellular response between the two materials it 
can be assumed that implants composed of either cpTi or 13 – 17% TiZr subjected to a similar 
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sandblasting and acid-etching procedure will achieve similar levels of osseointegration when 
used clinically. 
Overall, these results indicate that the in vitro outcomes observed with Ti modSLA, which 
have been shown to have a positive correlation with clinical outcomes,165 are also demonstrated 
in MSC and NHOst cells grown on TiZr modSLA. Many other cell types are involved in 
osseointegration and subsequent remodeling of the peri-implant bone, which were not examined 
in this study. Moreover, we used commercially available MSCs and NHOst cells, which were 
from single donors. Thus, our results do not consider variability inherent to the human population, 
or the health status of the donors themselves. Despite these caveats, our data support the 
hypothesis that osteoblastic differentiation and maturation in response to the modSLA surface 
contribute to the clinical performance of TiZr implants.146,148,166 
Conclusions 
Ti and TiZr were successfully modified to enhance surface hydrophilicity, create micro-
roughness, and induce nanostructure formation. The surfaces at the micron scale achieved by 
grit-blasting and acid-etching were similar and similar degrees of surface energy were obtained 
for both materials. Differences in bulk material led to variations in surface nanostructure 
morphology and density, osteoblastic differentiation and maturation of MSCs and NHOst cells 
were enhanced on both Ti modSLA and TiZr modSLA to a comparable extent. It can be indirectly 
concluded that the clinical use of 13 – 17% TiZr alloyed metals for dental implants will lead to a 
successful outcome comparable to those observed with cpTi. 
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Chapter 4. Osteogenic Response of Human MSCs and 
Osteoblasts to Hydrophilic and Hydrophobic 
Nanostructured Titanium Implant Surfaces 
Abstract 
Microstructured implant surfaces created by grit blasting and acid etching titanium (Ti) 
support osseointegration. This effect is further enhanced by storing in aqueous solution to retain 
hydrophilicity, but this also leads to surface nanostructure formation. The purpose of this study 
was to assess the contributions of nanostructures on the improved osteogenic response of 
osteoblast lineage cells to hydrophilic microstructured Ti. Human mesenchymal stem cells 
(MSCs) and normal human osteoblasts (NHOsts) were cultured separately on non-
nanostructured/hydrophobic (SLA), nanostructured/hydrophilic (modSLA), or 
nanostructured/hydrophobic (SLAnano) Ti surfaces. XPS showed elevated carbon levels on SLA 
and SLAnano compared to modSLA. Contact angle measurements indicated only modSLA was 
hydrophilic. Confocal laser microscopy revealed minor differences in mean surface roughness. 
SEM showed the presence of nanostructures on modSLA and SLAnano. MSCs and NHOst cells 
exhibited similar morphology on the substrates and osteoblastic differentiation and maturation 
were greatest on modSLA. These results suggest that when the appropriate microstructure is 
present, hydrophilicity may play a greater role in stimulating MSC and NHOst osteoblastic 
differentiation and maturation than the presence of nanostructures generated during storage in 
an aqueous environment. 
Introduction 
Successful dental implantation is measured by the degree of osseointegration between the 
surface of the implant material and bone tissue.167,168 Surface modifications altering implant 
topography140,169 and energy23,144 on titanium (Ti) and Ti-based alloys141,145 have been heavily 
emphasized in current research efforts in order to overcome problems associated with 
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osseointegration. Surface roughness at the micro-level enhances osteoblast differentiation and 
local factor production30,31,61,142,170,171 by mimicking resorption pit structural features172. 
Microscale and submicroscale features are sensed by osteoblast lineage cells via integrin alpha-
1,beta-1 (α1β1) and alpha-2,beta-1 (α2β1) signaling,155,157,161,173 leading to osteoblast 
differentiation of mesenchymal stem cells (MSCs) and maturation of committed osteoblasts 
(NHOst cells)173 and osteoblast-like MG63 cells.161 
Recent studies have suggested that nanostructured topography provides a surface structure 
much more analogous to that of natural bone.142,164,174–177 Nanoscale surface features mimic the 
extracellular matrix with which cells normally interact, thereby influencing the type, quantity, and 
adsorbed protein conformation, integrin signaling, and signaling pathways that work together to 
control cellular adhesion, proliferation, and differentiation.178 However, many studies examining 
the role of nanotopography have used patterned tissue culture polystyrene (TCPS) as the 
substrate,154,179,180 which is very different from materials used clinically such as Ti. Thus, it is 
difficult to extrapolate the reported findings to implant surface effects. 
Hydrophilic (high energy) implant surfaces have also been shown to improve clinical 
outcomes,23,144 particularly when the surface is microtextured.155 Recently it was shown that 
when grit blasted/acid etched Ti implants were stored in water or saline to retain their hydrophilic 
surface post-processing, nanostructures formed on the surface due to reorganization of the 
outermost oxide layer.52 It is not clear what contribution the nanostructures make to the improved 
osseointegration seen with hydrophilic, microtextured Ti implants.181 Nonetheless, many studies 
have suggested the importance of a nanostructured surface for facilitating osteoblast 
differentiation and maturation in vitro.51,61,182 Furthermore, an in vivo rabbit study by Wennerberg 
et al., which used disc implants, suggests that the presence of nanostructures is beneficial for 
new bone formation.183 
The hypothesis of the present study is that nanostructures generated by storage in saline will 
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impact the overall biological response to hydrophilic, microstructured Ti. To do this, we cultured 
human MSCs and NHOst cells on Ti surfaces that were fabricated using the same methods 
employed for production of commercially available implants. Ti discs were grit blasted and acid 
etched, then stored in air (SLA); grit blasted, acid etched, and stored in saline (modSLA); or grit 
blasted, acid etched, stored in saline to generate nanostructures, then dried and stored in air 
(SLAnano). This experimental design enabled comparison of hydrophilicity + nanostructures; 
hydrophobicity + nanostructures; and hydrophobicity without nanostructures. 
Materials and Methods 
Ti Disc Preparation 
5 mm diameter and 1 mm thick discs were fabricated from Grade 4 Ti and subjected to one 
of the following modifications. 
SLA 
Sand-blasted with large grit particulate (250 – 500 µm corundum) followed by acid etching in 
a boiling mixture of HCl and H2SO4. Discs were cleaned in HNO3, rinsed in ultrapure water, 
packed in aluminum foil, and γ-irradiated before use. 
modSLA 
Same initial sandblasting and acid etching procedure as used for SLA samples, but 
subsequent steps took place under nitrogen to prevent exposure to air. The discs were rinsed, 
stored in 0.9% NaCl solution, and γ-irradiated before use. 
SLAnano 
modSLA samples that were removed from 0.9% NaCl solution after aging 5 weeks, a 
procedure outlined by Wennerberg et al. Once removed from solution, samples were rinsed in 
ultrapure water, packed in aluminum foil, and γ-irradiated before use. 
Surface Characterization 
Scanning Electron Microscopy (SEM)  
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Surface topography was qualitatively evaluated using SEM (Ultra60 FE-SEM, Zeiss). Six 
images at varying magnifications were captured on each of n=3 discs per surface modification 
using 5 kV accelerating voltage for a total of 18 images per modification. 
X-ray Photoelectron Spectroscopy (XPS) 
Chemical composition of the samples (n=3) was obtained from the sample surfaces by XPS 
(Thermo K-Alpha XPS, Thermo Fisher Scientific). Spectra were collected using a 400 µm X-ray 
spot size at three different locations on each individual sample. 
Contact Angle Measurement 
Measurements were obtained using a goniometer (CAM 250, Ramé-Hart). Samples (n=3) 
were measured in three different locations and dried with nitrogen between each measurement. 
A drop volume of 2 µL was used per individual measurement and a contact angle was calculated 
every 5 seconds for 20 seconds. The four measurements were then averaged together to obtain 
one of the three measurements per disc. 
Confocal Laser Microscopy (CLM) 
Surface roughness of the samples (n=3) was evaluated using a confocal laser microscope 
(Lext, Olympus). Three measurements per sample were taken over an area of 644 µm x 644 µm 
with a 20x objective and a scanning pitch of 50 nm. A cutoff wavelength of 100 µm was used 
when calculating surface roughness (Sa) and peak-to-valley height (Sz). 
Cell Culture 
Human MSCs (Lonza Biosciences, Walkersville, MD) were cultured in MSC growth medium 
(MSCGM; Lonza Biosciences). NHOst cells (Lonza Biosciences) were cultured using Dulbecco’s 
modified Eagle medium (DMEM CellGro®; Mediatech, Inc., VA) supplemented with 10% fetal 
bovine serum (FBS, Life Technologies, Carlsbad, CA) and 1% penicillin-streptomycin (Life 
Technologies). All cells were 4th passage and cultured at 37°C in 5% CO2 and 100% humidity. 
MSCs and NHOsts were cultured on unmodified/non-patterned tissue culture polystyrene 
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(TCPS), SLA, SLAnano, or modSLA at a density of 10,000 cells/cm2 in a 96-well plate. After 24 
h, discs were transferred to a new 96-well plate with fresh medium and subsequently fed every 
48 h until confluence. 
Cell Morphology 
MSCs and NHOst cells were plated on SLA, SLAnano, or modSLA at a density of 5,000 
cells/cm2 in a 96-well plate and media were changed after 24 h. Cells were cultured for 72 h, 
washed in PBS, and then fixed in 3.7% paraformaldehyde. After a 10 min fixation, surfaces were 
washed with PBS, and permeabilized with 0.05% Triton X-100 for 10 min. Surfaces were washed 
again with PBS, and incubated in a staining solution consisting of 0.165 µM AlexaFluor 488 
phalloidin (Life Technologies) and 2 µg/mL Hoechst 33342 (Life Technologies) to visualize actin 
filaments and nucleic acids respectively. After staining, surfaces were mounted on glass cover 
slips using SlowFade (Life Technologies) and images were captured with a Laser Scanning 
Microscope (Zeiss LSM 710, Carl Zeiss SMT Ltd., Cambridge, UK) at an excitation of 488 nm 
for actin filaments and an excitation of 405 nm for nucleic acids using a 40x objective. 
Biological Response 
At confluence, cells were incubated with fresh media for 24 h. Media were collected and 
ELISAs were used to measure levels of osteocalcin (Biomedical Technologies Inc., Stoughton, 
MA), osteoprotegerin (R&D Systems, Minneapolis, MN), vascular endothelial growth factor-A 
(VEGF, R&D Systems), bone morphogenetic protein-2 (BMP2, PeproTech, Rocky Hill, NJ), 
interleukin 6 (IL6, R&D Systems), and interleukin 10 (IL10, R&D Systems) following 
manufacturer’s instructions. Cells attached to surfaces were washed twice with 0.2 ml PBS. 
Three 5 mm discs were combined in 0.5 ml of 0.05% TritonX-100 for each individual sample in 
a total sample size of six (n=6). Cells were lysed by sonication at amplitude 40 using an 
ultrasonicator (Vibra-Cell, Sonics, Newtown, CT). 
DNA content in the cell lysate was measured (QuantiFluor™ dsDNA system, Promega, 
Osseointegration in Metabolically Compromised Conditions • Spring 2019 
Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 53 
Madison, WI) using a fluorescence detector (Synergy H1 Hybrid Reader, BioTek, Winooski, VT) 
at an excitation of 485 nm and emission of 538 nm. Immunoassay levels were normalized to 
DNA content. Cell lysate was also analyzed for alkaline phosphatase specific activity as the 
release of p-nitrophenol from p-nitrophenylphosphate (Sigma-Aldrich, St. Louis, MO) at a pH of 
10.25 and a temperature of 37°C. Absorbance was measured at 405 nm and alkaline 
phosphatase activity was quantified using a standard curve. Activity was normalized to total 
protein content in the cell lysates, as determined by bicinchoninic acid protein assay kit (Thermo 
Fisher Scientific). 
To quantify mRNA, cells were plated as described above. At confluence on TCPS, cells were 
incubated with fresh media for 12 h. Samples were harvested using a TRIzol® (Invitrogen, 
Carlsbad, California) extraction method. Six 5 mm discs were combined in TRIzol® for each 
individual sample in a total sample size of six (n=6). RNA was quantified using a NanoDrop 
spectrophotometer (Thermo Fisher Scientific) and then reverse transcribed into 250 ng/µL 
cDNA. Real-time PCR was performed using a fluorescent dye (Power SYBR Green, Applied 
Biosystems, Foster City, CA) and StepOnePlus™ Real-Time PCR system (Applied Biosystems) 
to quantify starting mRNA levels using gene specific primers (Table 1). Specific genes were 
amplified for 40 cycles and levels of mRNA were normalized to GAPDH. 
Statistical Analysis 
Data from surface characterization experiments are presented as the mean ± standard error 
(SE). Data for surface analyses represent 3 measurements per disc, resulting in an n=9 per 
variable. For cell morphology, no quantitative analyses were performed. All cell culture 
experiments had an N=6 independent cultures for each variable. Experiments were repeated at 
least three times to ensure validity of the results. Data from individual experiments were not 
combined and data shown in the figures are from representative experiments. A one–way 
analysis of variance was performed followed by a Bonferroni correction to maintain an 
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experiment-wise error rate (α) of 0.05. All statistical analyses were performed using JMP 
statistical software. 
Results 
Material Characterization 
Low magnification SEM imaging (Fig.9A – C) revealed a similar topography among SLA, 
SLAnano, and modSLA. Confocal microscopy confirmed these qualitative observations (Fig.9G 
– I), resulting in no significant differences among the mean surface roughness’s (Sa) or the mean 
peak-to-valley height (Sz) of the SLA (Sa = 1.65 ± 0.01 µm; Sz = 23.17 ± 0.82 µm), SLAnano (Sa 
= 1.79 ± 0.03 µm; Sz = 25.55 1 ± 0.80 µm), and modSLA (Sa = 1.74 ± 0.01 µm; Sz = 21.88 ± 0.51 
µm). At a higher SEM magnification, no nanostructures were observed on SLA (Fig.9D) while 
similar needle-like nanostructures were observed on SLAnano (Fig.9E) and modSLA (Fig.9F). 
Using ImageJ software (National Institutes of Health, USA), a morphometric analysis was 
conducted by superimposing a grid composed of 20 evenly spaced squares arranged into a 4x5 
matrix onto the highest magnification SEM images. The diameter and peak distance to its closest 
neighbor were obtained for the centermost nanostructure within each square for a total of 60 
measurements per material. Differences between SLAnano and modSLA mean nanostructure 
diameter (11.44 ± 0.38 nm; 10.21 ± 0.34 nm, respectively) and mean nanostructure separation 
(18.87 ± 0.7 nm; 12.95 ± 0.5 nm, respectively) were observed.  
XPS survey spectra displayed titanium (Ti), oxygen (O), and carbon (C) as the main atomic 
components of the SLA, SLAnano, and modSLA surfaces (Fig.9J – L). The chemical 
composition was almost identical between SLA and SLAnano with spectral analyses indicating 
a high presence of Ti, O, and C. The spectral analysis for modSLA revealed a lower quantity of 
C compared to that detected on SLA and SLAnano. Measured contact angles are also shown in 
Figure 9. SLA (Fig.9M) and SLAnano (Fig.9N) had hydrophobic surfaces with contact angles 
of 126 ± 4° and 132 ± 4° respectively while modSLA (Fig.9O) had a hydrophilic surface with 0°  
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contact angle. 
 
Figure 9. Material characterization of the non-nanostructured/hydrophobic SLA, 
nanostructured/hydrophobic SLAnano, and nanostructured/hydrophilic modSLA surface 
modifications. Substrates were examined by scanning electron microscopy at 20Kx (A – C) and 
200Kx (D – F). Surface roughness and morphology were assessed using laser confocal microscopy 
measured using a 644 µm x 644 µm scan size. Topographical images shown were taken with a 60 
µm x 60 µm to exaggerate surface features (G – I). Surface chemical composition was assessed 
using XPS with spectra of O, Ti, and C shown (J – L). Surface energy was assessed using contact 
angle measurements (M – O). 
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Cell Morphology 
Figure 10 shows both the stained components of the MSCs and NHOst cells superimposed 
with the rough metallic surfaces of the SLA, SLAnano, and modSLA (actin – green; DNA – blue). 
Striations of the actin filaments and the nucleus can be visualized in each of the images. The 
actin filaments in both cell types adopted a parallel orientation that did not exhibit a preference 
for any particular structure. Nuclei and the immediate surrounding actin filaments mostly avoid 
the valleys (dark areas) of the rough surfaces; however, the more distal actin filaments can be 
seen spanning valleys. MSCs and NHOst cells cultured on TCPS exhibited morphologies 
comparable to those reported in the literature for non-patterned TCPS. 
Biological Response 
DNA content was significantly lower on SLA, SLAnano, and modSLA compared to TCPS for 
both MSCs (Fig.11A) and NHOst cells (Fig.11E) with modSLA exhibiting significantly lower DNA 
Figure 10. Cell staining of MSCs (A – C) and NHOst cells (D – F) on SLA, SLAnano, or modSLA 72 h after cell 
seeding. Actin filaments are stained green and nucleic acids are stained blue. Each image was taken using a 40x 
objective. 
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compared to SLA and SLAnano. Compared to TCPS, MSCs and NHOst cells cultured on SLA, 
SLAnano, and modSLA had significantly higher alkaline phosphatase specific activities 
(Fig.11B, F) and production of osteocalcin (Fig.11C, G) and osteoprotegerin (Fig.11D, H). 
Alkaline phosphatase specific activity in the MSC cultures was comparable on the modified 
surfaces. MSCs cultured on modSLA produced significantly higher osteocalcin and 
osteoprotegerin compared to SLA and SLAnano with SLAnano producing significantly lower 
osteocalcin compared to SLA. Alkaline phosphatase specific activity and osteocalcin production 
by NHOst cells were significantly higher compared to SLA and SLAnano with significantly lower 
alkaline phosphatase specific activity detected on SLAnano compared to SLA. No significant 
differences in NHOst osteoprotegerin production were detected between modSLA and SLA; 
however, production on both was significantly greater compared to SLAnano. 
MSCs and NHOst cells cultured on modified surfaces produced significantly higher quantities 
of VEGF (Fig.12A, E), BMP2 (Fig.12B, F), and the anti-inflammatory cytokine IL10 (Fig.12C, 
G) compared to those cultured on TCPS. The opposite effect was observed for the production 
of the pro-inflammatory cytokine IL6 (Fig.12D, H) where significantly lower quantities were 
detected on modified surfaces compared to TCPS. VEGF, BMP2, and IL10 production by MSCs 
was significantly greater on modSLA compared to SLA and SLAnano with a significantly lower 
production detected on SLAnano compared to SLA. No significant differences were detected in 
NHOst VEGF production among modified surface. NHOst cells cultured on SLAnano produced 
significantly lower quantities of BMP2 compared to SLA and modSLA which were not 
significantly different from each other. IL10 production by NHOst cells was significantly higher 
on modSLA compared to SLA and SLAnano with a significantly lower production detected on 
SLAnano compared to SLA. Both MSCs and NHOst cells cultured on modSLA exhibited 
significantly lower productions of IL6 compared to SLA and SLAnano. No significant differences 
were detected between MSC IL6 production between SLA and SLAnano while NHOsts produced 
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a significantly lower amount of IL6 on SLAnano compared to SLA. 
  
Figure 11. Effects of surface nanoscale features and energy on the maturation of MSCs (A – D) 
and NHOst cells (E – H). MSCs and NHOst cells were plated separately on TCPS, SLA, SLAnano, 
or modSLA grown to confluence. At confluence, cells were incubated in fresh media for 24 h, 
collected, and measured for (A, E) DNA content, (B, F) alkaline phosphatase specific activity, (C, 
G) osteocalcin, and (D, H) osteoprotegerin. Data shown are the mean ± standard error (SE) of six 
independent samples. *p < 0.05 vs. TCPS; #p < 0.05 vs. SLA; $p < 0.05 vs. SLAnano. 
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BMPs, receptor, and antagonist expression are shown in Figure 13. Compared to TCPS, 
significantly higher mRNA expressions of BMP4, BMP7, BMPR1A, and NOG were detected for 
MSCs (Fig.13A – D) and NHOst cells (Fig.13E – H) on SLA, SLAnano, and modSLA. MSCs 
cultured on modSLA had significantly higher expressions of each gene with significantly lower 
BMP4 and NOG expressions detected on SLAnano compared to SLA. NHOst cells cultured on 
modSLA exhibited significantly higher expressions of BMP4, BMP7, and NOG compared to SLA 
and SLAnano. SLAnano significantly upregulated NHOst BMPR1A expression compared to SLA 
and modSLA. NHOst NOG expression was significantly greater on SLAnano compared to SLA. 
mRNA levels of ITGα1 (Fig.14A, E), ITGα2 (Fig.14B, F) and ITGβ1 (Fig.14D, H) were 
significantly higher on modified surfaces compared to TCPS for both cell types. Additionally, 
MSC and NHOst ITGα5 (Fig.14C, G) expression was significantly lower on modified surfaces 
compared to TCPS except for MSCs cultured on SLAnano which was significantly greater. MSCs 
cultured on modSLA exhibited significantly higher mRNA levels of ITGα1, ITGα2, and ITGβ1 
compared to SLA and SLAnano with significantly lower mRNA levels of ITGα1 and ITGβ1 on 
SLAnano compared to SLA. No significant difference was detected in MSC ITGα2 mRNA levels 
between SLA and SLAnano. Among modified surfaces, NHOst expression of ITGα1 was not 
significantly different. NHOst cells cultured on modSLA had significantly higher ITGα2 and ITGβ1 
mRNA levels compared to SLA and SLAnano. MSCs and NHOst cells cultured on SLAnano 
exhibited significantly higher ITGα5 expression compared to SLA and modSLA. No significant 
differences were detected between SLA and modSLA MSC ITGα5 expression while NHOst 
ITGα5 expression was significantly lower on modSLA compared to SLA.  
Discussion  
Implant surface properties dictate the resulting molecular events that take place at the cell-
material interface. Studies have highlighted the importance of surface properties such as 
roughness, topography, chemistry, and energy in the modulation of cell proliferation and 
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Figure 12. Effects of surface nanoscale features and energy on the soluble factor production of MSCs (A – D) 
and NHOst cells (E – H). MSCs and NHOst cells were plated separately on TCPS, SLA, SLAnano, or modSLA 
grown to confluence. At confluence, cells were incubated in fresh media for 24 h, collected, and measured for (A, 
E) VEGF, (B, F) BMP2, (C, G) interleukin 10, and (D, H) interleukin 6. Data shown are the mean ± standard error 
(SE) of six independent samples. *p < 0.05 vs. TCPS; #p < 0.05 vs. SLA; $p < 0.05 vs. SLAnano. 
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differentiation.23,61,140–142,144,145,167–170 In the present study, Ti metal was treated to exhibit either 
a hydrophilic or hydrophobic nanostructured surface in order to distinguish between the effects 
these parameters have on osteogenic responses of MSCs and NHOst cells. Using a 
hydrophobic, non-nanostructured surface (SLA) as a control, cells at two different stages in the 
osteoblast lineage were grown separately to confluence on the modified surfaces. Subsequent 
examination of mRNA expression and protein production showed that a hydrophilic 
nanostructured surface facilitated the greatest increase in osteogenic markers. Interestingly, our 
data suggest that a hydrophobic nanostructured surface may stunt or delay the osteogenic 
capacity of MSC and NHOst cells compared to a hydrophobic non-nanostructured surface.  
Although many other cell types are involved in osseointegration and the subsequent 
remodeling of peri-implant bone, MSCs and NHOst cells are critical for the process of bone 
mineralization. We used commercially available MSCs and NHOst cells from single donors, 
which limits the scope of our results since it does not consider variability inherent to the human 
population, or the health of the donors themselves. Despite these limitations, our results indicate 
that the positive osteogenic effects nanostructures have on MSC and NHOst cells are dependent 
on the inclusion of hydrophilicity.  
Scanning electron microscopy confirmed the presence or absence of nanostructures on the 
modified Ti surfaces. In accordance with previous studies, sand blasting and acid etching 
techniques generated submicron scale roughness but did not induce nanostructure 
formation.52,63 Instead, nanostructure formation was dependent upon the reorganization of the 
oxide layer facilitated by the aqueous NaCl solution. Consistent with this idea, nanostructures 
with a similar size were present on SLAnano and modSLA but not SLA. The exact process of 
nanostructure formation is unknown; however, many studies have fabricated nanostructures on 
metallic surfaces using a variety of methods involving changes in temperature, pressure, and 
chemical treatments. The modification process used in this study also provided a consistent
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Figure 13. Effects of surface nanoscale features and energy on BMP mRNA levels of MSCs and NHOst cells. 
MSCs and NHOst cells were plated separately on TCPS, SLA, SLAnano, or modSLA grown to confluence. At 
confluence, cells were incubated in fresh media for 12 h, collected, and measured mRNA levels of BMP4, BMP7, 
BMPR1A, and NOG. *p < 0.05 vs. TCPS; #p < 0.05 vs. SLA; $p < 0.05 vs. SLAnano. 
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micro-roughness among SLA, SLAnano, and modSLA, allowing for an accurate separation 
between the effects of the nanostructures and the surface hydrophilicity. 
The hydrophilicity of the surfaces was validated using x-ray photoelectron spectroscopy and 
contact angle measurements. The XPS spectra revealed that the thin Ti oxide layer consists 
mainly of TiO2. Additionally, the presence of C(1s) is indicative of aliphatic carbons due to the 
adsorption of carbon-containing molecules from the air.71 Exposure to air increased the value of 
the peak corresponding to the presence of C(1s) carbon which was detected on SLA and 
SLAnano surfaces similar to previous studies.52,71 Immediate storage in saline without any 
exposure to air was an effective method for preventing organic impurity deposition resulting in a 
very low C(1s) peak on the surface of modSLA.52,71,184 Consistent with the XPS results, contact 
angle measurements demonstrated SLA and SLAnano to be hydrophobic and modSLA to be 
super-hydrophilic. 
Cytoskeleton staining revealed that SLA, SLAnano, and modSLA surfaces were able to 
support a normal osteoblastic morphology as demonstrated by the clear, branched morphology 
adopted by MSCs185 and NHOst cells.186 Cytoskeleton organization of the cell is essential for 
focal adhesion, stress fiber formation, and spreading, and is dependent on the spatial distribution 
of both micro- and nanostructured topographies.164,187 Cell morphology influences gene 
expression,188 and MSC differentiation relies in part on extracellular mechanical cues inherent 
to the underlying structure of the cytoskeleton.185 It has been shown previously that MSC 
adipogenesis is preceded by round cell morphology while MSC osteoblastogenesis is preceded 
by a branched cell morphology when cultured on titanium substrates.185 The branched 
morphology displayed by MSCs undergoing osteoblastogenesis is like that observed in mature 
osteoblasts grown on titanium substrates.186 Moreover, the production and expression of 
osteoblastic markers further support enhanced osteoblastogenesis on the SLA, SLAnano, and 
modSLA.  
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Figure 14. Effects of surface nanoscale features and energy on integrin mRNA levels of MSCs and NHOst cells. 
MSCs and NHOst cells were plated separately on TCPS, SLA, SLAnano, or modSLA grown to confluence. At 
confluence, cells were incubated in fresh media for 12 h, collected, and measured mRNA levels of ITGα1, ITGα2, 
ITGα5, and ITGβ1. *p < 0.05 vs. TCPS; #p < 0.05 vs. SLA; $p < 0.05 vs. SLAnano. 
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A decrease in DNA compared to TCPS was accompanied by an increase of osteoblastic 
markers of differentiation and maturation on SLA, SLAnano, and modSLA for both cell types. 
Previous studies have shown that MSCs and NHOst cells grown on microstructured Ti surfaces 
produce an osteogenic environment facilitating their differentiation and maturation with the 
highest being produced on modSLA followed by SLA.70,158 These include the early marker of 
osteoblastic differentiation, alkaline phosphatase specific activity; the late marker of osteoblastic 
differentiation, osteocalcin; the osteoclast inhibitory factor, osteoprotegerin; the angiogenic 
factor, VEGF; and the osteogenic factor, BMP2. Additionally, modified surfaces had the ability 
to mitigate the inflammatory response compared to TCPS as indicated by the increased 
production of the anti-inflammatory cytokine interleukin 10 (IL10) and the decreased production 
of the pro-inflammatory cytokine interleukin 6 (IL6) in accordance with previous reports.158 
Interestingly, the inflammatory response was highest on SLAnano among modified surfaces. 
Additionally, MSC osteocalcin, VEGF, BMP2, and NHOst alkaline phosphatase specific activity, 
osteoprotegerin, and BMP2 on SLAnano were lowest among modified surfaces. Although each 
modification was able to support a healthy osteoblastic phenotype, it was frequently observed 
that SLAnano had a comparatively diminished capacity to enhance production of osteoblastic 
markers. 
MSC and NHOst gene expression was less upregulated by SLAnano compared to SLA and 
modSLA. In general, for both cell types, the expression of BMPs (BMP4, BMP7), receptors 
(BMPR1A), and antagonists (NOG) was highest on modSLA followed by SLA as seen 
previously.61,71,158 Additionally, both cell types primarily expressed α5β1 subunits when grown 
on TCPS but shifted to the production of α1β1 and α2β1 subunits when grown on rough titanium 
substrates. A further increase was observed for α2β1 subunits on hydrophilic and 
nanostructured substrates as previously described.161–163 However, removal of the hydrophilicity 
while retaining nanostructures resulted in fluctuations in osteoblastic gene expression. MSC 
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expression of BMP4, its receptor BMPR1A,189 and its specific antagonist NOG159,190 decreased 
on SLAnano suggesting a lessened capacity to stimulate an osteogenic environment by 
nanostructures in the absence of hydrophilicity. SLAnano also altered the expression of BMP 
complexes in NHOst cells. NOG expression was increased compared to SLA without a similar 
increase in BMP4; furthermore, BMPR1A expression was highest on SLAnano.  
Alterations in the balance of BMPs, their receptors, and antagonist results in altered bone 
remodeling, a potential outcome indicated by the in vitro gene expression modulated by 
SLAnano. Integrins are also important for both cell attachment and maintenance of the 
osteoblastic phenotype, and an altered expression of integrin subunits was observed on 
SLAnano. Although pro-osteoblastic integrin subunits increased on SLAnano, α1 and β1 were 
decreased compared to SLA. Moreover, an increase of the non-osteoblastic subunit α5 was 
observed for both MSCs and NHOst cells cultured on SLAnano with its expression being greater 
than TCPS. Together, the expression of BMP and integrin complexes suggests that the bone 
remodeling process is somewhat diminished on a hydrophobic and nanostructured surface. 
However, this is capable of being recovered with the addition of surface hydrophilicity. 
Previous studies analyzing the biological response to a hydrophobic and nanostructured 
surface determined favorable effects of nanostructures on osteoblastic differentiation and 
maturation. This contrasts with other studies comparing SLA to a hydrophobic, nanostructured 
surface.191 Using thermally nanomodified hydrophobic Ti (NMSLA) and Ti-6Al-4V alloy surfaces, 
it was shown that the osteoblastic differentiation of MG63 cells was enhanced compared to a 
microrough and hydrophobic SLA. Interestingly, human MSC response to the NMSLA 
modification suggested that differentiation was suppressed by the superposition of 
nanostructures.191 In these studies, nanostructures were classified as submicron, reporting a 
size range from 40 to 200 nm, while the nanostructure size range produced on surfaces used in 
this study was between 10 and 11 nm. It is possible that osteoblastic differentiation and 
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maturation can be altered by varying the size and shape of the nanostructures, an idea 
previously suggested.164 
Our results may be partially explained by a recent study investigating the influence of 
nanostructures and hydrophilic Ti substrates on fibrinogen and fibronectin protein adsorption 
and the degree of blood coagulation.192 It was shown that a hydrophilic and nanostructured 
surface led to the highest protein adsorption levels and the most pronounced degree of blood 
coagulation whereas the effects of a hydrophobic nanostructured surface on these outcomes 
were weak.192 This suggests that the effects the surface parameters have on early protein 
adsorption may dictate the rate of MSC osteoblastic differentiation or NHOst maturation. The 
effect of the nanostructures can be recovered and improved through the addition of the 
hydrophilicity providing the optimum conditions of osteoblastic differentiation and maturation. 
Conclusions 
Clinical grade Ti was successfully modified to fabricate microrough surfaces exhibiting 
hydrophobic or hydrophilic nanostructured surfaces. Although modified surfaces were able to 
support osteoblastic morphology in MSCs, indicated by staining of the cytoskeleton, production 
and expression of markers of osteoblastic differentiation and maturation suggest that an average 
nanostructure size of approximately 11 nm may delay the process of osteoblastogenesis. The 
effect of the nanostructures can be recovered with the addition of hydrophilicity. In order to 
promote enhanced osteoblastic differentiation of MSCs and maturation of NHOst cells, a 
nanostructured Ti surface will be dependent on an increased surface hydrophilicity. 
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Chapter 5. Regulation of Osteoclasts by Osteoblast 
Lineage Cells Depends on Titanium Implant Surface 
Properties 
Abstract 
A critical stage during osseointegration of a titanium (Ti) implant is primary bone remodeling, 
which involves cross talk among osteoclast precursors, osteoclasts, mesenchymal stem cells 
(MSCs), and osteoblasts. This phase couples the processes of bone formation and resorption. 
During remodeling, osteoclasts produce factors capable of regulating MSC migration and 
osteogenesis. Furthermore, they degrade primary bone, creating a foundation with a specific 
chemistry, stiffness, and morphology for osteoblasts to synthesize and calcify their matrix. MSCs 
and osteoblasts receiving cues from the implant surface produce factors capable of regulating 
osteoclasts in order to promote net new bone formation. The purpose of this study was to 
determine the effects Ti implant surfaces have on bone remodeling. Human MSCs and normal 
human osteoblasts (NHOsts) were cultured separately on 15mm grade 2 smooth PT, 
hydrophobic-microrough SLA, hydrophilic-microrough Ti (mSLA) (Institut Straumann AG, Basel, 
Switzerland), or tissue culture polystyrene (TCPS). After 7d, conditioned media from surface 
cultures were used to treat human osteoclasts for 2d. Activity was measured by fluorescence of 
released collagen followed by mRNA quantification. This study demonstrates that MSC and 
NHOst cultures can suppress osteoclast activity in a surface dependent manner and osteoclast 
mRNA levels are selectively regulated by surface treatments. The substrate-dependent 
regulatory effect was mitigated when MSCs were silenced for integrin subunits and when 
conditioned media were denatured. These results indicate that MSCs and NHOsts regulate at 
least two aspects of remodeling: reduced fusion of new osteoclasts and reduced activity of 
existing osteoclasts. 
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Introduction 
Osseointegration is a complex cascade of biological events responsible for providing a direct 
structural and functional connection between the surface of a load-bearing implant and living 
bone. Greater bone apposition to implant materials results in functional stability, reducing the 
risk of failure while maintaining implant longevity. In addition to various intrinsic factors that 
enhance or inhibit osseointegration, the implant surface directly contacts the biological tissues 
and influences the outcome. 
Titanium (Ti) and its alloys are choice materials for both dental and orthopaedic implants 
because of their ability to form a passive oxide layer bestowing high biocompatibility and 
corrosion resistance.121 Because of its stability in biological systems, Ti has been used 
extensively to investigate the process of osseous wound healing and osseointegration. Our 
previous studies have identified several important surface characteristics including 
microroughness, hydrophilicity, and chemistry that stimulate osteogenesis, resulting in 
enhanced osseointegration. When grown on Ti surfaces that are microstructured and 
hydrophilic, mesenchymal stem cells (MSCs) and osteoblasts (OBs) produce factors that create 
an osteogenic environment by stimulating osteoblastic differentiation in progenitor cells distal to 
the implant; promoting vasculogenesis; reducing inflammation; and regulating osteoclastic 
resorption to achieve net new bone formation.61,70,71,80,161,193 
Much of the research regarding osseointegration revolves around bone-forming OBs and 
MSCs due in part to the necessity to achieve net new bone formation. Materials that do not 
promote osteogenesis, such as polymers like polyether-ether-ketone, result in a fibrous 
connective tissue interface.194 Although implant materials should actively promote bone 
formation, long-term stability requires solutions that not only result in net new primary bone 
formation but also provide continued osteogenic signals to maintain healthy bone remodeling. 
Bone-resorbing osteoclasts (OCs) are present during peri-implant healing, significantly 
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influencing implant outcomes by playing an important role during the initial and late phases of 
osseointegration.195 Bone is continuously remodeled through a finely balanced equilibrium of 
cell mediated extracellular matrix (ECM) degradation and formation. Bone remodeling is a 
versatile and ubiquitous process providing the mechanism for adaptation to mechanical stress, 
repair of micro-damage, and replacement of primary bone during osseointegration of implanted 
materials.32 Because it can occur in separate areas asynchronously, locally generated regulatory 
factors and environmental cues ensure the appropriate balance among OCs, OBs, and their 
precursors. Although it seems counterintuitive, implant materials for dental and orthopaedic 
applications should not inhibit OC-mediated bone resorption to promote net new bone formation, 
but instead promote a healthy communication among these cells to achieve osseointegration 
and maintain its longevity. 
Achieving implant stability is critical for successful osseointegration; however, insertion of a 
dental or orthopaedic implant influences the nature of bone healing.196 Immediately after 
insertion, implant stability depends on the initial mechanical interlock with the surrounding bone. 
Unless primary fixation is achieved via new bone formation between the implant surface and the 
existing bone bed, micromotion of the implant and localized inflammation may occur, frequently 
ending with osteolysis and implant failure.  In addition, the trauma of implant placement ruptures 
blood vessels and releases growth factors and proteins,62,197 which provide the local 
environment with a provisional ECM important for blood clot formation.198 The adsorption of 
these early proteins is dependent upon the surface topography with superior anchorage 
occurring on micro-roughened implant surfaces compared to smooth surfaces.199,200 Moreover, 
this protein layer serves as a scaffold for the migration of MSCs to the implant surface.201,202 
Surface design that facilitates this contact osteogenesis has been shown to control the 
fundamental processes that drive the osteoblastic differentiation of MSCs.22,203 A cell-rich 
immature bone (woven bone) is seen in the provisional connective tissue that surrounds newly 
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formed blood vessels.204 Woven bone forms in direct contact with the surface of the Ti implant 
and continues to form over 2 weeks.205 Although OCs are present in the peri-implant tissues as 
early as 1 week following implantation, it is not until after formation of the woven bone that OC 
activity in relation to osseointegration begins.195 This marks the beginning of the progressive 
removal of woven bone, creating space for new lamellar bone formation and replacing passive 
primary stability with active secondary fixation through biological bonding.206 
Modifications to the implant surface topography, chemistry, and hydrophilicity are employed 
as a means of controlling bone–implant interactions and shortening the time of bone fixation. 
Furthermore, it is known that the communication among OCs, MSCs, and OBs is coupled to 
provide control of bone mass and healing. Commitment of OC precursors to mature OCs is 
dependent on production of RANKL (receptor activator of the NFκB ligand)207 and its physiologic 
inhibitor OPG (osteoprotegerin)208 by OBs and MSCs. Implant surface microstructure and 
hydrophilicity facilitate increased production of OPG by MSCs and OBs, leading to increased 
bone formation. In this regard, much attention has been given to the anabolic aspects of 
osseointegration. In contrast, there is little information regarding the OC-mediated catabolic 
processes associated with bone remodeling. It remains unclear as to whether implant surface 
topography can affect the process of osteoclastogenesis or OC function. A thorough 
understanding of healing, repair, modeling, and remodeling of bone is critical for the 
establishment and maintenance of osseointegration of dental and orthopaedic implants. Given 
that the process of bone adaptation and maturation are critical features for the long-term success 
of osseointegration, continued attention to the molecular processes underlying these events may 
create new biological design criteria for implant surface design. This insight is critical to optimize 
an implant surface capable of simultaneously enhancing peri-implant osteogenesis while also 
positively influencing the later stages of osseointegration. Therefore, the objective of this study 
was to determine the effects microrough and hydrophilic Ti surfaces have on a novel in vitro 
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model of bone remodeling by studying their distal influence on OC formation and activity and the 
mechanisms responsible for the influence. 
Materials and Methods 
Ti disk preparation 
 Grade 2 Ti disks, 15mm in diameter and 1mm in thickness, were provided by Institut 
Straumann AG (Basel, Switzerland). Disks were degreased in acetone and processed for 30s in 
in a 55°C 2% ammonium fluoride/2% hydrofluoric acid/10% nitric acid solution to produce 
pretreatment Ti disks (PT). SLA substrates were prepared by subjecting PT substrates to sand 
blasting (250 – 500μm corundum) and acid etching (HCl/H2SO4). Disks were cleaned in HNO3, 
rinsed in deionized water, air dried, and packed in aluminum foil. mSLA substrates were 
produced using the same sandblasting and acid etching procedure as used for SLA, but 
subsequent steps took place under nitrogen gas to prevent exposure to air. mSLA disks were 
rinsed and stored in 0.9% NaCl solution. The methods used to characterize the surface 
microroughness, contact angle, and carbon contamination of the surfaces (PT [SA=0.59µm; 
θCA=93.6°; %C=31], SLA [SA=3.58µm; θCA=120.9°; %C=35], mSLA [SA=3.64µm; θCA=0°; 
%C=17]) have been reported previously.209 All disks were γ-irradiated prior to use. 
OC Cell Culture 
Human OC precursors (OCPs; Lonza Biosciences, Walkersville, MD) were cultured on a 
human type I collagen coated, 96-well OsteoLyse™ Assay Kit (Lonza Biosciences). OCPs were 
differentiated into mature OCs using osteoclast precursor growth medium (OCGM, Lonza 
Biosciences) supplemented with 33ng/ml macrophage colony stimulating factor (M-CSF, Lonza 
Biosciences) and 66ng/ml receptor activator of nuclear factor kappa-B ligand (RANKL, Lonza 
Biosciences). OCPs were also cultured in OCGM supplemented with 33ng/ml M-CSF without 
RANKL for use as a negative control. 
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Establishment of Osteoclast Phenotype and Treatment Period 
In order to establish the OC phenotype and treatment period, OCPs were harvested at 3d, 
7d, 9d, and 14d and subjected to the following assays. 
OC Activity 
OC activity was measured by the release of the europium conjugated human type I collagen 
coated on the bottom of the OsteoLyse™ Assay Kit at each time point. 200μl of a fluorophore 
releasing reagent (Lonza Biosciences) was placed in each well of a 96-well black, clear-bottom 
assay plate (Corning Inc., Corning, NY). 10μl of cell culture supernatant was transferred to each 
well of the assay plate containing the fluorophore releasing reagent. Fluorescence of each well 
of the assay plate was measured with an excitation wavelength of 340nm and an emission 
wavelength of 615nm over a 400μs period after an initial delay of 400μs.  
Gene Expression 
To quantify mRNA, cells were plated as described above. At each time point, mRNA was 
isolated from cells using a TRIzol® (Invitrogen, Carlsbad, California) extraction method. RNA 
was quantified using a NanoDrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA) 
and then reverse transcribed into 250 ng/µL cDNA. Real-time PCR was performed using a 
fluorescent dye (Power SYBR Green, Applied Biosystems, Foster City, CA) to quantify starting 
mRNA levels using gene specific primers (Table 3). Levels of mRNA are normalized to GAPDH. 
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Scanning Electron Microscopy (SEM) Imaging 
 OCs were qualitatively evaluated using SEM (Hitachi FE-SEM Su-70, Tokyo, Japan) at 
each time point. In addition, the collagen coating of the OsteoLyse™ Assay Kit was assessed 
before and after OC treatment. For assessment of the collagen coating, OCs were trypsinized 
for 5min. All samples were then fixed in 4% paraformaldehyde for 15min after three rinses in 1x 
PBS. Samples were then dehydrated stepwise in increasing ethanol concentrations of 15%, 
30%, and 45% for two hours, followed by 60%, 75%, 90% and 100% (x3) for at least 1 hour. The 
samples were then critically dried using a 1:1 exchange of 100% ethanol and 
hexamethyldisilazane (HMDS, Sigma-Aldrich, St. Louis, MO) for 30min in a chemical safety 
hood, then twice with 100% HMDS for 30min. Sample wells were trimmed to allow even sputter 
coating, then dried in a desiccator for 24hrs prior to platinum sputter coating. Samples were 
imaged with 56μA ion current, 5kV accelerating voltage and 8mm working distance. 
Representative images were selected from 18 images per well and n=4 per group. 
Tartrate-Resistant Acid Phosphatase (TRAP) Staining 
OCs were stained for tartrate-resistant acid phosphatase (TRAP) and were analyzed using 
light microscopy. OC groups (n=4) were prepared based on a modified manufacture’s protocol 
(Sigma-Aldrich). Briefly, OCs were rinsed three times with 1x PBS, fixed in a fixative solution 
comprising of 25mL citrate solution, 65mL acetone, and 8mL of 37% formaldehyde for 15min. 
Followed by 3 rinses in deionized water. Staining solution consisting of 45mL of deionized water 
at 37°C, 1mL diazotized Fast Garnet GBC solution, 0.5mL Naphthol AS-BI Phosphate Solution, 
2mL Acetate solution, and 1mL Tartrate solution was prepared and 200μL of staining solution 
was added to each well and allowed to incubate for 1hr at 37°C. Samples were counterstained 
with 200μL hematoxylin solution for 2min and rinsed in deionized water prior to imaging with a 
Carl Zeiss Primo Vert™ Inverted Microscope (Zeiss, Oberkochen, Germany). Representative 
images were selected from 18 images per well and n=4 per group. 
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MSC and NHOst Cell Culture 
Human MSCs (Lonza Biosciences) were cultured in MSC growth medium (MSCGM; Lonza 
Biosciences). Normal human osteoblasts (NHOsts, Lonza Biosciences) were cultured using 
Dulbecco’s modified Eagle medium (DMEM, CellGro®; Mediatech, Inc., VA) supplemented with 
10% fetal bovine serum (FBS, Life Technologies, Carlsbad, CA) and 1% penicillin-streptomycin 
(Life Technologies). MSCs and NHOsts were separately cultured on tissue culture polystyrene 
(TCPS), PT, SLA, or mSLA at a density of 10,000 cells/cm2 at 37°C in 5% CO2 and 100% 
humidity. Media were changed 24h after plating and every 48h thereafter for 7d. At 7d, cells 
were incubated with fresh media for 24h, which was used for subsequent experiments. 
Indirect Effects of MSC/NHOst Conditioned Media on OCs 
MSCs, NHOsts, and OCPs were separately cultured as described previously. After culture 
for each cell type, 200μl media from MSCs or NHOsts were transferred to wells of the 
OsteoLyse™ Assay Kit containing differentiated OCs. In order to control for the initial 
concentrations of M-CSF and RANKL used to differentiate the OCs, an additional group of 
differentiated OCs was incubated with 200μl of MSC or NHOst media supplemented with 
33ng/ml M-CSF and 66ng/ml RANKL. For each experiment, positive (differentiated OCs 
receiving OCGM supplemented with 33ng/ml M-CSF and 66ng/ml RANKL) and negative 
(undifferentiated OCPs receiving OCGM supplemented with 33ng/ml M-CSF) controls were 
used. Differentiated OCs were treated for 2d, followed by quantification of activity and gene 
expression. 
Cell Presence and Conditioned Media Effects on OCs 
In order to determine whether the observed indirect effects of conditioned media were 
dependent on the presence of cells, MSCs were cultured on TCPS or mSLA and compared to 
conditioned media collected from TCPS and mSLA without seeded cells.  Both the cellular and 
acellular TCPS and mSLA were incubated and received media changes in the exact same 
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manner for 7d followed by treatment with MSCGM for 24hr. After treatment, conditioned media 
were supplemented with 33ng/mL M-CSF and 66ng/mL RANKL and used treat differentiated 
OCS for 2d. Positive and negative controls were also used. 
Proteins and Conditioned Media Effects on OCs 
Whether proteins were the primary factor for the observed effects of conditioned media on 
OCs was determined by two methods of denaturation: 1) proteinase K or 2) heat. For proteinase 
K denaturation, MSCs were cultured on either TCPS or mSLA as described previously. After 
treatment with MSCGM, conditioned media were collected and treated with 200μg/ml proteinase 
K (Sigma-Aldrich) for 1h at 37°C. Proteinase K activity was then neutralized with 5mM Pefabloc® 
SC (Sigma-Aldrich) for 2h at 37°C. For heat treatment, conditioned media were placed in an 
80°C water bath for 2h. Heat treated media were then cooled to room temperature by placing 
samples on ice for 10 min. Denatured conditioned media were then supplemented with 33ng/mL 
M-CSF and 66ng/mL RANKL prior to treating differentiated OCs for 2d using positive and 
negative controls. 
ITGA2 and ITGB1 Silencing 
MISSION® shRNA lentiviral transduction particles (Sigma-Aldrich) were used to silence 
human MSCs for either ITGA2 (SHCLNV-NM_002203) or ITGB1 (SHCLNV-NM_002211). MSCs 
were plated at 20,000 cells/cm2 and cultured overnight at 37°C in 5% CO2 and 100% humidity. 
Particles were added to the cells at a multiplicity of infection of 2 in culture media supplemented 
with 8μg/ml hexadimethrine bromide for 18h. Transduced cells were selected using MSCGM 
supplemented with 0.5 μg/ml of puromycin. Silencing of ITGB1 and ITGA2 were confirmed using 
real-time qPCR and maintained over the period of culture (data not shown). A 70% reduction in 
mRNA levels compared to the wild-type control was considered the minimum acceptable 
decrease. 
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Effects of ITGA2 and ITGB1 Silencing on Indirect Effects of MSC Conditioned Media 
To determine if signaling via the α2 or β1 integrin subunit was required for the indirect effects 
of conditioned media on OCs, wild type (WT) and silenced MSCs were cultured on TCPS or 
mSLA for 7d in MSCGM followed by a 24hr treatment with MSCGM. Conditioned media were 
supplemented with 33ng/ml M-CSF and 66ng/mL RANKL and used treat differentiated OCS for 
2d. Positive and negative controls were also used. 
Paracrine Effects of OPG and TGFβ1 in Conditioned Media 
The contribution of osteoprotegerin (OPG) and transforming growth factor β1 (TGFβ1), two 
known regulators of OC activity and function, to the indirect effects of conditioned media on OCs 
were also evaluated. Conditioned media were collected from cultures of MSCs on TCPS or 
mSLA as previously described. Conditioned media were supplemented with either 2μg/ml or 
0.5μg/ml anti-TGFβ1 type II receptor antibody (R&D Systems, Minneapolis, MN); 1μg/ml or 
0.1μg/ml soluble type II receptor (R&D Systems); or 2μg/ml or 0.5μg/ml anti-OPG antibody (R&D 
Systems, Minneapolis, MN). All conditioned media were then supplemented with 33ng/ml M-
CSF and 66ng/mL RANKL and used treat differentiated OCs for 2d. Positive controls 
supplemented with each treatment were also used. 
Statistical Analysis 
Data from surface characterization experiments and in vitro assays are presented as the 
mean ± standard error (SE) per variable (n=6). A one–way analysis of variance was performed 
with a two-tailed Tukey correction and α = 0.05. All statistical analyses were performed using 
JMP statistical software. 
Results 
Initial studies established the OC phenotype and treatment period (Fig.15). Activity of OCs 
is shown as differentiated OCs (OCPs receiving M-CSF and RANKL) per undifferentiated OCs 
(OCPs receiving M-CSF) within the same time point. A significant increase in OC activity was 
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observed at each time point (Fig.15A). Gene expression data are shown by indicating the source 
of the media (OCGM) and the presence (+) or absence (-) of RANKL. No difference in OCP CA2 
mRNA was detected at 3d, 7d, and 9d (Fig.15B). At 14d, CA2 mRNA increased to levels 
comparable to 3d OC cultures. CA2 mRNA further increased in OCs 7d post-culture then 
decreased at 14d. Similar CTSK expression was observed among OCPs and 3d OC cultures 
Figure 15. Establishment of OC phenotype and treatment period. OCPs were differentiated with M-CSF (negative 
control) or M-CSF and RANKL (positive control) on an OsteoLyse Kit. After 3d, 7d, 9d, and 14d OC activity was 
measured by absorbance following the addition of 10μl of media to 200μl of a fluorophore releasing agent. 
Afterwards, mRNA was isolated from OCs and CA2, CTSK, CSTB, ITGAV, ITGB3, and OCSTAMP were 
measured. Data shown are the mean ± standard error (SE) of six independent samples. Groups not sharing a 
letter are statistically significant at an α=0.05. 
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(Fig.15C). CTSK expression in 7d OCs was highest and subsequently decreased at 9d and 14d. 
OCP expression of CSTB (Fig.15D), ITGAV (Fig.15E), ITGB3 (Fig.15F), and OCSTAMP 
(Fig.15G) was lower compared to OCs. CSTB and ITGAV expression increased to similar levels 
on 7d, 9d, and 14d OCP cultures compared to 3d. No differences were detected in OCP ITGB3 
and OCSTAMP expression. For OCs, similar levels of CSTB, ITGAV, and ITGB3 mRNA were 
detected at 3d and 14d cultures; however, CSTB was highest in 9d OC cultures while ITGAV 
and ITGB3 were highest in 7d OC cultures. Peak OCSTAMP expression was observed in 3d 
OC cultures. OCSTAMP expression declined at 7d and further decreased to similar levels at 9d 
and 14d. 
Figure 16. Qualitative assessment of OCs. TRAP staining (Left) and SEM imaging (Right) of OCs at each harvest 
point. OCPs cultured with M-CSF and without RANKL serve as negative controls while OCPs cultured with M-
CSF and RANKL serve as positive controls. 
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Qualitative assessment of the OC phenotype at each time point is shown in Figure 16. As 
early as three days, RANKL supplemented OCPs began to aggregate and fuse into 
multinucleated OCs as indicated by TRAP stain. At 7d, increased TRAP stain multi-nucleation 
as well as ruffled border formation in SEM images was seen. This phenotype continued to 
develop through 9d. The 9d RANKL negative cultures had larger cells attributed to the actions 
of M-CSF; however, they lacked the magnitude of surface area, TRAP stain intensity, and multi-
nucleation compared to OCs. Interestingly, TRAP stain intensity and multi-nucleated cell density 
decreased in the 14d RANKL positive cells while both increased in the 14d RANKL negative 
cells suggesting that the phenotypic integrity of OCPs and OCs was lost by 14d. Although the 
collagen coating is slightly altered by trypsin, differentiated OCs degrade much of the collagen 
coating by 9d of culture and only a few fragments of protein are left by 14d. 
Figure 17 shows the indirect effects microstructured Ti substrates have on OC activity via 
MSCs (Fig.17A, B) and NHOsts (Fig.17C, D) after treatment for 2d. The sources of the 
treatment media (OCGM or MSCs/NHOsts cultured on TCPS or PT, SLA, or mSLA disks) are 
shown below each group. Furthermore, indications of whether treatment media were 
supplemented with (+) or without (-) RANKL are shown below each group. For each cell type, 
the OC activity was highest in the positive control and lowest in the negative control. Compared 
to the positive control, OC activity was reduced following treatment with media collected from 
cultures of MSCs (Fig.17A) and NHOsts (Fig.17C) grown on TCPS and microstructured Ti. 
Similar effects were seen when media collected from MSCs and NHOsts were supplemented 
with RANKL and M-CSF (Fig.17B, D respectively). OC activity was reduced to comparable 
levels in groups treated with media collected from MSCs and NHOsts cultured on TCPS and PT 
with or without RANKL and M-CSF supplementation. A further reduction in OC activity was 
observed after treatment with media from SLA cultured MSCs followed by mSLA cultured MSCs. 
Supplementing MSC treatment media with RANKL and M-CSF abrogated this effect. OCs 
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treated with media collected from SLA and mSLA cultured NHOsts were not sensitive to the 
effects of RANKL and M-CSF supplementation observed with MSC treatment. 
Data regarding gene expression following treatment with MSC and NHOst conditioned media 
(CM) supplemented with M-CSF and RANKL are shown in Figure 18. For all genes, expression 
was higher in the positive control compared to the negative control. MSC-CM treatment reduced 
OC CA2 (Fig.18A) and CSTB (Fig.18B) expression compared to the positive control. CA2 
Figure 17. The indirect effects of Ti surface cultured osteoblast lineage cell conditioned media on osteoclast 
activity. OCPs were differentiated on an OsteoLyse Kit with M-CSF and RANKL. MSCs and NHOsts were 
separately cultured on TCPS, PT, SLA, or mSLA. After 7d, MSC and NHOst media were collected, supplemented 
with or without M-CSF and RANKL, and used to treat OCs, leaving a negative (OCPs + M-CSF) and positive 
(OCPs + M-CSF + RANKL) control. After treatment for 2d, 10μl of media was placed into 200μl of a fluorophore 
releasing agent and absorbance measured. Data shown are the mean ± standard error (SE) of six independent 
samples. Groups not sharing a letter are statistically significant at an α=0.05. 
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expression further decreased when OCs were treated with SLA and mSLA MSC-CM. CSTB 
expression decreased after MSC-CM treatment and continued to decrease in a surface 
dependent manner with no differences detected between SLA and mSLA MSC-CM. OCSTAMP 
(Fig.18C) was reduced to similar levels for all MSC-CM treatments. CTSK (Fig.18D) mRNA 
levels decreased when treated with mSLA MSC-CM. Although not different from the positive 
control, OC CTSK expression decreased when treated with SLA MSC-CM compared to TCPS 
and PT MSC-CM. No differences in OC ITGAV (Fig.18E) expression were detected between 
the positive control and OCs treated with SLA and mSLA MSC-CM; however, OCs treated with 
TCPS and PT MSC-CM had significantly higher ITGAV expression compared to the positive 
control and mSLA MSC-CM. OC ITGB3 expression (Fig.18F) increased compared to the 
positive control following treatment. 
Treatment with NHOst-CM reduced CA2 (Fig.18G) expression to similar levels. OC CSTB 
(Fig.18H) mRNA levels decreased when treated with TCPS and PT NHOst-CM and further 
decreased when treated with SLA and mSLA NHOst-CM. OCSTAMP (Fig.18I) mRNA levels 
were reduced in OCs to similar levels; however, OCs treated with TCPS NHOst-CM had 
significantly higher OCSTAMP mRNA levels compared to those treated with mSLA NHOst-CM. 
CTSK (Fig.18J) expression was reduced in OCs treated with TCPS, PT, and SLA NHOst-CM 
and further reduced in OCs treated with mSLA NHOst-CM. No differences in ITGAV (Fig.18K) 
expression were detected in OCs treated with NHOst-CM compared to the positive control. 
However, mSLA NHOst-CM reduced ITGAV expression compared to other treatments. ITGB3 
(Fig.18L) mRNA levels were highest in OCs treated with TCPS and PT NHOst-CM. ITGB3 
mRNA remained unchanged compared to the positive control in OCs treated with SLA and mSLA 
NHOst-CM. 
For experiments to determine the mechanisms responsible for the indirect regulation of OCs, 
a simplified model was used that included only MSCs cultured on either TCPS or mSLA. Figure
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19A demonstrates that the observed inhibitory effect is dependent on the presence of cells 
conditioning the media prior to treatment, although there is an equal inhibitory effect on OCs due 
Figure 18. The indirect effects of Ti surface cultured osteoblast lineage cell conditioned media on osteoclast gene 
expression. OCPs were differentiated on an OsteoLyse Kit with M-CSF and RANKL. MSCs and NHOsts were 
cultured on TCPS, PT, SLA, or mSLA. After 7d, MSC and NHOst media were collected, supplemented with M-
CSF and RANKL, and used to treat OCs, leaving a negative (OCPs + M-CSF) and positive (OCPs + M-CSF + 
RANKL) control. After treatment for 2d, OCs were harvested and mRNA levels of CA2, CSTB, OCSTAMP, CTSK, 
ITGAV, and ITGB3 quantified. Data shown are the mean ± standard error (SE) of six independent samples. 
Groups not sharing a letter are statistically significant at α=0.05. 
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to treatment with acellular MSCGM. ITGA2 silenced MSCs (Fig.19B) and ITGB1 silenced MSCS 
(Fig.19C) decreased OC activity compared to the positive control. shITGA2 MSCs cultured on 
TCPS decreased OC activity compared to WT. The decrease in OC activity by mSLA MSC-CM 
was attenuated by silencing ITGA2. Similar results were observed for shITGB1 MSCs; however, 
no difference in OC activity was detected between TCPS WT MSC-CM and TCPS shITB1 MSC-
CM. In order to determine whether the inhibitory effect was due to proteins, two methods of 
protein denaturation were employed. Treatments subjected to proteinase K digestion (Fig.19D) 
decreased OC activity to levels comparable to the negative control regardless of the initial 
surface. Interestingly, heat denaturation of proteins (Fig.19E) increased OC activity compared 
to the intact protein treatments, although the activity was significantly lower than the positive 
control. 
The addition of an antibody against TGFβ type 2 receptor (Fig.20A) or soluble TGFβ type 2 
receptor (Fig.20B) decreased OC activity when added to TCPS MSC-CM to levels like mSLA 
MSC-CM. OC activity was unchanged when these factors were added to mSLA MSC-CM. 
Furthermore, no effects on OC activity were detected when an antibody against osteoprotegerin 
was added to either TCPS or mSLA MSC-CM, although the activity was significantly lower in 
mSLA MSC-CM compared to TCPS MSC-CM (Fig.20C). In all instances, addition of either 
antibody or soluble protein had no effect on the positive control. 
Discussion 
Implant design that promotes both early bone formation while maintaining healthy cellular 
signaling throughout the remaining stages of osseointegration will achieve long-term implant 
stability. It is now understood that surface properties modulate immune cell function and factors 
produced by macrophages influence osteogenesis.209,210 Others have shown that osteocytes 
make direct contact with the implant surface, suggesting their importance in maintaining healthy 
bone remodeling as well as the longevity of implant osseointegration.211,212 However, no studies 
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Figure 19. The indirect effects of conditioned media are mediated through integrin signaling and dependent on 
cells and proteins. (A) MSCs were cultured on TCPS or mSLA and compared to their acellular counterparts. 
TCPS and mSLA containing no cells were incubated with MSCGM and received media changes identical to 
MSC cultured TCPS or mSLA. MSCs silenced for either ITGA2 (B) or ITGB1 (C) were cultured on TCPS or 
mSLA and compared to their WT controls. Conditioned media were subjected to protein denaturation via 
proteinase K (D) or heat (E) and compared to non-denatured controls. After 7d, conditioned media were 
collected, supplemented with M-CSF and RANKL, and used to treat OCs, leaving a negative (OCPs + M-CSF) 
and positive (OCPs + M-CSF + RANKL) control. After treatment for 2d, 10μl of media was placed into 200μl of 
a fluorophore releasing agent and absorbance measured. Data shown are the mean ± standard error (SE) of 
six independent samples. Groups not sharing a letter are statistically significant at α=0.05. 
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have sought to 
investigate how implant 
surface properties 
modulate MSC and 
NHOst communication 
with OCs, an integral part 
of the bone remodeling 
phase of 
osseointegration. The 
results of this study 
demonstrate that implant 
surface properties can 
impact downstream 
events during 
osseointegration. A novel in vitro model of bone remodeling was developed and used to assess 
the influence commercially available Ti implant surfaces have on osteoclastogenesis and OC 
activity. CM collected from MSCs and NHOsts cultured on smooth, microrough, and/or 
hydrophilic Ti surfaces decreased OC activity with NHOst cultures having a more robust effect. 
Gene expression was selectively regulated rather than completely shut down suggesting that 
the OCs have the capacity to return once the regulatory stimulus favors bone resorption. 
The OsteoLyse™ assay kit is a cell culture plate coated with europium-conjugated human 
type I collagen used in experiments of OC differentiation and activity.213–215 OC resorptive activity 
is directly proportional to the release of Eu-labeled collagen fragments. Although type I collagen 
is the most abundant protein in bone, the assay lacks the complexity of native bone, including 
the presence of bone mineral. Furthermore, ITGAV and ITGB3 complex binding can occur on 
Figure 20. The influence of TGF-β1 and Osteoprotegerin on the indirect effects of 
conditioned media. MSCs were cultured on TCPS or mSLA for 7d. Conditioned media 
was collected and supplemented with M-CSF and RANKL as well as either (A) anti-TGF-
β type 2 receptor antibody, (B) soluble TGF-β type 2 receptor, or (C) anti-osteoprotegerin 
antibody. Conditioned media was then used to treat OCs, leaving a negative (OCPs + M-
CSF) and positive (OCPs + M-CSF + RANKL) control. After treatment for 2d, 10μl of 
media was placed into 200μl of a fluorophore releasing agent and absorbance measured. 
Data shown are the mean ± standard error (SE) of six independent samples. Groups not 
sharing a letter are statistically significant at α=0.05. 
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multiple bone matrix proteins not present in the assay substrate. Shifting to bone or dentine may 
alter the expression patterns observed in the present study and may be necessary to confirm 
our results. Lastly, the assay does not allow cell culture beyond 14d as indicated by the 
phenotypic changes in both the OCPs and OCs. This could be due to the complete resorption 
of the collagen coating leading to cell death or foreign body giant cell (FBGC) fusion. Because 
OCs and OCPs are from the hematopoietic lineage,216 they are sensitive to many chemokines 
including interleukin 4 (IL-4). IL-4 is the driving factor for FBGC fusion and is produced by OCs 
and OCPs.217,218 As a result, the chosen period of our model permits only 9d of total OC culture.  
Despite these limitations, our model proved to be a practical in vitro tool for studying bone 
remodeling. Our results confirm countless observations that MSCs and NHOsts release factors 
capable of limiting the degree and extent to which OCs resorb bone. However, for the first time 
we have shown that the attenuating effect is enhanced when cultured on microstructured and/or 
hydrophilic Ti surfaces. CM were supplemented with RANKL and M-CSF to ensure that their 
abrupt removal was not the cause of the decreased OC activity. The observed effect went largely 
unchanged, although differences were detected between SLA and mSLA MSC-CM without 
supplementation. Despite this observation, our results suggest that surface microroughness may 
play a larger role in mitigating OCs than hydrophilicity. Furthermore, these observed effects are 
not due to the influence Ti surfaces have on cell attachment, proliferation, or death. Previously 
we have shown that cell proliferation is reduced on Ti surfaces compared to TCPS, but 
osteogenic differentiation is increased.61,71,93 Although, SLA and mSLA have the fewest number 
of cells attached, CM from these surface cultures resulted in the greatest decrease in OC activity. 
Differential gene expression in osteoclasts following treatment with CM suggests that 
pathways in OCs are selectively targeted. The fusion marker, OCSTAMP, was markedly reduced 
in OCs following treatment with CM from both cell types suggesting that a portion of the 
regulatory influence acts to prevent OC fusion. In order to initiate resorption, mature OCs attach 
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to the mineralized bone matrix, forming a sealing zone. Their initial attachment and subsequent 
activation are mediated by integrins, specifically, the osteopontin/vitronectin receptor, αVβ3.219–
221 Attachment of αVβ3 induces signaling mechanisms that control cytoskeletal reorganization, 
which is important for the spreading, motility, and sealing zone organization.222–224 Interestingly, 
expression of either subunit did not decrease, suggesting that this signaling complex maintains 
its activity after treatment with MSC or NHOst CM. Following formation of the sealing zone by 
αVβ3 signaling, the resorption lacuna beneath the OC forms where its membrane is folded 
forming the ruffled border. The OC can release hydrogen ions through the ruffled border via 
activity of carbonic anhydrase II (CA2), thereby reducing the pH and dissolving the mineralized 
portion of the ECM. In humans, CA2 deficiency causes non-functional osteoclasts and 
osteopetrosis.225 Its expression is induced through RANKL dependent pathways so its reduction 
would reduce the ability of the osteoclast to maintain optimal pH gradients, thus decreasing 
activity.226 
In addition to regulating pH in the resorption lacunae, osteoclasts secrete enzymes like 
lysosomal cysteine proteinases and matrix metalloproteinases are then secreted to degrade the 
organic matrix.26,27 Cathepsin K (CTSK) is one of the main cysteine proteinases secreted into 
the resorption lacuna.26,227 CTSK has been shown to degrade insoluble type I collagen, and 
inhibition of its enzymatic activity in vitro and in vivo models prevents matrix degradation.228,229 
Osteoclasts are also rich in cystatin B (CSTB), a natural inhibitor of cysteine proteinases. A 
balance between CTSK and CSTB is important for regulating cell survival as addition of CSTB 
to osteoclasts protects them from experimentally induced apoptosis.230 The decreased CTSK 
and CSTB accompanying CM treatment suggests that organic matrix degradation is subsiding, 
and OCs may be attempting to regulate their survival. Interestingly, NHOsts had a more robust 
effect on CTSK expression compared to MSCs. In general, NHOsts produce higher quantities 
of regulatory factors compared to MSCs, suggesting that regulation may be dependent on the 
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cell type. 
The potential regulatory difference between cell types was the impetus for choosing MSCs 
to study mechanisms mediating OCs. In addition, we focused on the modulating effects of mSLA. 
Microroughness was the more important surface feature in terms of reducing OC activity, but 
our previous studies indicated that mSLA is superior at facilitating MSC 
differentiation.53,70,71,93,158 MSCs are attachment dependent and interact with their underlying 
substrate via integrins such as α2β1. Silencing of both the ITGA2 and ITGB1 subunits in MSCs 
attenuated the inhibitory effect on OCs. Interestingly, TCPS shITGA2 MSC-CM decreased OC 
activity suggesting a unique signaling through the α2 integrin subunit. 
Proteins produced by MSCs cultured on Ti surfaces are crucial to the observed phenomena 
in the present study. Although there is an inhibitory effect on OCs due to factors present in the 
basal growth media, MSC-CM decreased OC activity, which further declined with mSLA MSC-
CM treatment. Heat denaturation of the CM mitigated the inhibition of OC activity. Interestingly, 
proteinase K digestion inhibited OC activity more. Proteinase K cleaves peptide bonds adjacent 
to the carboxylic group of aliphatic and aromatic amino acids.231 If proteins have complicated 
secondary, tertiary, and/or quaternary structures, proteinase K may be unable to access certain 
amino acids preventing their complete degradation. This could lead to selective degradation and 
exacerbate the effect if antagonistic proteins are denatured over agonistic proteins. Moreover, 
susceptible proteins could be digested in a way that leaves the residual fragments active. 
Alternatively, addition of proteinase K and its neutralizer may have diluted the CM preventing 
OCs from receiving sufficient nutrients to stay healthy. 
There is a myriad of signals capable of regulating OCs. One mechanism by which MSCs 
control OCs is mediated by TGFβ1-dependent regulation of OPG production.80 TGFβ1 enhances 
the proliferation of MSCs and osteoblasts and stimulates ECM protein production like type I 
collagen. Latent TGFβ1 and latent TGFβ binding protein are synthesized and stored in the ECM. 
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Most of the TGFβ1 produced by OBs cultured on Ti is in latent form, and the amount incorporated 
into the matrix is increased on rougher surfaces.82 Once the bone remodeling phase of 
osseointegration begins, OCs degrade the newly synthesized matrix releasing the stored, latent 
TGFβ1 and convert it into active TGFβ1. Once activated, TGFβ1 regulates OCs, in part, by 
regulating production of OPG. OPG serves as a decoy receptor for RANKL, which prevents 
RANKL-RANK binding on the OCP surface inhibiting OC differentiation.83 A feedback 
mechanism is in place that allows osteoblasts to produce soluble RANKL in order to deplete 
excess OPG if the regulatory stimulus favors new osteoclast formation. Microrough Ti substrates 
facilitate increased production of OPG by osteoblasts; however, levels of RANKL do not change. 
Thus, the net effect is bone formation without bone resorption. Soluble TGFβ type 2 receptor 
and anti-TGFβ type 2 receptor antibody will compete with endogenous TGFβ. Addition of these 
factors to TCPS MSC-CM but not mSLA MSC-CM decreased OC activity, suggesting that TGFβ 
signaling is an important regulatory protein produced by MSCs cultured on TCPS. However, 
TGFβ was not a contributing factor to the regulation of OCs by surfaces. This could be due to 
the overwhelming presence of other factors. Furthermore, the addition of anti-OPG antibody to 
both the TCPS and mSLA MSC-CM did not mitigate the decreased OC activity confirming the 
importance of OPG as a regulator of OC fusion rather than a regulator of OC activity. 
Conclusions 
We have shown that microstructured Ti surfaces indirectly regulate OC activity and gene 
expression. After surface recognition by integrins, MSC and NHOst protein production is 
modulated and responsible for the decreased activity of existing OCs and reduced fusion of new 
OCs. In addition, OC gene expression is selectively regulate suggesting more than one pathway 
of control may be involved. Of the proteins responsible, TGFβ and OPG do not contribute to the 
surface dependent regulation in vitro. 
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Chapter 6. Bisphosphonates Inhibit Surface Mediated 
Osteogenesis 
Abstract 
Bisphosphonates target osteoclasts, slowing bone resorption and providing rationale to 
support osseointegration. However, bisphosphonates may negatively affect osteoblasts, 
impairing peri-implant bone formation. The goal of this study was to assess the effects 
bisphosphonates have on surface mediated osteogenesis of osteoblasts. MG63 cells were 
cultured on 15mm grade 2 titanium disks: smooth PT, hydrophobic-microrough SLA, or 
hydrophilic-microrough mSLA (Institut Straumann AG, Basel, Switzerland). Tissue culture 
polystyrene (TCPS) was used as a control. At confluence, cells were treated with 0M, 10-8M, 10-
7M, and 10-6M of alendronate, zoledronate, or ibandronate for 24h. Sprague Dawley rats were 
also treated with 1μg/kg/day ibandronate or phosphate buffered saline control for 5wk. Calvarial 
osteoblasts (rOBs) were isolated, characterized, and cultured on surfaces. Osteogenic markers 
in the media were quantified using ELISAs. Bisphosphonate treatment reduced osteocalcin, 
osteoprotegerin, osteopontin, BMP2, PGE2, TGFβ1, IL10, and VEGF in MG63 cells. The effect 
was more robust on rough surfaces, and higher concentrations of bisphosphonates stunted 
production to TCPS/PT levels. Ibandronate conditioned rOBs produced less osteogenic markers 
similar to direct bisphosphonate treatment. These results suggest bisphosphonate exposure 
jeopardizes the pro-osteogenic response osteoblasts have to microstructured surfaces. Their 
effects persist in vivo and negatively condition osteoblast response in vitro. Clinically, 
bisphosphonates could compromise osseointegration. 
Introduction 
Bisphosphonates (BPs) are synthetic compounds characterized by two C–P bonds sharing 
a carbon atom (P–C–P), making them chemically stable analogues of pyrophosphates (P–O–
P). Substitution of oxygen with carbon makes BPs completely resistant to enzymatic hydrolysis 
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while maintaining their affinity for bone mineral.232 Differences in side chain moieties at the R1 
and R2 positions of the P–C–P bond explain the wide variance in the physiochemical properties 
and physiological effects among BPs.232 Substitutions of a hydroxyl and a nitrogen containing 
group have proven to greatly increase affinity and adherence to the hydroxyapatite surface as 
well as their anti-resorptive potency. As a result, the molecular mechanisms of action and tissue 
distribution of these aminobisphosphonates are restricted to the skeleton making them widely 
used to treat diseases of calcium metabolism.233 These anti-resorptive effects have also led to 
their use to positively influence osseointegration of titanium (Ti) dental and orthopaedic implants.  
The primary mechanism by which BPs prevent bone loss is through actions on bone 
resorbing osteoclasts. BPs preferentially bind to exposed bone mineral at surfaces undergoing 
resorption where they are then internalized by osteoclasts, disrupting their resorptive ability.234 
While these actions on osteoclasts are well known, their effects on other bone cells like 
osteocytes, osteoblasts, and mesenchymal stem cells (MSCs) are less understood. Low 
concentrations of BPs were shown to prevent apoptosis of osteocytes and osteoblasts.235 This 
effect is mediated by hexameric connexion-43 hemichannels, calcium influx, and activation of 
the extracellular signal-regulated kinases, suggesting that intracellular uptake is not required.236 
BPs were also shown to stimulate the proliferation of osteoblasts and their progenitors as well 
as enhance alkaline phosphatase activity, mineral formation, and expression of bone 
morphogenetic protein (BMP)-2, collagenase-3, osteocalcin, and osteoclast inhibitory factors.237 
Other studies, however, have reported adverse effects of BP treatment. Calcium 
deposition,238 collagen production,239 mineralized bone nodule formation,240 and response to 
parathyroid hormone (PTH)241 are impaired by BPs. Furthermore, BPs can impede 
angiogenesis,242 cause microfracture accumulation,243 and are associated with osteonecrosis of 
the jaw (ONJ),244 all of which can be detrimental to the formation of healthy bone tissue 
especially during implant osseointegration. Much controversy as to the efficacy of BP therapy 
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on implant osseointegration stems from these contrasting observations. 
Despite these discrepancies, current research does reveal that BPs modulate osteoblast 
biosynthesis; however, the current knowledge has been limited to osteoblasts cultured on tissue 
culture polystyrene (TCPS). Osteoblast differentiation and maturation are very different when 
cultured on implant surfaces compared to TCPS.70,71 Surface microtopography and hydrophilicity 
enhance the production of osteoblast markers in MG63 osteoblast-like cells,245 primary human 
osteoblasts and MSCs,22 and fetal rat calvarial cells,246 without supplements typically used to 
induce osteoblast differentiation. The increased osteogenic potential of these implant surfaces 
in vitro correlates with a more rapid and sufficient osseointegration in preclinical and clinical 
studies. It is unknown whether BPs affect the surface mediated osteogenesis of osteoblasts, but 
other osteotropic agents such as 1α,25-dihydroxy vitamin D3 (1α,25(OH)2D3)247 and 17β-
estradiol75 are known to modulate the cellular response and work synergistically with implant 
surface characteristics. 
As the population of patients receiving BPs continues to grow, it is imperative to determine 
these effects as they could directly influence the ability of implants to osseointegrate and 
maintain their longevity clinically. Unravelling these molecular mechanisms may help expand the 
utility of BPs, ensure their overall safety, and limit their contraindications. The goal of this study 
was to test the hypothesis that clinically used, nitrogen-containing bisphosphonates 
(alendronate, zoledronate, and ibandronate) modulate the pro-osteogenic response osteoblasts 
have to implant surface roughness and hydrophilicity. 
Materials and Methods 
 MG63 Cell Culture 
Human MG63 cells (ATCC, Manassas, VA) were separately cultured on tissue culture 
polystyrene (TCPS) or 15mm diameter, 1mm thick, grade 2 Ti disks modified as described 
previously to be smooth/hydrophobic (PT), microrough/hydrophobic (SLA), or 
Osseointegration in Metabolically Compromised Conditions • Spring 2019 
Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 94 
microrough/hydrophilic (mSLA). Disks were provided as a gift from Institut Straumann AG 
(Basel, Switzerland). Cells were seeded at a density of 10,000 cells/cm2 and incubated at 37°C 
in an atmosphere of 5% CO2 and 100% humidity using Dulbecco’s modified Eagle medium 
(DMEM; Mediatech, Manassas, VA) supplemented with 10% fetal bovine serum (FBS; Life 
Technologies, Carlsbad, CA) + 1% penicillin-streptomycin (Life Technologies). Media were 
changed 24h after plating and every 48h thereafter until cells reached confluence on TCPS. 
Biological Response 
Confluent cultures were incubated with fresh media supplemented with either 0M, 10-8M, 10-
7M, or 10-6M alendronate (C4H12NNaO7P2•3H2O; Merck Sharp & Dohme, Kenilworth, NJ), 
zoledronate (C5H10N2O7P2•H2O; Novartis AG, Basel, Switzerland) or ibandronate 
(C9H22NNaO7P2•H2O; AuroMedics, East Windsor, NJ) for 24h. Radioimmunoassay kits were 
used to measure intact osteocalcin (Biomedical Technologies, Stoughton, MA) and 
prostaglandin E2 (PGE2; Perkin Elmer, Wellesley, MA) levels in alendronate and zoledronate 
treated cultures. Active transforming growth factor β1 (TGFβ1) was measured prior to 
acidification of the conditioned media, using an ELISA kit specific for human TGFβ1 (Promega 
Corp., Madison, WI). Total TGFβ1 was measured after acidifying the media and latent TGFβ1 
was defined as total TGFβ1 minus active TGFβ1. For ibandronate treated MG63 cultures, 
ELISAs were used to measure levels of intact osteocalcin (Alfa Aesar, Haverhill, MA), 
human/mouse/rat BMP2 (PeproTech, Rocky Hill, NJ), osteopontin (R&D Systems, Minneapolis, 
MN), interleukin 6 (IL6; R&D Systems), and interleukin 10 (IL10; R&D Systems) following 
manufacturer’s instructions. ELISAs for osteoprotegerin (R&D Systems) and vascular 
endothelial growth factor VEGF-A (VEGF-A; R&D Systems) were used for all MG63 cultures. 
Experiments treating MG63 cells with either alendronate or zoledronate were normalized to cell 
number, while ibandronate treated cultures were normalized to DNA content. 
Cell number or DNA content was determined in all cultures 24h after BP treatment. For cell 
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number, cells were released from the surfaces by two sequential incubations in 0.25% trypsin 
for 10min at 37°C. Released cells were counted using an automatic Z1 Coulter Cell Particle 
Counter (Beckman Coulter, Fullerton, CA). Cell lysates were then collected by centrifuging the 
cells after counting. For DNA content, cell monolayers were washed twice with 0.2ml phosphate-
buffered saline (PBS), lysed in 0.05% Triton X-100, and homogenized by sonication at 40A using 
a Vibra-Cell ultrasonicator (Sonics & Materials Inc., Newtown, CT). DNA content in the cell lysate 
was measured with PicoGreen (Promega, Madison, WI) using a Synergy H1 Hybrid Reader 
fluorescence detector (BioTek, Winooski, VT) at an excitation of 485nm and emission of 538nm. 
Alkaline phosphatase specific activity [orthophosphoric monoester phosphohydrolase, alkaline; 
E.C. 3.1.3.1] was assayed in cell lysates by measuring the conversion of p-nitrophenylphosphate 
to p-nitrophenol at pH 10.25 and a temperature of 37°C. Absorbance was measured at 405nm. 
Activity was normalized to total protein content in the cell lysates as determined by a 
bicinchoninic acid protein assay kit (Thermo Fisher Scientific, Waltham, MA). 
Rat Calvarial Osteoblast Isolation and Biological Response 
All subsequent experiments were carried out under an Institutional Animal Care and Use 
Committee approved protocol at Virginia Commonwealth University (protocol AD10000675) and 
reported according to ARRIVE guidelines. All animals were treated humanely per the guidelines 
outlined in the Guide for the Care and Use of Laboratory Animals by the National Institutes of 
Health. CD Sprague Dawley rats were single-housed in an individually ventilated, solid-bottomed 
polysulfone cage and kept at a temperature of 17-28ºC with a humidity of 40-70% and a 12/12 
h light/dark cycle. All rats were given ad libitum access to standard pellet and water and received 
fresh food daily.  
Six, 9mo old, virgin, female CD Sprague Dawley rats (Charles River Laboratories, 
Wilmington, MA) were injected subcutaneously with 25μg/kg ibandronate (n=3) or PBS (n=3) on 
day 0 and on day 25. Rats were euthanized 5wk after the first injection (day 35), so each animal 
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received a total of two injections of ibandronate or PBS. After euthanasia via CO2 inhalation, the 
heads were cleaned with 70% ethanol and betadine solution and the frontal and parietal bones 
excised. Connective tissue was then removed, and the remaining bone was minced into pieces 
approximately 1mm x 1mm. Explants from each animal in the same group were pooled together 
into a 100mm x 20mm Petri dish with DMEM + 10% FBS + 1% penicillin-streptomycin. Petri 
dishes were incubated at 37°C in an atmosphere of 5% CO2 and 100% humidity until cells 
reached confluence. Cells were passaged and explants were placed into a new Petri dish. This 
process was repeated until migration of osteoblasts from the explants stopped. 
The osteoblastic phenotype of primary rat osteoblasts (rOBs) was confirmed by treating 
confluent cultures of rOBs with either 0M or 10-8M 1α,25(OH)2D3 (Enzo Biochem, Farmingdale, 
NY) for 24h. Conditioned media were measured for intact rat osteocalcin (Alfa Aesar) and 
alkaline phosphatase specific activity was quantified in cell lysates. Verified rOBs (passage<4) 
were cultured on modified Ti substrates as described for the MG63 cells (Section 2.2). At 
confluence, cells were incubated with fresh DMEM for 24h. Responses were assessed using 
ELISAs measuring osteocalcin, rat/mouse osteopontin (R&D Systems), mouse osteoprotegerin 
(R&D Systems), human/mouse/rat BMP2 (PeproTech), mouse receptor activator of nuclear 
kappa-B ligand (RANKL; R&D Systems), and rat VEGF-A (R&D Systems). Alkaline phosphatase 
specific activity was measured in cell lysates and normalized to total protein content. 
Immunoassays were normalized to DNA content. 
Statistical Analysis 
Data are presented as the mean ± standard error (SE) of n=6 cultures per variable. All 
experiments were repeated at least three times to ensure validity of the results. Data shown in 
the figures are from representative experiments. A t-test was used was used to determine 
significant differences for experiments assessing the osteoblastic phenotype of rOBs. A two-way 
analysis of variance (ANOVA) was used to model the mean production of biological variables by 
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MG63 cells or rOBs cultured on four different surfaces (TCPS, PT, SLA, mSLA) and treated with 
four different BP concentrations (0M, 10-8M, 10-7M, 10-6M). The model included main effects for 
surface and BP concentration, as well as a surface by BP concentration interaction. If a 
significant interaction was identified between variables, mean differences between the levels of 
surface were compared at specific levels of BP concentration (and vice versa). If no significant 
interaction was present, mean differences were compared separately within each variable. A 
two-tailed Tukey correction was used to adjust for multiple comparisons to maintain an 
experiment-wise error rate (α) of 0.05. All statistical analyses were performed using JMP 
statistical software (SAS Institute Inc., Cary, North Carolina). 
Results 
MG63 Cell Response 
Alendronate 
Control (0M) MG63 cultures had reduced cell numbers (Fig.21A) on Ti surfaces compared 
to TCPS and further reduced on SLA and mSLA compared to PT. When treated with 
alendronate, cell number remained similar on PT and TCPS but was reduced on SLA except 
when treated with 10-6M alendronate. mSLA cultures had reduced cell numbers similar to SLA. 
Within each surface cell number increased when treated with 10-6M alendronate compared to 
10-8M. 10-6M treated PT and SLA cultures saw increased cell numbers compared to other 
concentrations. Alkaline phosphatase specific activity (Fig.21B) was reduced on all surfaces. 
Treatment with 10-6M alendronate increased activity compared to no treatment for TCPS, PT, 
and SLA cultures. Osteocalcin levels (Fig.21C) significantly increased on mSLA compared to 
PT and TCPS. Treatment with 10-6M alendronate decreased osteocalcin levels within surface 
cultures compared to non-treated controls for mSLA. On other surfaces, the decrease was 
significant to the 10-8M treatment. Osteoprotegerin (Fig.21D) and latent TGFβ1 (Fig.21E) levels 
increased on SLA and mSLA cultures compared to TCPS and PT cultures. 10-6M alendronate 
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treatment decreased MG63 
osteoprotegerin production on all 
surfaces and decreased latent TGFβ1 
levels in SLA and mSLA cultures. 
PGE2 (Fig.21F) levels were increased 
on SLA and mSLA compared to TCPS 
and PT across all concentrations. 
TCPS, SLA, and mSLA cultures 
treated with 10-6M alendronate had 
significant reductions in VEGF 
(Fig.21G) production compared to 
untreated controls. 
Zoledronate 
Cell number (Fig.22A) significantly 
decreased on SLA compared to PT 
and TCPS and further decreased on 
mSLA for untreated MG63 cultures. 
Treatment with 10-7M zoledronate 
resulted in increased cell numbers 
compared to non-treated controls on 
each surface. These numbers were 
similar to 10-6M treatment for SLA and mSLA cultures. Few differences were detected with 
alkaline phosphatase specific activity (Fig.22B); however, none of these differences were due 
to treatment with zoledronate. Surface topography significantly increased osteocalcin levels 
(Fig.22C) while treatment with zoledronate decreased its production to similar levels across all 
Figure 21. Effects of alendronate treatment on MG63 cells cultured 
on microstructured and hydrophilic Ti substrates. MG63 cells were 
cultured separately on TCPS, PT, SLA, or mSLA. At confluence, cells 
were treated with 0M (control), 10-8M, 10-7M, or 10-6M alendronate 
for 24h. After 24h, cells were counted (A) and alkaline phosphatase (B) 
specific activity was quantified in lysates. Media were assayed for 
osteocalcin (C), osteoprotegerin (D), latent TGFβ1 (E), PGE2 (F), and 
VEGF (G). Data shown are the mean ± standard error (SE) of six 
independent samples. Letters denote significance among alendronate 
treatments within the same substrate culture. Groups not sharing a 
letter are statistically significant at α=0.05. Symbols denote significance 
among surface cultures within the same alendronate treatment. *p < 
0.05 vs. TCPS; #p < 0.05 vs. PT; $p < 0.05 vs. SLA. 
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surfaces. Osteoprotegerin (Fig.22D) 
production was similar to osteocalcin, 
although mSLA production after 
treatment remained higher compared 
to PT and TCPS. Furthermore, 
treatment decreased production on all 
surfaces compared to non-treated 
controls. Increased latent TGFβ1 
(Fig.22E) levels were detected in 
mSLA cultures. Treatment with high 
concentrations of zoledronate 
decreased latent TGFβ1 production 
compared to non-treated controls or 
lower concentrations. PGE2 (Fig.22F) 
and VEGF (Fig.22G) increased in a 
surface dependent manner. Treatment 
with 10-7M or 10-6M zoledronate 
reduced the production of PGE2 in SLA 
and mSLA cultures and the production 
of VEGF in PT and mSLA cultures. 
VEGF was reduced in SLA cultures 
when treated with 10-6M zoledronate.  
Ibandronate 
Compared to TCPS, DNA content (Fig.23A) was reduced on all surfaces. A further reduction 
was observed on SLA and mSLA compared to PT. Treatment with ibandronate increased the 
Figure 22. Effects of zoledronate treatment on MG63 cells cultured 
on microstructured and hydrophilic Ti substrates. MG63 cells were 
cultured separately on TCPS, PT, SLA, or mSLA. At confluence, cells 
were treated with 0M (control), 10-8M, 10-7M, or 10-6M zoledronate for 
24h. After 24h, cells were counted (A) and alkaline phosphatase 
specific activity (B) was quantified in lysates. Media were assayed for 
osteocalcin (C), osteoprotegerin (D), latent TGFβ1 (E), PGE2 (F), and 
VEGF (G). Data shown are the mean ± standard error (SE) of six 
independent samples. Letters denote significance among zoledronate 
treatments within the same substrate culture. Groups not sharing a 
letter are statistically significant at α=0.05. Symbols denote significance 
among surface cultures within the same zoledronate treatment. *p < 
0.05 vs. TCPS; #p < 0.05 vs. PT; $p < 0.05 vs. SLA. 
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DNA content within surface cultures. 
Alkaline phosphatase specific activity 
(Fig.23B) was reduced in response to 
surface topography. Treatment with 10-
7M or 10-6M ibandronate reduced 
activity further on Ti substrates while 
10-6M ibandronate treatment reduced 
the activity on TPCS. Production of 
osteocalcin (Fig.23C), osteoprotegerin 
(Fig.23D), BMP2 (Fig.23E), 
osteopontin (Fig.23F), and VEGF 
(Fig.23G) were significantly increased 
on SLA compared to TCPS and PT and 
mSLA compared to TCPS, PT, and 
SLA. MG63s cultured on TCPS or Ti 
substrates produced less osteocalcin, 
BMP2, osteopontin, and VEGF when 
treated with ibandronate. 
Osteoprotegerin production was 
reduced in SLA cultures when treated 
with ibandronate; however, mSLA 
cultures were not sensitive to the 10-8M concentration. Ti substrates facilitated the decreased 
production of IL6 (Fig.24A) and the increased production of IL10 (Fig.24B). Treatment with 
ibandronate decreased production of IL6 in TCPS and PT cultures while stimulating production 
in SLA and mSLA at 10-6M and 10-7M/10-6M concentrations respectively. Ibandronate treatment 
Figure 23. Effects of ibandronate treatment on MG63 cells cultured 
on microstructured and hydrophilic Ti substrates. MG63 cells were 
cultured separately on TCPS, PT, SLA, or mSLA. At confluence, cells 
were treated with 0M (control), 10-8M, 10-7M, or 10-6M ibandronate 
for 24h. After 24h, cell lysates were assayed for DNA content (A) and 
alkaline phosphatase specific activity (B). Media were assayed for 
osteocalcin (C), osteoprotegerin (D), BMP2 (E), osteopontin (F), and 
VEGF (G). Data shown are the mean ± standard error (SE) of six 
independent samples. Letters denote significance among ibandronate 
treatments within the same substrate culture. Groups not sharing a 
letter are statistically significant at α=0.05. Symbols denote significance 
among surface cultures within the same ibandronate treatment. *p < 
0.05 vs. TCPS; #p < 0.05 vs. PT; $p < 0.05 vs. SLA. 
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decreased production of IL10 in all cultures. 
Rat Calvarial Osteoblast Response 
Addition of 10-8M 1α,25(OH)2D3 to confluent cultures of rOBs increased osteocalcin and 
alkaline phosphatase specific activity, confirming their successful isolation and expansion. DNA 
content of rOBs (Fig.25A) was reduced on Ti surfaces compared to TCPS for both treatment 
groups. When cultured on the same surface, ibandronate rOBs had decreased DNA content 
compared to PBS rOBs. Similarly, decreased levels of alkaline phosphatase specific activity 
(Fig.25B) were observed on Ti surfaces with the lowest levels occurring on SLA and mSLA for 
both groups of osteoblasts. Ibandronate treatment decreased alkaline phosphatase specific 
activity in rOBs cultured on TCPS and PT compared to PBS rOBs. Osteocalcin production 
(Fig.25C) was increased in a surface dependent manner (mSLA>SLA>PT>TCPS) for all rOBs; 
however, ibandronate rOBs had decreased productions when cultured on SLA and mSLA 
compared to PBS rOBs. Osteoprotegerin levels (Fig.25D) decreased on Ti surfaces compared 
to TCPS while ibandronate treatment was able to stimulate its production compared to PBS. 
Figure 24. Effects of ibandronate treatment on MG63 cell inflammatory response cultured on microstructured and 
hydrophilic Ti substrates. MG63 cells were cultured separately on TCPS, PT, SLA, or mSLA. At confluence, cells were 
treated with 0M (control), 10-8M, 10-7M, or 10-6M ibandronate for 24h. After 24h, media were collected and assayed for IL6 
(A) and IL10 (B). Data shown are the mean ± standard error (SE) of six independent samples. Letters denote significance 
among ibandronate treatments within the same substrate culture. Groups not sharing a letter are statistically significant at 
α=0.05. Symbols denote significance among surface cultures within the same treatment. *p < 0.05 vs. TCPS; #p < 0.05 vs. 
PT; $p < 0.05 vs. SLA. 
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Production of BMP2 (Fig.25E), 
osteopontin (Fig.25F), VEGF 
(Fig.25G), and RANKL (Fig.25H) was 
increased in rOBs cultured on Ti 
surfaces compared to TCPS. When 
cultured on the same surface, 
ibandronate rOBs had decreased 
production compared to PBS rOBs. 
Discussion 
Bisphosphonates are commonly 
used to treat metabolic bone disorders 
due to their high affinity for bone and 
their antiresorptive effects via actions 
on osteoclasts. Because BPs slow the 
rate and severity of bone resorption, it 
is reasonable to assume that they 
could significantly impact the 
osseointegration of dental and 
orthopaedic implants, particularly 
during the bone modeling and 
remodeling phases. This suggests that 
BPs could affect bone formation as well 
as bone resorption. The results of the 
present study confirm that osteoblasts respond to nitrogen-containing BPs and demonstrate that 
implant surface properties modulate their response. 
Figure 25. Response of calvarial osteoblasts isolated from aged rats 
treated with ibandronate to microstructured and hydrophilic Ti 
substrates. Six 9-month-old, female, virgin, CD Sprague-Dawley rats 
were treated with either 25μg/kg ibandronate (n=3) or PBS (n=3) on 
day 0 and again on day 25. Rats were euthanized on day 35. Calvarial 
osteoblasts were isolated and cultured separately on TCPS, PT, SLA, 
or mSLA in DMEM. At confluence, cells were treated with fresh DMEM 
for 24h. After 24h, media were collected, and cell lysates were assayed 
for DNA content (A) and alkaline phosphatase specific activity (B). 
Media were assayed for osteocalcin (C), osteoprotegerin (D), BMP2 
(E), osteopontin (F), VEGF (G), and RANKL (H). All osteoblasts used 
were of passage 3 or less. Data shown are the mean ± standard error 
(SE) of six independent samples. Letters denote significance between 
ibandronate and PBS (control) treatments within the same substrate 
culture. Groups not sharing a letter are statistically significant at 
α=0.05. Symbols denote significance among surface cultures within the 
treatment. *p < 0.05 vs. TCPS; #p < 0.05 vs. PT; $p < 0.05 vs. SLA. 
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The physicochemical and biological profile of clinically available BPs are dose-dependent 
and vary with the chemistry of the compound making it difficult to extrapolate findings from one 
BP to another with respect to its actions. Differences in pharmacokinetics, pharmacodynamics, 
affinity to bone, cell permeability, and intracellular protein binding between mechanistically 
similar BPs contribute significantly to their potency. For these reasons, the response of MG63 
cells to three different nitrogen-containing BPs at three different concentrations was assessed 
to determine whether the observed effects were similar. This study shows for the first time that 
the surface mediated osteogenesis of MG63 cells and rOBs is impaired by BP treatment. These 
results support previous observations in our lab75,84,93,247,248 and others249,250 showing that the 
response of cells to osteotropic agents is surface-dependent. The observed effects were dose 
dependent and were more robust in SLA and mSLA cultures compared to PT and TCPS cultures, 
indicating that BPs could affect cells differently depending on their specific state of differentiation 
and/or maturation. 
Typically, microrough and/or hydrophilic SLA and mSLA cultures of osteoblasts exhibit a 
more differentiated and mature phenotype compared to smooth PT and TCPS cultures.82 Late 
stage modulators of differentiation and mineralization, osteocalcin, BMP2, and osteopontin, as 
well as the angiogenic factor, VEGF, were increased on microstructured surfaces while the early 
differentiation marker, alkaline phosphatase specific activity was decreased. Moreover, 
osteoblasts on microstructured substrates produce factors that favor osteogenesis over 
osteoclastic resorption by producing increased TGFβ1 and osteoprotegerin, which inhibit 
osteoclast activation.80 The effects of alendronate, zoledronate, or ibandronate on confluent 
cultures of MG63 cells are consistent with studies showing that BPs enhance the proliferation of 
osteoblasts,251,252 as indicated by the increased cell number or DNA content. BP treatment was 
also able to reduce production of VEGF suggesting impeded angiogenesis as described 
previously.242 However, our results are inconsistent with studies describing their ability to 
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increase production of osteogenic markers.237 With the exception of alkaline phosphatase 
specific activity, BP treatment decreased all pro-osteogenic markers as well as the anti-
inflammatory cytokine IL10. Many of the markers measured in this study were more susceptible 
to BP treatment in SLA and mSLA cultures compared to TCPS and PT cultures, and, for IL6 
production, had opposite effects between TCPS/PT and SLA/mSLA cultures. These results 
along with findings suggesting BPs both increase253 and decrease254 IL6 production by 
osteoblast-like cells, indicate that BPs could affect cells differently depending on the specific 
state of differentiation and/or maturation. 
The inconsistencies among studies could also be influenced by the alternate pathways 
through which Ti surface topography facilitates osteogenesis compared to TCPS. On TCPS, 
osteoblastic differentiation occurs through the canonical Wnt3A pathway while also primarily 
expressing the α5β1 integrin complex.70,161 Surface mediated differentiation occurs through the 
calcium-dependent Wnt5A pathway and shift to the production of α1β1 and α2β1 integrin 
complexes.70,161 In addition, this occurs with media supplements typically used to induce 
osteoblastic differentiation. Very few studies have investigated the effects BPs have on surface 
mediated differentiation and maturation of osteoblasts, and many are concerned with the effects 
BP coated Ti substrates have on osteogenesis.255 rOBs isolated from 1d old Sprague Dawley 
rats saw no changes in osteoblastic markers when cultured on Ti substrates coated with 
immobilized pamidronate.256 Another study reported positive osteogenic effects of Ti surfaces 
coated with immobilized alendronate on human osteoblasts and MSCs.257 However, the 
chemical process used to coat the substrates could easily distort the already highly variable 
chemical effects of the BPs. Many of these studies also used osteogenic media to induce 
differentiation.257,258 Since the differentiation of cells driven by surface topography and 
osteogenic media are divergent,71 BPs could alter downstream signalling mechanisms 
differently. 
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Differences in BP chemistries were also evident when comparing their biological effects. 
Alendronate was most inhibitory at the highest concentration, 10-6M, and occasionally elicited 
pro-osteogenic effects at the lowest concentrations by increasing osteocalcin and PGE2 on 
certain surfaces. Zoledronate was effective at all concentrations; however, its effects were 
mostly limited to the more differentiated SLA and mSLA cultures. Ibandronate had the greatest 
impact on the production of osteogenic factors on all surface cultures as well as at all 
concentrations. Interestingly, each BP had a different effect on alkaline phosphatase specific 
activity as it was increased by alendronate, not affected by zoledronate, and impaired by 
ibandronate. Despite these differences, high concentrations of each BP were able to reduce the 
osteogenic potential of SLA and mSLA to similar levels as TCPS and PT. This has significant 
clinical implications suggesting BP usage impairs the osteoblast response to microstructured 
surfaces and potentially slowing the rate of osseointegration.  
Because the effects of BPs have shown to be dependent on cell type, we obtained primary 
cell cultures from a clinically relevant animal model in order to verify our findings. Moreover, we 
were interested in whether the effects of BP treatment in vivo could persist well after 
administration. Relatively lower-affinity BPs have demonstrated extended bone mineral density 
maintenance for up to a year despite a resolution of turnover markers with that time frame. This 
indicates that the primary determinant of the antiresorptive potency for bisphosphonates is more 
likely to be the biochemical and cellular effects of BPs on bone cells, as illustrated by correlations 
between potency for effects at the molecular/cellular level and antiresorptive potency in animal 
models.259 9-month old female rats were used in the present study because they closely match 
the age when human patients would likely begin receiving BPs as a first line therapy for 
metabolic bone disorders.260 
Ibandronate was selected for the animal study out of the three tested BPs since it has an 
average inhibitory potency compared to other nitrogen containing BPs.259 Ibandronate 
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conditioned rOBs displayed decreased markers of osteogenesis compared to PBS conditioned 
rOBs. Unlike MG63 cells, however, BP treatment decreased osteoprotegerin production and 
increased RANKL production on microstructured surfaces. Previously, it was shown that the 
osteoblast-specific production of osteoprotegerin decreases while RANKL increases with age in 
humans261 and rodents.79 Perhaps the maturation of aged osteoblasts facilitated by 
microstructured Ti surfaces accelerates this senescent-like phenotype. Additionally, BPs have 
been shown to increase serum osteoprotegerin in vivo, which correlates with increased bone 
mineral density.262 It is unknown if the increased osteoprotegerin reflects a direct effect of BPs 
on osteoblasts or an indirect effect by altering osteoclastogenesis and thereby altering the 
catabolism of osteoprotegerin. Regardless, our data suggest that the effects of BP treatment 
persists well after administration in vivo, and negatively influences the ability of osteoblasts 
isolated from BP-treated animals to undergo osteogenesis on microstructured surfaces in vitro. 
The present study is not without its limitations. First, the correlation between BP potency in 
vitro and in vivo is rather poor, which may be due to the lack of consideration of the relative 
affinity of BPs for bone when establishing in vitro models. Moreover, there is little information on 
the concentrations that osteoblasts, osteocytes, or osteoclasts are exposed to in vivo, so our 
experiment was designed to mimic clinical treatment.233,263–265 Treatment method, dose, and 
frequency were determined based on findings that total amount, not frequency, of ibandronate 
injections is important for drug efficacy and the optimal dose was 1.0μg/kg.263–265 Subcutaneous 
injection was chosen instead of oral administration to ensure total dosage delivery to each rat. 
25 days was chosen to mimic monthly injections used clinically while also minimizing distress 
arising from frequent injections. It should be noted that 1.0μg/kg of ibandronate is approximately 
83.5 M, which is roughly 8 times higher than the highest concentration used for in vitro 
experiments.  
Perhaps the most important limitation to our study is that the main cell type investigated was 
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the MG63 cell line, which are immature osteoblast-like cells originally isolated from a male 
human osteosarcoma and most recipients of BPs are post-menopausal females. BPs have been 
frequently demonstrated to elicit antitumor effects including inhibition of proliferation and 
induction of apoptosis in human myeloma cells266,267 and osteosarcoma cells268,269 in vitro. The 
exact mechanisms for the observed antitumor effects are unclear, although studies suggest BPs 
may act by decreasing certain tumor-stimulating cytokines like TGFβ1270 or by decreasing 
angiogenic factors like VEGF.271,272 Production of both latent TGFβ1 and VEGF were inhibited 
by BPs when MG63 cells were cultured on SLA and mSLA surfaces but not in TCPS or PT 
cultures. Although ibandronate inhibited VEGF production in TCPS and PT cultures at all 
concentrations, alendronate inhibited production of VEGF on TCPS at 10-6M compared to no 
treatment, while zoledronate inhibited production of latent TGFβ1 in TCPS cultures and VEGF 
on PT cultures compared to no treatment. Moreover, certain concentrations of BPs favored 
proliferation over apoptosis as indicated by cell number and DNA content. In general, much 
higher concentrations (>10μM) of BPs than what was used for the present experiments are 
needed to affect tumor cell proliferation and survival.273,274 Furthermore, confirmation of the 
effects in primary rOBs also serves to eliminate any possible tumor specific effects. 
Conclusions 
We have shown that MG63 cells and rOBs are sensitive to surface roughness and 
hydrophilicity and their response to nitrogen containing BPs is modified by this topography. Since 
BP treatment was more robust in cells cultured on rough and/or hydrophilic surfaces compared 
to smooth substrates, this effect may be dependent on cell maturation state, as well as donor 
sex and age. These results suggest that bisphosphonate exposure may jeopardized the pro-
osteogenic response osteoblasts have to microstructured surfaces. Their effects persist in vivo 
and condition osteoblasts to negatively influence their in vitro response. Clinically, 
bisphosphonates could compromise peri-implant bone formation slowing the rate and quality of 
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implant osseointegration. Although our results were observed in both MG63 cells and rOBs, 
confirmation of our findings in vivo need to be conducted. 
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Chapter 7. Ibandronate Treatment Before and After 
Implant Insertion Impairs Osseointegration in Aged 
Rats with Ovariectomy Induced Osteoporosis 
Abstract 
Excessive decreases in bone volume (BV) and bone mineral density (BMD) can lead to 
osteoporosis, potentially hindering implant osseointegration. Bisphosphonates are commonly 
used to combat osteoporosis by slowing osteoclast-mediated resorption; however, functional 
osteoclasts are integral to bone remodeling and, thus, implant osseointegration, potentially 
contraindicating bisphosphonate use during implantation. To optimize the use of implant 
technologies in patients with compromised bone structure and metabolism, we need a more 
complete understanding of the biological response to surface design. The goal of this study was 
to assess the effects of osteoporosis and bisphosphonates on osseointegration of titanium (Ti) 
implants with microstructured surfaces, which have been shown to support osteoblast 
differentiation in vitro and rapid osseointegration in vivo. Forty, 8-month-old, virgin, female CD 
Sprague Dawley rats underwent ovariectomy (OVX) or sham (SHOVX) surgery. After 5 weeks, 
animals were injected subcutaneously with either the bisphosphonate (BIS), Ibandronate 
(25μg/kg), or phosphate-buffered saline (PBS) every 25 days. 1 week after the initial injection, 
Ø2.5mm x 3.5mm microrough (SLA; grit-blasted/acid etched) implants were placed 
transcortically in the distal metaphysis of each femur resulting in four groups: 1) SHOVX+PBS; 
2) SHOVX+BIS; 3) OVX+PBS; and 4) OVX+BIS. After 28d, qualitative properties of the bone 
and implant osseointegration were assessed using micro-computed tomography (microCT), 
calcified histomorphometry (Van Gieson’s stain), and removal torque testing. microCT revealed 
decreased bone volume in OVX rats, which was slowed by bisphosphonate treatment. Reduced 
bone-to-implant contact (BIC) was evident in OVX+PBS compared to SHOVX+PBS. Although 
BV/TV was increased in OVX+BIS compared to OVX+PBS, bisphosphonate treatment had no 
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effect on BIC. Removal torque testing revealed a higher maximum torque, torsional stiffness, 
and torsional energy in SHOVX compared to OVX with no effects due to bisphosphonate 
treatment. Our results show that osseointegration is decreased in osteoporotic animals. 
Ibandronate halts the progression of osteoporosis but does not enhance osseointegration. 
Introduction 
Sufficient bone volume (BV) and bone mineral density (BMD) are two of the most important 
patient factors for predicting the long-term success of dental and orthopaedic implant 
osseointegration, which is defined as the direct anchorage of an implant to mature bone tissue 
without the growth of fibrous tissue.275–277 These factors significantly diminish with age and their 
reduction is exacerbated by certain factors including postmenopausal estrogen deficiency. 
Osteoporosis is also characterized by excessive decreases in BMD and BV as a result of 
increased rates of bone turnover. An estimated 53.6 million U.S. adults over the age of 50 were 
affected by osteoporosis or osteopenia in 2010.4 By 2030, its prevalence is projected to increase 
to 71.4 million people.4 Furthermore, 80% of those affected by osteoporosis were 
postmenopausal women.4 Although data on the outcomes of dental and orthopaedic implants in 
osteoporotic patients are very limited, the compromised qualitative properties of the bone, 
strength, and healing associated with osteoporosis suggest these patients experience lower 
rates of implant success. 
Healthy osseointegration is critically dependent on bone remodeling, which involves the 
reciprocal communication among osteoblasts, osteoclasts, mesenchymal stem cells (MSCs), 
and osteoclast precursors (OCPs).195,196,278 During remodeling, osteoclasts resorb a volume of 
bone leaving behind a foundation with a specific chemistry,55 stiffness,153 and morphology206 for 
osteoblasts to synthesize and calcify their matrix. Osteoclasts produce factors (both independent 
and as a byproduct of matrix resorption) capable of regulating MSC and osteoblast migration 
and their subsequent osteogenesis.32 In turn, MSCs and osteoblasts release factors capable of 
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limiting the degree and extent to which osteoclasts resorb bone. Any defects in the coupling of 
bone resorption to bone formation has not only been implicated in impaired healing and 
osseointegration but also the onset and progression of osteoporosis. Although age-related 
mechanisms contributing to osteoporosis may originate from accelerated bone resorption or 
impaired bone formation,279 these processes are not independent. 
Bisphosphonates are commonly used to combat osteoporosis by targeting osteoclasts, 
slowing the rate and severity of bone resorption. These events translate to decreased bone 
turnover and increased BV and BMD.280 Bisphosphonates have also been reported to exert 
anabolic effects on osteoblasts in vitro by stimulating proliferation236,237, preventing 
apoptosis,235,281 and enhancing production of alkaline phosphatase, bone morphogenetic protein 
(BMP)-2, type-I collagen, and osteocalcin,237,282–284 The positive effects bisphosphonates have 
on osteoblasts has provided some rationale for their use to enhance osseointegration. Other 
studies, however, have reported impaired mineralized bone nodule formation238,240 and 
responses to parathyroid hormone (PTH) with bisphosphonates.241,285–288 Furthermore, 
bisphosphonates can impede angiogenesis242,289,290 and are associated with osteonecrosis of 
the jaw (ONJ) at high doses,244,291 both of which can be detrimental to peri-implant bone 
formation and osseointegration. Moreover, functional osteoclasts are integral to healthy bone 
remodeling. Therapeutic interventions targeting either half of this process will inevitably affect its 
counterpart, contraindicating the use of bisphosphonates when bone remodeling is of the utmost 
importance like implant osseointegration. 
Considering the growing number of osteoporotic patients292 and high rate of bisphosphonate 
prescriptions,293 the success of implant outcomes and osseointegration in this demographic has 
turned into a significant dental and orthopaedic challenge. To optimize the use of implant 
technologies in patients with compromised bone structure and metabolism, a more complete 
understanding of the biological response to surface design and the impact of bisphosphonate 
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treatments on osseointegration are needed. The goal of this study was to assess the effects 
post-menopausal osteoporosis and bisphosphonate treatment have on the osseointegration of 
clinically used microstructured titanium (Ti) implants. 
Materials and Methods 
This study was conducted under approval of the Institutional Animal Care and Use 
Committee at Virginia Commonwealth University. All experiments were carried out in 
accordance with approved procedures and reported according to ARRIVE guidelines. All 
animals were treated humanely per the guidelines outlined in the Guide for the Care and Use of 
Laboratory Animals by the National Institutes of Health. Animals were single-housed in an 
individually ventilated, solid-bottomed polysulfone cage and kept at a temperature of 17-28ºC 
with a humidity of 40-70% and a 12/12 h light/dark cycle. 
Implant Preparation 
 Ti implants were designed to fit a rat femur and provided by Institut Straumann AG (Basel, 
Switzerland). 3.5mm long implants with a 2.5mm outer diameter and a 0.8mm pitch were initially 
machined from a rod of grade 4 Ti. They were then processed for 30s in a 55°C 2% ammonium 
fluoride/2% hydrofluoric acid/10% nitric acid solution. Implants were sand-blasted with large grit 
particulate (250 – 500 µm corundum) followed by acid etching in a boiling mixture of HCl and 
H2SO4 to generate implant with a surface similar to the clinically used SLA implant.52 Implants 
were cleaned in HNO3, rinsed in ultrapure water, packed in aluminum foil, and γ-irradiated before 
use. 
Implant Characterization 
Scanning Electron Microscopy (SEM) 
Scanning electron microscopy (SEM; Hitachi SU-70 FE-SEM, Hitachi, Tokyo, Japan) was 
used to qualitatively evaluate implant surface structure and roughness. Six images at varying 
magnifications were captured on 3 implants per surface modification using 5 kV accelerating 
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voltage for a total of 18 images. 
Laser Confocal Microscopy 
Laser confocal microscopy (LCM, Zeiss LSM 710, Zeiss, Oberkochen, Germany) was used 
to quantitatively evaluate surface micro-roughness. Measurements on each implant (n=3) were 
taken over an area of 106.2µm x 106.2µm with a 20x objective and a scanning pitch of 50nm. A 
Gaussian high-pass filter with a cutoff wavelength of 100µm was used when calculating average 
surface roughness (Sa) over three scans per implant (total n=9). 
X-Ray Photoelectron Spectroscopy (XPS) 
Chemical composition of the samples (n=3) was obtained from the sample surfaces by XPS 
(Thermo K-Alpha XPS, Thermo Fisher Scientific, Waltham, MA, USA). Spectra were collected 
using a 500µm spot size, using an XR5 gun and Al Kα x-ray source at 15kV. Scans were taken 
with a 20ms dwell time and 1eV step size. Three different locations on each sample (total n=9) 
were analyzed. 
Animals and Surgical Procedures 
A schematic detailing the timing of surgical procedures and treatments is shown in Figure 
26. All surgical procedures were performed at the same session under isoflurane inhalation 
anesthesia. 40, 8-month-old, skeletally mature, virgin, female CD Sprague-Dawley rats (Charles 
River Laboratories, Wilmington, MA) underwent ovariectomy (OVX; n=20) or sham OVX 
(SHOVX; n=20) surgery. The OVX and SHOVX surgeries were performed by Charles River 
Laboratories. Development of the osteoporotic phenotype occurred over the next 5 weeks.  
Bisphosphonate Treatment 
Animals received two bisphosphonate injections. The first injection was at 5wk post-OVX; 
animals received subcutaneous injections of either the bisphosphonate (BIS), ibandronate 
(AuroMedics Pharma LLC, Dayton, NJ, USA) (25μg/kg), or phosphate buffered saline (PBS) 
resulting in four groups: 1) SHOVX + PBS (n=10 animals); 2) SHOVX + BIS (n=10 animals); 3) 
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OVX + PBS (n=10 animals); 4) OVX + BIS (n=10 animals). One week after the first injection, the 
implants were placed (described below). Animals received a second injection of ibandronate or 
PBS 25 days after the first injection; thus, animals had bisphosphonate treatment before and 
after the placement of the implants. Treatment method, dose, and frequency were based on 
previous reports detailing that total amount, not frequency, of ibandronate injections is important 
for drug efficacy with an optimal dose of 1.0μg/kg/day.294 A subcutaneous injection was chosen 
over oral administration to ensure total dosage delivery to each rat. 25 days was chosen to mimic 
monthly injections used clinically while also minimizing distress arising from frequent injections. 
This timing has also been successfully employed previously.295 
Transcortical Implant Surgeries 
One week after the first injections, SLA modified implants were placed transcortically into the 
Figure 26. Schematic of the Experimental Procedures. 40, 8-month old, skeletally mature, virgin, female CD Sprague-
Dawley rats underwent ovariectomy (OVX; n=20) or sham OVX (SHOVX; n=20) surgery. After 5 weeks, animals were injected 
with either ibandronate (BIS) or phosphate buffered saline (PBS) at a concentration of 25µg/kg/25days followed by insertion 
of a Ti SLA implant 1 week later. Implants were allowed to osseointegrate for 28d. 
Osseointegration in Metabolically Compromised Conditions • Spring 2019 
Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 115 
distal metaphysis of both femurs. Animals were anesthetized with 5% isoflurane gas inhalation. 
The hind limbs were prepared by shaving and cleaning using ethanol and chlorohexidine. 
Anesthesia was maintained at 4% isoflurane in O2 gas inhalation for the duration of the surgical 
procedure. Cleaned, anesthetized animals were placed in a supine position and covered with a 
sterile surgical drape. An 8mm incision was made over the medial side of the right knee. 
Overlying muscle was separated, and the distal femur was exposed using blunt dissection to a 
point immediately above the articular capsule. A high-speed dental hand-piece was used to 
create a progressively larger pilot hole in the distal femur using a series of increasing diameter 
drill bits (Ø1.0mm, Ø1.6mm, Ø2.0mm, and Ø2.2mm) with a 3.5mm drill stop. Ti SLA implants 
were then screwed into place by hand using a custom-made driver. Following implant placement, 
custom-made stainless-steel cover screws were placed on the end of the implant to prevent 
bone from growing into the internal threading of the implant. The periosteum and muscle were 
reapposed and sutured in place using resorbable sutures and the skin was closed with 9mm 
wound clips. These steps were then repeated for the left femur. Animals recovered from 
anesthesia on a water-circulating warming pad and were injected subcutaneously with 1mg/kg 
buprenorphine SR LAB. All animals had access to water ad libitum for the duration of the study; 
however, food access was regulated. 
Diet and Pair Feeding 
The diet of ovariectomized animals is a potential source of at least two confounding variables. 
The first is the tendency of rats to have increased appetites following OVX. This can lead to 
excessive weight gain potentially altering the mechanical loading on the implant thus affecting 
the osseointegration.296 In order to eliminate weight gain as a confounding variable, the animals 
in this study were pair fed. Each week SHOVX+PBS animals had their food intake monitored by 
calculating the difference in available food weight in a 24-hour period. The average difference 
across the four SHOVX+PBS animals was given to each animal in the three remaining groups 
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daily. The success of the pair feeding regimen was verified by weekly weighing of all animals for 
the duration of the study. 
The content of the food can also confound the results studies involving ovariectomized 
animals. Many rodent feeds are made from products known to contain phytoestrogens. 
Phytoestrogens are structurally similar with 17β-estradiol causing them to have estrogenic 
and/or anti-estrogenic effects potentially preventing bone loss.297 Because the dietary estrogenic 
activity is a concern, all animals were given a phytoestrogen-free diet (Advanced Protocol 
Verified Casein Diet 10 IF, LabDiet, St. Louis, MO, USA). 
Tissue Analysis 
 Transcortical implants were allowed to osseointegrate for 28d, after which rats were 
euthanized via CO2 inhalation. The hind limbs from each animal were isolated for removal torque 
testing (n=5 animals/group) or micro-computed tomography (microCT) and histological analysis 
(n=5 animals/group). Each limb was treated as a separate sample providing an effective sample 
size of 10 per group for both the removal torque testing and microCT/histological analysis. 
MicroCT 
MicroCT (SkyScan 1173, Bruker, Kontich, Belgium) was used to assess the osteoporotic 
phenotype in the femoral head as well as evaluate peri-implant bone growth and bone-to-implant 
contact (BIC) in the distal femur. Femurs used for microCT were stored and fixed in 10% neutral 
buffered formalin for at least 24hr prior to imaging. The femoral heads of fixed samples were 
scanned at a resolution of 1120x1120 pixels (image pixel size of 12.94µm) over 360° using a 
1.0mm aluminum filter, 85kV voltage, 94μA current, and 270ms exposure time. 5 x-ray 
projections were acquired every 0.2° and averaged. A standard Feldkamp reconstruction was 
done using NRecon Software (Bruker) with a beam hardening correction of 20% and a Gaussian 
smoothing kernel of 0. To calibrate for cortical tissue mineral density and trabecular bone mineral 
density, 4mm epoxy resin rods containing concentrations of 0.25 and 0.75gcm-3 calcium 
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hydroxyapatite (CaHA). Cortical and trabecular bone were isolated, and densities determined 
separately using CTAn analysis software (Bruker). Total porosity and trabecular number were 
also quantified from the isolated trabecular bone. 
The distal femoral metaphysis was scanned at a resolution of 1120x1120 pixels (image pixel 
size of 13.66µm) over 360° using a 0.25mm brass filter, 120kV voltage, 66μA current, and 420ms 
exposure time. 5 x-ray projections were acquired every 0.2° and averaged. After reconstruction, 
a uniform volume of interest (VOI) was isolated. The VOI began at the base of the implant and 
extended 3mm towards its apex to eliminate any variability arising from the implant not being 
exactly at bone level for every sample. The VOI was shrink-wrapped, dilated 2 pixels around the 
implant, and subtracted from the original VOI. The remaining bone and implant were thresholded 
and quantified as the total bone volume (BV) and then normalized to the total uniform VOI (TV) 
to get bone volume over total volume (BV/TV). The BIC was calculated using a separate BV that 
encompassed only the bone in direct contact with the implant. The same VOI was dilated 10 
pixels around the implant, rethresholded, further dilated by 3 pixels, and subtracted from the 
original VOI. After eroding the remaining VOI by 3 pixels, the remaining BV was normalized to 
the implant volume. 
Histology 
 Following imaging with microCT, samples were placed in fresh 10% neutral buffered 
formalin and sent to be commercially processed for calcified histological staining (Histion, 
Everett, WA, USA). Femurs were embedded in methyl methacrylate, sectioned longitudinally 
relative to the implant and transaxially relative to the femur (transcortical), and stained with 
Stevenel’s blue and van Gieson. Sections were imaged using bright field light microscopy with 
an AxioCam MRc5 camera and Axio Observer Z1 and analyzed using ZEN 2012 Blue Edition 
software (Zeiss). Histomorphometry was then used to evaluate peri-implant bone growth and 
BIC. 
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New peri-implant bone growth was quantified within a uniform rectangular region of interest 
(ROI) for all samples that was 3.56mm in width by 3.0mm in length with an area of 10.7mm2. 
The ROI was drawn 0.3mm beneath the distal portion of the implant and centered. The area of 
all bone within the ROI was then quantified (BV) and normalized to the area of the ROI (TV). 
The area of bone contained within the ROI divided by the area of the ROI was defined as the 
histological BV/TV. In addition, the perimeter of the implant contained within both the trabecular 
region and the cortical region of the bone was measured. The trabecular BIC and cortical BIC 
were determined by dividing the length of bone in direct contact with the implant by the trabecular 
and cortical perimeter length respectively. The total BIC was calculated by summing both lengths 
of contact and dividing by the total perimeter of the implant. 
Removal Torque 
Removal torque testing was performed on fresh, non-fixed samples using an ElectroForce 
3200 Series III test instrument (TA Instruments, New Castle, DE, USA). Because of their 
asymmetrical shape, femurs were mounted in 1cm diameter flexible polyurethane tubing to 
ensure no movement of the femur during analysis (Fig.31A). The tubing was cut into 5cm 
segments and halved longitudinally to provide access to the transcortical implant. Femurs were 
secured to the tubing with polyurethane adhesive and allowed to cure overnight at 4°C prior to 
testing. The transcortical implant in each hind limb was then fit to a custom-made driver and 
aligned to the testing machine axis to ensure no initial torque was present on the implant (0Nm). 
A clamp was then carefully tightened, securing each sample in place with no initial compressive 
load present on the implant (0Nm). A 0Nm compressive load was critical to guarantee no axial 
mismatch between the implant and the testing apparatus, which could greatly alter our results. 
Torque was then applied to each sample with a rotational speed of 0.1°s-1 with an axial 
displacement of 0.8mm/360° to ensure no compressive load was applied to the sample during 
the duration of each test. Torque vs. degree graphs were generated for each sample and fit to 
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a bilinear model in order to distinguish the toe-region from the linear region using an open-source 
least squares spline modeling package (SLM - Shape Language Modeling version 1.14) for 
MATLAB (MathWorks, Natick, MA, USA). The linear region of each graph was then evaluated 
for the maximum torque, torsional energy (area below linear region), and torsional stiffness 
(slope of linear region). 
Osteoblast Response In Vitro 
To further assess the effects of bisphosphonate treatment, following euthanasia, calvarial 
osteoblasts were isolated from the frontal and parietal bones of rats in each of the four 
experimental groups. After removal of the periosteum and soft tissue, bone fragments were 
digested for 15min at 37°C with 0.25% trypsin-EDTA (Life Technologies, Carlsbad, CA). Bones 
were minced into pieces approximately 1mm x 1mm and placed into a 100mm x 20mm Petri 
dish with Dulbecco’s modified Eagle medium (DMEM; Mediatech, Manassas, VA) + 10% fetal 
bovine serum (FBS) + 1% penicillin-streptomycin (Life Technologies). At confluence, cells were 
subpassaged and cultured as above. The osteoblast phenotype of each of the four groups of 
isolated cells was confirmed by measuring alkaline phosphatase specific activity and osteocalcin 
production after treatment of confluent cultures with either 0M or 10-8M 1α,25-dihydroxy vitamin 
D3 (1α,25(OH)2D3; Enzo Biochem, Farmingdale, NY) for 24hrs on tissue culture polystyrene 
(TCPS). 
Validated rat osteoblasts (rOBs) from each experimental group were cultured on TCPS or 
15mm Ti SLA disks. Disks were prepared from Ti sheets but subjected to the same sand-blasting 
and acid etching procedure as described above. Cells were plated at a density of 10,000 
cells/cm2 and incubated at 37°C in an atmosphere of 5% CO2 and 100% humidity. Media were 
changed 24h after plating and every 48h thereafter for 7d. At 7d, cells were incubated with fresh 
DMEM for 24h. Media were collected and immunoassays were used to measure levels of intact 
rat osteocalcin (Alfa Aesar, Haverhill, MA) rat/mouse osteopontin (R&D Systems, Minneapolis, 
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MN), mouse osteoprotegerin (R&D Systems), human/mouse/rat BMP2 (PeproTech), mouse 
receptor activator of nuclear kappa-B ligand (RANKL; R&D Systems), and rat vascular 
endothelial growth factor-A (VEGF; R&D Systems). 
After collection of media, cell monolayers were washed twice with 0.2ml PBS, lysed in 0.05% 
Triton X-100, and homogenized by sonication at 40 amplitude using a Vibra-Cell ultrasonicator 
(Sonics & Materials Inc., Newtown, CT). DNA content in the cell layer lysate was measured with 
PicoGreen (Promega, Madison, WI) using a Synergy H1 Hybrid Reader fluorescence detector 
(BioTek, Winooski, VT) at an excitation of 485 nm and emission of 538 nm. Alkaline phosphatase 
specific activity [orthophosphoric monoester phosphohydrolase, alkaline; E.C. 3.1.3.1] was 
assayed by measuring the conversion of p-nitrophenylphosphate to p-nitrophenol at pH 10.25 
and temperature of 37°C. Absorbance was measured at 405nm. Activity was normalized to total 
protein content in the cell lysates as determined by bicinchoninic acid protein assay kit (Thermo 
Fisher Scientific, Waltham, MA). Immunoassay data were normalized to DNA content. 
Statistical Analysis 
Based on previous studies,193,296 in order to detect a 30% mean difference with 20% variance 
and a type I error rate of 0.05, a two-tailed one-way ANOVA power analysis determined a sample 
size of 10 per group is necessary to maintain 80% power. In order to ensure that differences in 
mechanical loading would not affect the results, identical implants were placed in the right and 
left hind limbs. In addition, animals received the same systemic treatment (e.g. OVX/SHOVX or 
ibandronate/PBS), which prevents any potential carry-over effects between legs. Since both legs 
were treated identically, it is safe to assume that movement or loading in one limb will not affect 
the movement or loading experienced by the other limb. The design of our study permits the 
assumption that implants from individual limbs can be treated as independent data points rather 
than dependent. Data are presented as the mean ± standard error (SE) for each analysis. All 
cell culture experiments had a sample size of six (n=6) and repeated at least three times to 
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ensure validity of the results. Data shown in the figures are from representative experiments. A 
one–way analysis of variance with a two-tailed Tukey correction was performed to adjust for 
multiple comparisons to maintain an experiment-wise error rate (α) of 0.05. All statistical 
analyses were performed using JMP statistical software (SAS Institute, Cary, NC, USA).  
Results 
Transcortical Implant 
Characterization 
Qualitative images of 
the transcortical Ti SLA 
implants as well as the 
cover screw are shown in 
Figure 27. Gross 
morphology of the 
stainless-steel cover 
screw and Ti SLA implant 
can be seen in Figure 
27A and Figure 27B 
respectively. SEM images 
of the transcortical Ti SLA 
implants (Fig.27C – F) reveal the rough surface induced by the sand-blasting and acid etching 
procedure, resulting in a combination of microscale and submicron-scale surface features. 
These complex features were also strewn with unmodified areas characterized by flat and 
smooth sections. Together the sand-blasting and acid etching procedure led to an average 
surface roughness (Sa) of 3.91 ± 0.09 µm as measured by confocal microscopy (Table 4). XPS 
survey spectra (Table 4) displayed titanium (Ti), oxygen (O), and carbon (C) as the main atomic 
Figure 27. Qualitative Characterization of Ti SLA Implants. Photographs showing the 
dimensions of the stainless-steel cover screw (A) and Ti SLA implant (B). The space 
between each mark represents 1mm. Surface morphology was assessed using 
scanning electron microscopy (C – D). 
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components of the SLA implant. 
Evaluation of Pair Feeding and Osteoporotic Phenotype 
Animals from the four groups maintained similar weights and levels of activity throughout the 
duration of the study. Select week results from the overall ANOVA F-test (Week 1: F3,36 = 1.5, p 
= 0.2376; Week 4: F3,36 = 1.1, p = 0.3467; Week 8: F3,36 = 0.6, p = 0.6041; Week 10: F3,36 = 0.2, 
p = 0.8946) indicate a successful pair feeding regimen. 
MicroCT was used to evaluate the osteoporotic phenotype of the femoral head with 
representative images shown in Figure 28A – D. The cortical tissue mineral density (Fig.28E) 
was not affected by the OVX nor treatment with ibandronate. However, the trabecular bone 
mineral density (Fig.28F) was significantly reduced in OVX animals compared to SHOVX 
animals. Treatment with ibandronate mitigated the loss of the trabecular bone mineral density. 
Total porosity (Fig.28G) was increased in OVX animals receiving PBS compared to SHOVX 
animals. OVX animals receiving ibandronate had a total porosity similar to both SHOVX animals 
and OVX animals receiving ibandronate. Trabecular number (Fig.28H) decreased in OVX 
animals receiving PBS compared to the other groups. 
MicroCT 
3D reconstructions of microCT scans (Fig.29A – D) showed peri-implant bone formation in 
all animal groups. Furthermore, the transcortical implants did not contact the growth plate 
eliminating any potential influence on the bone formation in our defined VOI. The BV/TV 
(Fig.29E) decreased in OVX animals compared to SHOVX, and the severity of the reduction 
was lessened in OVX animals receiving ibandronate. Osseointegration was achieved in all 
animal groups as well. BIC values (Fig.29F) obtained through microCT analysis were reduced 
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in OVX animals compared to SHOVX animals after 4 weeks. Ibandronate treatment of both 
SHOVX and OVX animals did not influence BIC values. 
 
Figure 28. Characterization of the Ovariectomy Induced Osteoporotic Phenotype. 8-month-old, female, virgin, CD Sprague 
Dawley rats underwent sham ovariectomy (SHOVX) or ovariectomy (OVX) surgery. After 5 weeks, animals were injected with 
either ibandronate (BIS) or phosphate buffered saline (PBS) at a concentration of 25µg/kg/25days followed by insertion of a 
Ti SLA implant 1 week later. After 28d of osseointegration, femurs were isolated and placed in 10% formalin. Femoral heads 
of the animals were analyzed with 3D microCT reconstructions (A – D). Cortical tissue mineral density (E), trabecular bone 
mineral density (F), total porosity (G), and trabecular number (H) were quantified from the microCT reconstructions. Data 
shown are the mean ± standard error (SE) of ten samples. Groups not sharing a letter are statistically significant at an α=0.05. 
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Figure 29. MicroCT Assessment of Implant Osseointegration. 8-month-old, female, virgin, CD Sprague Dawley rats underwent 
sham ovariectomy (SHOVX) or ovariectomy (OVX) surgery. After 5 weeks, animals were injected with either ibandronate (BIS) 
or phosphate buffered saline (PBS) at a concentration of 25µg/kg/25days followed by insertion of a Ti SLA implant 1 week 
later. After 28d of osseointegration, femurs were isolated and placed in 10% formalin. Distal femurs of the animals were 
analyzed with 3D microCT reconstructions (A – D). Bone volume over total volume (BV/TV; E) and bone-to-implant contact 
(BIC; F) were quantified from the microCT reconstructions. Data shown are the mean ± standard error (SE) of ten (n=10) 
independent samples. Groups not sharing a letter are statistically significant at an α=0.05. 
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Histology 
Histological sections of transcortical implants from each animal group (Fig.30A – D) 
confirmed the results seen from the microCT analysis. More trabecular bone can be seen in the 
SHOVX groups (Fig.30A, B) compared to the OVX groups (Fig.30C, D). Quantification of the 
total bone area with a fixed region of interest (Fig.30E) was significantly higher in SHOVX 
animals compared to OVX animals. Administration of ibandronate mitigated some of the loss in 
OVX animals. BIC (Fig.30F) was higher in SHOVX compared to OVX animals and were not 
influenced by ibandronate treatment. 
Figure 30. Histological Assessment of Implant Osseointegration. 8-month-old, female, virgin, CD Sprague Dawley rats 
underwent sham ovariectomy (SHOVX) or ovariectomy (OVX) surgery. After 5 weeks, animals were injected with either 
ibandronate (BIS) or phosphate buffered saline (PBS) at a concentration of 25µg/kg/25days followed by insertion of a Ti SLA 
implant 1 week later. After 28d of osseointegration, femurs were isolated and placed in 10% formalin. Distal femurs of the 
animals were embedded in methyl methacrylate, sectioned longitudinally relative to the implant and transaxially relative to the 
femur (transcortical), and stained with Stevenel’s blue and van Gieson (A – D). Bone volume over total volume (BV/TV; E) 
and bone-to-implant contact (BIC; F) were quantified using histomorphometrics. Data shown are the mean ± standard error 
(SE) of six ten (n=10) independent samples. Groups not sharing a letter are statistically significant at an α=0.05. 
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Mechanical Testing 
Isolated femurs were secured in polyurethane tubing and aligned to the machine axis in a 
custom-fabricated sample holder to ensure no movement was created during the test (Fig.31A). 
Representative torque vs. degree graphs for each group (Fig.31B – E) display the bilinear model 
(red) fit to the experimental data (blue). The end of each curve identifies failure, and no 
secondary peaks were observed for any sample. The middle vertical dashed line (black) 
Figure 31. Removal Torque Assessment of Implant Osseointegration. 8-month-old, female, virgin, CD Sprague Dawley rats 
underwent sham ovariectomy (SHOVX) or ovariectomy (OVX) surgery. After 5 weeks, animals were injected with either 
ibandronate (BIS) or phosphate buffered saline (PBS) at a concentration of 25µg/kg/25days followed by insertion of a Ti SLA 
implant 1 week later. After 28d of osseointegration, femurs were isolated, and analyses were performed on fresh, non-fixed 
samples as outlined (A). Torque vs. degree graphs were generated for each sample and fit to a bilinear model in order to 
distinguish the toe-region from the linear region (B – E). The linear region of each graph was then evaluated for the maximum 
torque (F), torsional energy (G), and torsional stiffness (H). Data shown are the mean ± standard error (SE) of ten (n=10) 
independent samples. Groups not sharing a letter are statistically significant at an α=0.05. 
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separates the toe region (left section) and the linear region (right section) as determined by the 
least squares spline modeling package in MATLAB. The maximum torque (Fig.31F) and 
torsional energy (Fig.31G) was greatest in SHOVX animals and significantly reduced in OVX 
animals. Ibandronate treatment had no effect on either parameter. Torsional stiffness (Fig.31H) 
was greatest in SHOVX animals treated with PBS and lowest in OVX animals treated with PBS. 
SHOVX+BIS and OVX+BIS animal torsional stiffness values were not different from either 
SHOVX+PBS or OVX+PBS. 
In Vitro Response of Calvarial Osteoblasts 
1α,25(OH)2D3 stimulated osteocalcin production and alkaline phosphatase specific activity in 
confluent cultures of rOBs from all four experimental groups, confirming their successful isolation 
and expansion. DNA content (Fig.32A) and alkaline phosphatase specific activity (Fig.32B) in 
cultures grown on SLA were lower than in cultures grown on TCPS. DNA content was higher in 
cultures of osteoblasts isolated from ibandronate treated animals grown on TCPS compared to 
the other treatment groups. Among SLA cultures, DNA content was highest in SHAM+BIS 
osteoblasts. Ibandronate treatment decreased alkaline phosphatase specific activity among 
TCPS cultures, but no effect was observed in SLA cultures. SLA increased osteoblast 
osteocalcin (Fig.32C) production in all groups except SHAM+BIS, which remained like TCPS 
cultures. Furthermore, OVX+BIS osteoblasts had decreased osteocalcin production compared 
to OVX+PBS osteoblasts. Osteoprotegerin (Fig.32D) levels decreased in SLA cultures 
compared to TCPS. Osteoblasts isolated from OVX animals had decreased osteoprotegerin 
levels in TCPS cultures, although ibandronate treatment did stimulate its production. Production 
of BMP2 (Fig.32E), osteopontin (Fig.32F), VEGF (Fig.32G), and RANKL (Fig.32H) was 
increased on SLA compared to TCPS with the highest levels of BMP2, osteopontin, and RANKL 
occurring in OVX+PBS osteoblasts. The highest levels of VEGF were observed in SHAM+PBS 
osteoblasts. Ibandronate treatment led to decreased productions of these proteins in SLA 
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cultures compared to their respective PBS controls with SHAM+BIS osteoblasts producing 
amounts of osteopontin and VEGF to levels similar to those observed in TCPS cultures. 
Figure 32. In Vitro Response of Primary Calvarial Osteoblasts. Calvarial osteoblasts were isolated from each of the 
four groups of animals and cultured separately on either TCPS or SLA in DMEM. After 7d, cells were treated with fresh 
DMEM for 24h. After 24h, media were collected, and cell lysates were assayed for DNA content (A) and alkaline 
phosphatase specific activity (B). Media were assayed for osteocalcin (C), osteoprotegerin (D), BMP2 (E), osteopontin 
(F), VEGF (G), and RANKL (H). Data shown are the mean ± standard error (SE) of six (n=6) independent samples. 
Groups not sharing a letter are statistically significant at α=0.05. 
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Discussion 
Osseointegration involves a complex cascade of biological events, ultimately leading to the 
structural and functional connection between mature, lamellar bone and the inserted implant.277 
The cellular miscommunication associated with osteoporosis leads to excessive bone resorption 
and impaired bone remodeling, which challenges successful osseointegration and implant 
outcomes. Although bisphosphonates are known to increase BV and BMD by mitigating the 
resorptive damage caused by overactive osteoclasts, their continued disruption of bone 
remodeling may contribute to greater risks of compromised implant osseointegration. In order to 
improve osseointegration and long-term stability of implants in osteoporotic patients, we sought 
to determine the effects ibandronate treatment has on the osseointegration of microrough Ti 
implants in an aged, OVX-induced osteoporotic rat model. 
In the present study, microCT analyses, calcified histomorphometrics, and removal torque 
testing revealed decreased osseointegration in ovariectomized animals compared to SHAM 
operated controls. Moreover, ibandronate treatment did not affect BIC and removal torque 
values, although it was able to halt the progression of the osteoporotic phenotype as observed 
through increased BV/TV in ovariectomized animals. The physiological consequences of 
osteoporosis are known to alter cellular communication leading to lower qualitative properties of 
the bone and impaired healing.298 It is clear from this study and others that the estrogen deficient 
osteoporotic phenotype negatively impacts implant osseointegration.299–302 Previous studies, 
however, have lauded the use of bisphosphonates to reverse the negative effects of 
osteoporosis on implant osseointegration.303–309 On the other hand, BIC and removal torque 
values were either unaffected308,310 or decreased311 by bisphosphonate therapy in healthy 
animals. Despite the inhibitory effect bisphosphonates have on bone remodeling, the precise 
mechanism of action is not fully understood, which has led to many studies with variations in 
experimental methods. Selection of the appropriate animal model, development of the 
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osteoporotic phenotype, timing of both the bisphosphonate treatment and implant insertion as 
well as the route of bisphosphonate administration and location of implant placement are 
important factors. Conflicting results between these studies and ours can be largely explained 
through these differences. It should also be noted that the femoral implant model is not an exact 
replica of bone turnover in the oral cavity, which could limit the translation of our results to clinical 
outcomes for patients receiving dental implants rather than orthopaedic implants. 
An ovariectomized rat is a well-characterized model that closely mimics postmenopausal 
osteoporosis in humans. Basic multicellular unit-based endocortical and cancellous bone 
remodeling occurs in both rats and humans.312,313 Estrogen deficiency in both humans and rats 
leads to an increased presence of osteoclasts on the endocortical bone surface causing 
cancellous and endocortical bone loss by altering the balance between bone formation and bone 
resorption.314–316 In contrast, there is increased bone formation at the periosteal surface.314,317 
As a result of the opposing changes in radial growth and endocortical remodeling, cortical bone 
volume generally remains unchanged in ovariectomized rats, similar to what was observed in 
this study. However, trabecular bone turnover is known to be elevated in ovariectomized 
rats,318,319 which explains the increased total porosity as well as the decreased trabecular 
number in PBS treated ovariectomized rats. 
Evidence also suggests that both the age of the animal during OVX and implant insertion 
could significantly influence the results. While rats reach skeletal maturity around 3 months, their 
growth rate changes continuously for the first 6 months of life.320 In some instances, bone 
elongation in rats may persist up to their first 8 months.320 OVX of growing rats results in 
cancellous osteopenia due to increased resorption of growth plate calcified cartilage.315 The 
amount of primary spongiosa that serves as a template for future bone apposition is 
subsequently decreased.315 As bone growth slows with age, the contribution of altered 
endochondral ossification to the skeletal effects of OVX diminishes, and the contribution of 
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altered bone remodeling increases and eventually becomes the predominant mechanism for the 
alteration of cancellous bone mass. 
Further methodological complications arise when bone remodeling targeting therapies and 
implant osseointegration are introduced to the ovariectomized rat model. Many previous reports 
using this model to investigate implant osseointegration and bisphosphonate therapy perform 
the OVX surgery in rats under the age of 6 months.303–309 In spite of not approximating the 
relative timing of the onset of menopause in humans, it is difficult to attribute the impaired 
osseointegration to altered bone remodeling. A few of these studies do refer to the 
ovariectomized skeletal phenotype as estrogen-deficient osteoporosis rather than 
postmenopausal; however, no attempt was made to control for the number of phytoestrogens 
present in the animal diet, potentially altering the results. Another study using ovariectomized 6 
– 9 month old retired breeders found that osseointegration of implants was enhanced by 
bisphosphonate therapy.321 The multiple pregnancies and lactations incurred by the retired 
breeders has been shown to result in osteopenia.322 Compared to age-matched virgins, OVX of 
retired breeders results in less bone loss and more variable indices of bone mass and 
turnover.322 
Regardless of the age at OVX, the osteoporotic phenotype needs sufficient time to develop 
as the combination of rat age and skeletal site used influence the resulting temporal pattern of 
bone loss.323 Studies treating animals with bisphosphonates306 or inserting implants305 on the 
same day as the OVX surgery do not fully capture the impact the physiological changes the 
osteoporotic phenotype has on implant osseointegration. Furthermore, studies treating animals 
with bisphosphonates either on the same day of the implant surgery or immediately after are not 
appropriate models to study the effects postmenopausal osteoporosis have on the 
osseointegration of implants. Clinically, patients diagnosed with osteoporosis will not remain 
untreated until after a surgical intervention. 
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The effects of bisphosphonates have also been shown to be dose-dependent and vary with 
the chemistry of the compound being tested. Daily and weekly treatment regimens are available 
for many of these bisphosphonates, but it is predicted that novel and simplified regimens with 
bisphosphonates given at intervals between doses of longer than 1 week will be more convenient 
for patients and improve adherence to therapy. Ibandronate has the potential to be effective 
when administered less frequently than once weekly. Preclinical studies using OVX rats found 
that the lowest dose of ibandronate that completely prevented bone loss was 1 µg/kg/day. 
Although the bone turnover in skeletally mature rats is approximately 3 – 5 times higher 
compared to humans, it decreases with age and OVX.316,324 Considering the age at OVX (8 
months), the bone turnover of the rats used in this study closely reflects that of adult human 
bone. In addition, intermittent and continuous dosing of ibandronate produced similar results, so 
administration of 25 µg/kg/25 days was selected to mimic monthly injections patients would 
receive clinically as well as minimizing animal distress.325 
3.5mm long and 2.5mm wide, grade 4, Ti implants were custom made for this study. This 
design allowed for a transcortical insertion, which more closely mimics clinical procedures as 
opposed to intramedullary canal insertion commonly performed on mice. The SLA surface 
modification is clinically used, and no studies have investigated this topography in response to 
either OVX induced osteoporosis and/or ibandronate treatment. Furthermore, this is the first 
reported use of these transcortical implants custom-made to fit rat femurs. Scanning electron 
microscopy, laser confocal microscopy, and x-ray photoelectron spectroscopy revealed a 
surface morphology, average surface roughness, and surface composition similar to what has 
been previously reported for implants processed in the same manner.209,210,326 
Primary calvarial osteoblasts were obtained from the osteoporotic animals and were used to 
evaluate potential phenotypic and/or proliferative changes. rOBs were cultured on 15mm 
diameter and 1mm thick Ti disks that were processed to have the same surface microstructural 
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features as those seen on the implants used in vivo. Both OVX and ibandronate treatment were 
able to condition rOBs in vivo to alter their response in vitro. Typically, cells cultured on rough 
surfaces display attributes of more differentiated and mature osteoblasts with decreased 
proliferative capacity and cell number than those on TCPS.327 While this was true for all groups, 
rOBs isolated from untreated OVX animals had higher productions of osteogenic markers 
compared to SHOVX, while bisphosphonate treatment decreased osteogenic and angiogenic 
markers compared to PBS treated cells. This suggests that the altered bone remodeling in OVX 
animals may be reinvigorated with implant surface properties, and bisphosphonate exposure 
may jeopardize the pro-osteogenic response osteoblasts have to microstructured surfaces. 
Furthermore, components of the osteoprotegerin/RANKL/RANK system, a critical pathway for 
the regulation of bone remodeling, were affected differently. In this study, rOBs displayed a 
decreased production of osteoprotegerin and an increased production of RANKL compared to 
TCPS. Previous studies have shown that aging in humans 261,328 and rodents78,79 leads to 
increased RANKL and decreased osteoprotegerin production by osteoblasts, which could be 
exacerbated by the enhanced maturation that Ti surfaces facilitate in osteoblasts. Interestingly, 
ibandronate treatment facilitated an increased osteoprotegerin and decreased RANKL 
productions indicating bisphosphonate treatment can influence and condition a shift from bone 
resorption to bone formation at the cellular level. Bisphosphonates have been shown to increase 
serum osteoprotegerin levels and that increases of osteoprotegerin correlate with increases in 
BMD.262 It is unclear if the increased osteoprotegerin reflects a direct effect of bisphosphonates 
on osteoblasts or an indirect effect by altering osteoclastogenesis and thereby altering the 
catabolism of osteoprotegerin. 
Conclusions 
In conclusion, our results show that osseointegration is decreased in osteoporotic animals. 
Clinically relevant doses of ibandronate were able to halt the progression of the osteoporotic 
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phenotype. However, these doses were unable to enhance the osseointegration of microrough 
titanium implants. These in vivo results were supported by in vitro studies examining the 
biological response of primary rat osteoblasts to SLA disks. 
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Chapter 8. Titanium Implant Surface Properties 
Enhance Osseointegration in Aged Osteoporotic 
Rats without Pharmacologic Intervention 
Abstract 
Successful osseointegration involves resorption of primary bone and its replacement with 
mature bone. Osteoporosis compromises bone remodeling, increasing rates of implant failure. 
Anti-osteocatabolic drugs can treat osteoporosis but continue to suppress bone remodeling, 
contraindicating their use during osseointegration. This study determined whether implant 
surfaces that promote osseointegration in normal rats can promote osseointegration in 
osteoporotic rats without pharmacologic intervention. Virgin female 8-month-old CD Sprague 
Dawley rats (N=25) were ovariectomized. At 6 weeks, microstructured/non-
nanostructured/hydrophobic (SLA), microstructured/nanostructured/hydrophobic (SLAnano), or 
microstructured/nanostructured/hydrophilic (mSLA) Ti implants (Ø2.5mm x 3.5mm; Institut 
Straumann AG, Basel, Switzerland) were placed in the distal metaphysis of each femur. At 28 
days, bone quality and implant osseointegration were assessed using microCT, 
histomorphometrics, and removal torque values (RTVs). Calvarial osteoblasts were isolated and 
cultured on Ø15mm SLA, SLAnano, or mSLA discs for 7 days. mSLA promoted increased bone-
to-implant contact and RTVs in vivo and facilitated increased osteoblastic marker production in 
vitro compared to SLA and SLAnano, suggesting that osseointegration occurs in osteoporotic 
animals, and implant surface properties improve its rate. When appropriate microstructure is 
present, hydrophilicity has a greater influence than nanostructures. These results provide critical 
insight for developing implants with improved osseointegration in patients with metabolic 
disorders of bone remodeling. 
Introduction 
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Osteoporosis is a systemic disease characterized by the microarchitectural deterioration of 
bone tissue leading to low bone mass and strength. It is one of the most common metabolic 
diseases and has become a significant topic of public health around the world as many countries 
begin to encounter the morbidities of an aging population. In 2010, the number of U.S. adults 
with osteoporosis or low bone mass (osteopenia) was estimated to be 53.6 million, representing 
54% of the U.S. population over the age of 50 years.4 Moreover, osteoporosis is more prevalent 
in postmenopausal women, affecting over 80% of the total estimated U.S. population with 
osteoporosis.4 The prevalence of the disease will continue to increase as the number of people 
aged 60 or older is expected to grow to nearly 2 billion by 2050.329 The comorbidities of 
edentulism and fracture risk with osteoporosis are driving the necessity to develop more 
permanent, predictable, and complication-free dental and orthopaedic implants for this 
demographic.330 
Osseointegration is important for determining the success of dental and orthopaedic implant 
outcomes as it results in the direct structural and functional connection between the surface of 
a load-bearing implant and living bone.196 This complex biological process involves the modeling 
of primary bone followed by its subsequent remodeling into mature bone, which is achieved 
through a locally regulated communication between bone resorbing osteoclasts and bone 
forming osteoblasts.196 The communication between osteoclasts and osteoblasts is also 
important for maintaining bone homeostasis, and any defects in the coupling of bone resorption 
to formation can lead to osteoporosis.331 Evidence suggests age-related osteoporosis develops 
from a combination of accelerated bone loss owing to excessive resorption and impaired bone 
formation during remodeling.331 Metabolic disorders like osteoporosis could jeopardize the bone 
healing process and thus the predictability of implant osseointegration.332 
Multiple cellular mechanisms that contribute to the dysfunctional coupling in osteoporosis 
have been identified. During osteoporosis development, the proliferation and recruitment of 
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mesenchymal stem cells (MSCs) to the site of resorption is hindered.333–336 MSCs also exhibit a 
reduced capacity to differentiate into osteoblasts and an increased capacity to differentiate into 
adipocytes.337–339 This shift from osteoblastogenesis to adipogenesis has been shown to 
contribute to the development of osteoporosis by reducing bone formation and increasing 
marrow fat accumulation.340,341 Those MSCs that do differentiate into mature osteoblasts suffer 
from a decreased life-span as well as an impaired bone-forming capacity with alterations in 
collagen stability, alignment, and composition.342–346 
Osteoporotic bone cells also have a decreased capacity to regulate osteoclasts as evident 
by their decreased production of transforming growth factor β1 (TGFβ1) and osteoprotegerin 
(OPG) and increased production of receptor activator of nuclear kappa-B ligand (RANKL).77–
79,262 These cells also produce many cytokines that have been implicated as stimulators of 
osteoclastic activity including interleukin 1 (IL-1), tumor necrosis factor α (TNFα), interleukin 6 
(IL-6), prostaglandin E2 (PGE2), and interleukin 11 (IL-11).77,347,348 In many respects, 
osteoporosis can be viewed as a breakdown of healthy cellular communication, a breakdown 
that can be locally reinvigorated using implants with optimized surface parameters. 
Implant surface characteristics have proven important for determining successful dental 
implant outcomes. The positive influence of surface topography on implant osseointegration, 
achieved through grit-blasting and acid-etching, has been a topic of investigation for several 
decades.29,349,350 Today, microrough surfaces dominate the market as they have been shown to 
achieve faster bone integration, a higher percentage of bone to implant contact (BIC), and a 
higher resistance to shear, as determined by removal torque values (RTVs), when compared to 
smooth implant surfaces.35 Surface nanoroughness142 and hydrophilicity55 have also been 
shown to be beneficial, particularly when the surface is microstructured. These features provide 
a surface structure much more analogous to natural bone, thereby influencing the adsorbed 
protein type, quantity, and conformation as well as downstream control of cellular adhesion, 
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proliferation, and differentiation. Moreover, when grown on these substrates, cells produce 
factors that regulate osteoclasts to achieve net new bone formation. It was recently shown that 
MSCs and osteoblasts grown on microstructured surfaces can regulate osteoclast activity and 
gene expression to different degrees depending on the properties of the substrate surface.326 
This suggests that small variations in surface properties alone can drastically regulate the fusion 
of new osteoclasts and the activity of existing osteoclasts. 
Much of the research in the field of implantology has been limited to healthy animals and 
patients. Variations in surface micro/nanoroughness, hydrophilicity, and chemistry may prove 
important when trying to achieve implant osseointegration in compromised patients. To optimize 
the use of implant technologies in patients with compromised bone structure and metabolism, a 
more complete understanding of surface design on osseointegration is needed. The goal of the 
present study was to determine whether changes in surface micro-/nanostructure and 
hydrophilicity are sufficient to promote osseointegration in an aged rat with untreated 
osteoporosis induced by ovariectomy. 
Materials and Methods 
Implant Preparation 
2.5mm diameter, 3.5mm long, 0.8mm pitch, Ti implants were provided by Institut Straumann 
AG (Basel, Switzerland). Implants were machined from a rod of grade 4 Ti degreased in acetone 
and processed for 30s in a 55°C 2% ammonium fluoride/2% hydrofluoric acid/10% nitric acid 
solution. Implants were then blasted with 250 – 500µm corundum and boiled in a mixture of HCl 
and H2SO4. This process was performed in air to generate sandblasted large grit acid etched 
(SLA) implants. A version of this procedure was performed under nitrogen with subsequent 
storage in 0.9% saline to generate modified SLA (mSLA) implants. A subset of mSLA implants 
were aged in saline for 1 month, removed from solution, rinsed in ultrapure water, and 
repackaged in Al foil to generate SLAnano implants. All implants were γ-irradiated before use. 
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Implant Characterization 
Scanning Electron Microscopy 
Scanning electron microscopy (SEM; Hitachi SU-70 FE-SEM, Hitachi, Tokyo, Japan) was 
used to qualitatively evaluate implant surface structure and roughness. Six images at varying 
magnifications were captured on implants (n=3) implants per surface modification using 5kV 
accelerating voltage for a total of 18 images. 
Laser Confocal Microscopy 
Laser confocal microscopy (LCM, Zeiss LSM 710, Zeiss, Oberkochen, Germany) was used 
to quantitatively evaluate surface micro-roughness. Measurements on each implant (n=3) were 
taken over an area of 106.2µm x 106.2µm with a 20x objective and a scanning pitch of 50nm. A 
Gaussian high-pass filter with a cutoff wavelength of 100µm was used when calculating average 
surface roughness (Sa) over three scans per implant (total n=9). 
X-Ray Photoelectron Spectroscopy (XPS) 
Chemical composition of the samples (n=3) was obtained from the sample surfaces by X-
Ray Photoelectron Spectroscopy (XPS, Thermo K-Alpha XPS, Thermo Fisher Scientific, 
Waltham, MA, USA). Spectra were collected using a 500µm spot size, using an XR5 gun and Al 
Kα x-ray source at 15kV. Scans were taken with a 20ms dwell time and 1eV step size. Three 
different locations on each sample (total n=9) were analyzed. 
Animals and Surgical Procedures 
This study was conducted under approval of the Institutional Animal Care and Use 
Committee at Virginia Commonwealth University. All experiments were carried out in 
accordance with approved procedures and reported according to ARRIVE guidelines. All 
animals were treated humanely per the guidelines outlined in the Guide for the Care and Use of 
Laboratory Animals by the National Institutes of Health. Animals were single-housed in an 
individually ventilated, solid-bottomed polysulfone cage and kept at a temperature of 17-28ºC 
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with a humidity of 40-70% and a 12/12 h light/dark cycle.  
A schematic detailing the timing of surgical procedures is shown in Figure 33. Ovariectomy 
(OVX) surgery was performed on 25, 8-month-old, virgin, female CD Sprague-Dawley rats 
(Charles River Laboratories, Wilmington, MA). The OVX induced osteoporotic phenotype 
developed over the next 6 weeks. All animals had access to water ad libitum for the duration of 
the study; however, OVX animals were pair fed a phytoestrogen-free diet (Advanced Protocol 
Verified Casein Diet 10 IF, LabDiet, St. Louis, MO, USA) to age matched sham OVX controls. 
The success of the pair feeding regimen was verified by weekly weighing of all animals for the 
duration of the study, as described previously.85 
Once the phenotype developed, SLA (n=10 animals), mSLA (n=10 animals), or SLAnano 
(n=5 animals) implants were inserted transaxially into the distal metaphyses of each femur under 
anesthesia. Animals were anesthetized with 5% isoflurane gas inhalation and maintained at 4% 
isoflurane in O2 gas inhalation for the duration of the surgical procedure. The hind limbs were 
prepared by shaving and cleaning using ethanol and chlorohexidine. For each hind leg, an 8mm 
incision was made over the medial side of the knee and the distal metaphysis was exposed 
using blunt dissection. A dental handpiece was used to create a 2.2mm diameter and 3.5mm 
deep hole. Implants were inserted and hand-tightened using a custom-made driver. A stainless-
steel cover screw was placed on the end of each implant to prevent bone from growing into the 
Figure 33. Schematic of the Experimental Procedures. 25, 8-month old, skeletally mature, virgin, female CD Sprague-Dawley 
rats were ovariectomized. The osteoporotic phenotype was allowed to develop for 6 weeks prior to insertion of either a non-
nanostructured/hydrophobic SLA, a nanostructured/hydrophobic SLAnano, or a nanostructured/hydrophilic modSLA was 
inserted into the distal metaphysis of each femur. Implants were allowed to osseointegrate for 28d prior to euthanasia. 
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internal threading of the implant. The periosteum and muscle were reapposed and sutured in 
place using resorbable sutures and the skin was closed with 9mm wound clips. Animals 
recovered from anesthesia on a water-circulating warming pad and injected subcutaneously with 
1mg/kg buprenorphine SR LAB. 
28d after the implant surgery rats were euthanized via CO2 inhalation. The hind limbs from 
each animal were isolated and prepped for analysis by micro-computed tomography (microCT) 
and histological analysis (n=5 animals/group). A separate cohort of animals receiving either SLA 
or mSLA implants were used for remsoval torque testing (n=5 animals/group). Each limb was 
treated as a separate sample providing an effective sample size of 10 per implant group for both 
the removal torque testing and microCT/histological analysis. 
Tissue Analysis 
MicroCT 
MicroCT (SkyScan 1173, Bruker, Kontich, Belgium) was used to assess the peri-implant 
bone growth and bone-to-implant contact (BIC). Femurs used for microCT were stored and fixed 
in 10% neutral buffered formalin for at least 24hr prior to imaging. The distal femoral metaphysis 
was scanned at a resolution of 1120x1120 pixels (image pixel size of 13.66 µm) over 360°using 
a 0.25mm brass filter, scanning energies of120kV and 66μA, 420ms exposure time, and 5 x-ray 
projections acquired every 0.2° and averaged. Using NRecon Software (Bruker), reconstruction 
of the scanned images was performed using a standard feldkamp algorithm with a beam 
hardening correction of 20% and a Gaussian smoothing kernel of 0. After reconstruction, 
samples were analyzed using CTAn version 1.16.4.1 (Bruker). Bone volume over total volume 
(BV/TV) was calculated by isolating a uniform volume of interest (VOI) for all samples which 
contained the distal 3mm of implant and surrounding bone. 3mm was chosen to eliminate any 
variability arising from the implant not being exactly at bone level for every sample. The implant 
was then thresholded, the VOI was shrink-wrapped and dilated 2 pixels around the implant and 
Osseointegration in Metabolically Compromised Conditions • Spring 2019 
Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 142 
subtracted from the original VOI. The remaining bone in the VOI was then thresholded and 
quantified yielding total bone volume (BV) and normalized to the total uniform volume of interest 
(TV). Bone-to-implant contact (BIC), which quantifies only the bone in direct contact with the 
implant, was quantified by isolating the distal 3mm of the implant. The implant was thresholded 
and shrink-wrapped, and the VOI was dilated 10 pixels around the implant and saved as a new 
volume of interest. In the new VOI, the implant was thresholded, dilated 3 pixels, and subtracted 
from the VOI. The remaining VOI was then eroded 3 pixels. The remaining bone in the final VOI 
was thus only in direct contact with the implant (BV) and was normalized to the volume of the 
implant (TV). 
Histology 
Following imaging with microCT, samples were placed in fresh 10% neutral buffered formalin 
and sent to be commercially processed for calcified histological staining (Histion, Everett, WA, 
USA). Femurs were embedded in methyl methacrylate, sectioned longitudinally relative to the 
implant and transaxially relative to the femur, and stained with Stevenel’s blue and van Gieson. 
Sections were imaged using bright field light microscopy with an AxioCam MRc5 camera and 
Axio Observer Z1 and analyzed using ZEN 2012 Blue Edition software (Zeiss). 
New peri-implant bone growth was quantified within a uniform rectangular region of interest 
(ROI) for all samples that was 3.5mm in width by 3.0mm in length for a total of 10.7mm2. The 
ROI was centered on each implant and began 0.3mm beneath its base. The area of all bone 
within the ROI was quantified yielding BV and normalized to the area of the ROI yielding TV. 
The area of bone contained within the ROI divided by the area of the ROI was defined as the 
histological BV/TV. In addition, the perimeter of the implant contained within both the trabecular 
region and the cortical region of the bone was measured. The trabecular BIC and cortical BIC 
were determined by dividing the length of bone in direct contact with the implant by the trabecular 
and cortical perimeter length respectively. The total BIC was calculated by summing both lengths 
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of contact and dividing by the total perimeter of the implant. 
Removal Torque 
Removal torque testing was performed on fresh, non-fixed samples using an ElectroForce 
3200 Series III test instrument (TA Instruments, New Castle, DE, USA). Because of their 
asymmetrical shape, femurs were mounted in 1cm diameter flexible polyurethane plastic tubing 
to ensure no movement of the femur during analysis (Fig. 5A). The tubing was cut into 5cm 
segments and halved longitudinally to provide access to the implant. Femurs were secured with 
polyurethane adhesive and allowed to dry overnight prior to testing. The implant on the samples 
were then fit to a custom-made driver and aligned to the testing machine axis to ensure no initial 
torque was present on the implant (0Ncm). Torque was then applied to the implants with a 
rotational speed of 0.1°s-1 with an axial displacement of 0.8mm/360° to ensure no compressive 
load was applied to the sample. Torque vs. degree graphs were generated for each sample and 
fit to a bilinear model in order to distinguish the toe-region from the linear region using an open-
source least squares spline modeling package (SLM - Shape Language Modeling version 1.14) 
for MATLAB (MathWorks, Natick, MA, USA). The linear region of each graph was then evaluated 
for the maximum torque, torsional energy (area below linear region), and torsional stiffness 
(slope of linear region). 
Osteoblast Isolation and Biological Response in Vitro 
Calvarial osteoblasts were also isolated from the frontal and parietal bones of euthanized 
rats using an explant technique. After removal of the periosteum and soft tissue, bones were 
digested for 15min at 37°C with 0.25% trypsin-EDTA (Life Technologies, Carlsbad, CA). Bones 
were minced into pieces approximately 1mm x 1mm and placed into a 100mm x 20mm Petri 
dish with Dulbecco’s modified Eagle medium (DMEM; Mediatech, Manassas, VA) + 10% fetal 
bovine serum (FBS) + 1% penicillin-streptomycin (Life Technologies). At confluence, cells were 
subpassaged and cultured as above. In order to ensure 1α,25-dihydroxy vitamin D3 
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(1α,25(OH)2D3; Enzo Biochem, Farmingdale, NY). The osteoblastic phenotype of each of the 
four groups of isolated cells was confirmed by measuring alkaline phosphatase specific activity 
and osteocalcin production after treatment of confluent cultures with either 0M or 10-8M 
1α,25(OH)2D3 for 24hrs (Supplementary Fig. 1) on tissue culture polystyrene (TCPS). 
Validated rat osteoblasts (rOBs; passage < 4) were separately cultured on TCPS or 15mm 
Ti SLA, SLAnano or mSLA discs. Discs were prepared from Ti sheets but subjected to the same 
implant sand-blasting and acid etching procedure as described above. Fabrication of these discs 
has been described previously.22 Cells were plated at a density of 10,000 cells/cm2 and 
incubated at 37°C in an atmosphere of 5% CO2 and 100% humidity. Media were changed 24h 
after plating and every 48h thereafter for 7d. At 7d, cells were incubated with fresh DMEM for 
24h. Media were collected and immunoassays were used to measure levels of intact rat 
osteocalcin (Alfa Aesar, Haverhill, MA) rat/mouse osteopontin (R&D Systems, Minneapolis, MN), 
mouse osteoprotegerin (R&D Systems), human/mouse/rat BMP2 (PeproTech), mouse receptor 
activator of nuclear kappa-B ligand (RANKL; R&D Systems), and rat vascular endothelial growth 
factor (VEGF; R&D Systems). 
After collection of media, cell monolayers were washed twice with 0.2ml PBS, lysed in 0.05% 
Triton X-100, and homogenized by sonication at 40 amplitude using a Vibra-Cell ultrasonicator 
(Sonics & Materials Inc., Newtown, CT). DNA content in the cell lysate was measured with 
PicoGreen (Promega, Madison, WI) using a Synergy H1 Hybrid Reader fluorescence detector 
(BioTek, Winooski, VT) at an excitation of 485 nm and emission of 538 nm. Alkaline phosphatase 
specific activity [orthophosphoric monoester phosphohydrolase, alkaline; E.C. 3.1.3.1] was 
assayed in cell lysates by measuring the conversion of p-nitrophenylphosphate to p-nitrophenol 
at pH 10.25 and temperature of 37°C. Absorbance was measured at 405nm. Activity was 
normalized to total protein content in the cell lysates as determined by bicinchoninic acid protein 
assay kit (Thermo Fisher Scientific, Waltham, MA). Immunoassay data were normalized to DNA 
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content. 
Statistical Analysis 
Based on previous studies,193,296 in order to detect a 30% mean difference with 20% variance 
and a type I error rate of 0.05, a two-tailed one-way ANOVA power analysis determined a sample 
size of 10 per group is necessary to maintain 80% power. In order to ensure that differences in 
mechanical loading would not affect the results, identical implants were placed in the right and 
left hind limbs. Since both legs were treated identically, it is safe to assume that movement or 
loading in one limb will not affect the movement or loading experienced by the other limb. The 
design of our study permits the assumption that implants from individual limbs can be treated as 
independent data points rather than dependent. Data are presented as the mean ± standard 
error (SE) for each analysis. All cell culture experiments had a sample size of six (n=6) and 
repeated at least three times to ensure validity of the results. Data shown in the figures are from 
representative experiments. Except for the removal torque experiment, a one–way analysis of 
variance was performed with a two-tailed Tukey correction to adjust for multiple comparisons. A 
t-test was used for the removal torque experiment. P values of <0.05 were considered significant 
for all statistical analyses and were performed using JMP statistical software (SAS Institute, 
Cary, NC, USA). 
Results 
Implant Characterization 
Qualitative SEM images (Fig.34A – I) revealed that the sandblasting and acid etching 
procedure maintained the overall threaded macrostructure of the implants (Fig.34A – C) while 
creating similar microtopographies (Fig.34D – F). At a higher magnification (Fig.34G – I), the 
presence of nanostructures was observed on SLAnano (Fig.34H) and mSLA (Fig.34I) implants. 
Nanostructures were absent from SLA implants (Fig.34G). Confocal microscopy confirmed the 
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similarities in microtopographies, revealing no differences among the implants’ mean surface 
roughness (Fig.34J). XPS (Fig.34K) showed carbon (C), oxygen (O), and titanium (Ti) to be the 
main atomic components of the SLA, SLAnano, and modSLA implants. No differences in 
chemical composition was detected between SLA and SLAnano. Compared to mSLA, both SLA 
Figure 34. Material Characterization of Implants. SLA, SLAnano, and mSLA substrates were examined by scanning 
electron microscopy (SEM) at 35x (A – C), 20Kx (D – F) and 100Kx (G – I). Surface roughness (Sa) was assessed using laser 
confocal microscopy measured using a 106.2µm x 106.2µm scan size (J). Surface chemical composition was assessed using 
X-Ray Photoelectron Spectroscopy (XPS) with spectra of O, Ti, and C shown (K). 
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and SLAnano had increased carbon content and decreased oxygen content. Similar titanium 
content was detected among all three implant surfaces.  
MicroCT and Histology 
3D reconstructions of microCT scans (Fig.35A – C) show the implant placement in the distal 
metaphysis of the femurs. The implants did not contact the growth plate eliminating any potential 
Figure 35. MicroCT Assessment of Implant Osseointegration. 8-month old, skeletally mature, virgin, female CD Sprague-
Dawley rats were ovariectomized. The osteoporotic phenotype was allowed to develop for 6 weeks prior to insertion of either 
a non-nanostructured/hydrophobic SLA, a nanostructured/hydrophobic SLAnano, or a nanostructured/hydrophilic modSLA 
was inserted into the distal metaphysis of each femur. Implants were allowed to osseointegrate for 28d prior to euthanasia. 
After 28d of osseointegration, femurs were isolated and placed in 10% formalin. Distal femurs of the animals were analyzed 
with 3D microCT reconstructions (A – C). Bone volume over total volume (BV/TV; D) and bone-to-implant contact (BIC; E) 
were quantified from the microCT reconstructions. Data shown are the mean ± standard error (SE) of ten independent 
samples. Groups not sharing a letter are statistically significant at an α=0.05. 
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influence on the bone formation in our defined VOI. The BV/TV (Fig.35D) was unaffected by the 
implant type. mSLA promoted increased BIC compared to SLA and SLAnano (Fig.35E). 
Representative histological sections from each group are shown in Fig.36A – C. mSLA 
promoted increased BV/TV (Fig.36D) and BIC (Fig.36E) compared to SLA and SLAnano. 
Removal Torque 
Figure 36. Histological Assessment of Implant Osseointegration. 8-month old, skeletally mature, virgin, female CD 
Sprague-Dawley rats were ovariectomized. The osteoporotic phenotype was allowed to develop for 6 weeks prior to insertion 
of either a non-nanostructured/hydrophobic SLA, a nanostructured/hydrophobic SLAnano, or a nanostructured/hydrophilic 
modSLA was inserted into the distal metaphysis of each femur. Implants were allowed to osseointegrate for 28d prior to 
euthanasia. After 28d of osseointegration, femurs were isolated and placed in 10% formalin. Distal femurs of the animals were 
embedded in methyl methacrylate, sectioned longitudinally relative to the implant and transaxially relative to the femur, and 
stained with Stevenel’s blue and van Gieson (A – C). Bone volume over total volume (BV/TV; D) and bone-to-implant contact 
(BIC; E) were quantified using histomorphometrics. Data shown are the mean ± standard error (SE) of six independent 
samples. Groups not sharing a letter are statistically significant at an α=0.05. 
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Since microCT and histomorphometrics revealed no differences between SLA and SLAnano, 
removal torque testing was performed on animals receiving either SLA or mSLA. Isolated femurs 
were secured in polyurethane tubing and aligned to the machine axis in a custom-fabricated 
sample holder to ensure no movement was created during the test (Fig.37A). Representative 
torque vs. degree graphs for SLA (Fig.37B) and mSLA (Fig.37C) display the bilinear model (red) 
Figure 37. Removal Torque Assessment of Implant Osseointegration. 8-month old, skeletally mature, virgin, female CD 
Sprague-Dawley rats were ovariectomized. The osteoporotic phenotype was allowed to develop for 6 weeks prior to insertion 
of either a non-nanostructured/hydrophobic SLA or a nanostructured/hydrophilic modSLA was inserted into the distal 
metaphysis of each femur. Implants were allowed to osseointegrate for 28d prior to euthanasia. After 28d of osseointegration, 
femurs were isolated and analyses were performed on fresh, non-fixed samples as outlined (A). Torque vs. degree graphs 
were generated for each sample and fit to a bilinear model in order to distinguish the toe-region from the linear region (B, C). 
The linear region of each graph was then evaluated for the maximum torque (D), torsional energy (E), and torsional stiffness 
(F). Data shown are the mean ± standard error (SE) of ten independent samples. Groups not sharing a letter are statistically 
significant at an α=0.05. 
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fit to the experimental data (blue). The middle vertical dashed line (black) separates the toe 
region (left section) and the linear region (right section) as determined by the least squares spline 
modeling package in MATLAB. The maximum torque (Fig.37D), torsional energy (Fig.37E), and 
torsional stiffness (Fig.37F) were increased around mSLA implants compared to SLA. 
In vitro Cell Response 
Addition of 10-8M 1α,25(OH)2D3 to confluent cultures of rOBs increased osteocalcin and 
alkaline phosphatase specific activity, confirming their successful isolation and expansion. DNA 
content (Fig.38A) and alkaline phosphatase specific activity (Fig.38B) were decreased in SLA 
cultures compared to TCPS. On microstructured surfaces, DNA content was further reduced in 
Figure 38. Response of primary calvarial osteoblasts isolated from ovariectomized aged rats to microstructured and 
hydrophilic Ti substrates. Calvarial osteoblasts were isolated and cultured separately on TCPS, SLA, SLAnano, or mSLA 
in DMEM. After 7 days, cells were treated with fresh DMEM for 24h. After 24h, media were collected, and cell lysates were 
assayed for DNA content (A) and alkaline phosphatase specific activity (B). Media were assayed for osteocalcin (C), BMP2 
(D), VEGF (E), osteopontin (F), RANKL (G), and osteoprotegerin (H). The ratio of RANKL to osteoprotegerin is shown in (I). 
All osteoblasts used were of passage 4 or less. Data shown are the mean ± standard error (SE) of six independent samples. 
Groups not sharing a letter are statistically significant at α=0.05. 
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mSLA cultures compared to SLAnano. No differences in alkaline phosphatase specific activity 
were detected on microstructured surfaces. rOBs cultured on modified surfaces produced higher 
quantities of osteocalcin (Fig.38C), BMP2 (Fig.38D), VEGF (Fig.38E), osteopontin (Fig.38F), 
and RANKL (Fig.38G) compared to TCPS cultures. Except for osteopontin, mSLA facilitated the 
greatest production of these factors while SLAnano stimulated the least. Although no differences 
were detected between mSLA and SLA osteopontin, a greater production was found on mSLA 
compared to SLAnano. No difference in RANKL production was detected between SLA and 
SLAnano cultures. Osteoprotegerin production (Fig.38H) was decreased to similar levels on 
modified surfaces compared to TCPS; however, the RANKL/OPG ratio (Fig.38I) was increased 
with the highest levels detected on mSLA. 
Discussion 
The morbidities associated with an aging population have increased the need for 
technologies that provide predictable implant osseointegration in dental and orthopaedic sites. 
Osteoporosis is one such metabolic condition that occurs when excessive bone resorption is not 
compensated by a concomitant increase in bone formation. The inability of osteoblasts to match 
the accelerated osteoclastic bone resorption with new bone formation implies a defect in the 
coupling process. The increased fracture rates351 and impaired healing352 associated with 
osteoporosis have become a significant dental and orthopaedic challenge. Systemic 
administration of drugs like bisphosphonates or osteoinductive agents like BMPs or parathyroid 
hormone-related protein (PTHrp) can improve clinical implantation outcomes by increasing bone 
volume (BV) and bone mineral density (BMD). However, these technologies can be expensive 
and sometimes require long-term administration. Evidence also indicates their use may have 
deleterious side effects including osteonecrosis of the jaw and are contraindicated for some 
applications. Therefore, approaches that do not rely on pharmacologic interventions are needed. 
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Much of the research regarding the pathophysiology of osteoporosis and mitigating its effects 
have focused on regulating the hyperactivity of osteoclasts. Impairment of osteoclasts will also 
cause an inhibitory effect on bone remodeling causing issues where bone turnover is of the 
utmost importance, such as osseointegration of dental implants. Alternatively, few studies have 
explored enhancing the osteoanabolic activity of osteoblasts and their progenitors, MSCs. 
Because of their capacity to self-renew and differentiation into various cell types, treatment 
strategies aimed at altering the differentiation direction of MSCs or augmenting normal 
endogenous MSCs could be a potential method for osteoporosis therapy. Specifically, for 
osteoporosis, this means targeting the altered differentiation potential of MSCs that favors 
adipogenesis over osteoblastogenesis. Promoting osteoblastic differentiation is not only 
important for promoting net new bone formation but also for the recruitment of other 
osteoprogenitor cells via paracrine signaling to hasten the peri-implant healing process. 
Although the goal of the present study was not concerned with systemic treatment of 
osteoporosis, the idea of locally mitigating the effects of osteoporosis by targeting MSC and 
osteoblast differentiation and maturation is pertinent to enhancing implant osseointegration in 
osteoporotic patients. 
In an approach that does not rely on pharmacologic interventions, we have shown that 
exploitation of the physical surface properties of Ti implants can promote peri-implant bone 
formation and osseointegration in a model of aged post-menopausal osteoporosis. Moreover, 
mSLA, a hydrophilic and micro-/nano-structured surface, promoted enhanced osseointegration 
compared to SLA, a hydrophobic and micro-structured surface, and SLAnano, a hydrophobic 
micro-/nanostructured surface. Higher BIC values and RTVs were observed in animals receiving 
mSLA implants. These values were similar to those found in non-compromised animals as 
previously reported.85 Interestingly, increased BV/TV was observed around the mSLA implants 
as determined by histomorphometrics. The unique mSLA surface is known to promote the 
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production of factors by cells that act via autocrine/paracrine signaling to induce bone formation 
locally and distal to the implant,61,80 which translates into enhanced contact and distal 
osteogenesis in vivo.196 Future studies are needed to assess the extent to which mSLA can 
promote peri-implant bone formation in osteoporotic animals as well as other compromised 
conditions. 
The processing technique used in this study allowed accurate separation between the effects 
of the nanostructures and the surface hydrophilicity. The sand blasting and acid etching 
procedure provided a consistent micro-roughness among SLA, SLAnano, and mSLA; however, 
this process did not induce nanostructure formation. Instead, nanostructure formation was 
dependent upon the reorganization of the oxide layer facilitated by the aqueous NaCl solution. 
Similar sized nanostructures were present on SLAnano and mSLA but not SLA. The exact 
process of nanostructure formation is unknown; however, many studies have fabricated 
nanostructures on metallic surfaces using a variety of methods involving changes in 
temperature, pressure, and chemical treatments. X-ray photoelectron spectroscopy (XPS) 
revealed that aqueous NaCl storage also maintained increased surface oxygen content by 
preventing carbon contamination on mSLA compared to SLA and SLAnano. Although SLAnano 
was originally prepared and stored in the same manner as mSLA, removal from NaCl solution 
was sufficient to reduce the oxygen levels and increase carbon levels to that of SLA. Due to the 
shape of the implant itself, quantification of the hydrophilicity by contact angle was not possible. 
However, the contact angle of the 15mm discs subjected to identical surface treatments has 
been reported previously.22 Additionally, the XPS results revealed a surface composition similar 
to what was reported on hydrophilic surfaces compared to hydrophobic surfaces.22 These results 
also confirm our findings reported for the SLA implant confirming batch-to-batch fabrication 
consistency.85 
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The mechanisms responsible for the enhanced osseointegration observed in vivo can be 
explained by much of our previous in vitro work. Estrogen is an osteoprotective hormone, and 
its deficiency leads to an elevated rate of bone turnover culminating in osteoporosis in females 
and, in some cases, older males. We showed that female osteoblasts are more sensitive to 
treatment with 17β-estradiol (E2) when cultured on microstructured Ti.73,75,81 Sensitivity to E2 
treatment was also shown to increase when these cells were cultured on SLA and mSLA 
compared to TCPS or PT. Furthermore, E2 treatment induces the expression of Wnt5a and 
Wnt11 signaling pathway components. On TCPS, MSC differentiation occurs through the 
canonical Wnt3A pathway, causing an accumulation of β-catenin in the cytoplasm and its 
translocation into the nucleus to serve as a transcriptional activator.67–69 Our studies have 
demonstrated surface mediated MSC differentiation downregulates genes associated with the 
Wnt3A pathway while upregulating genes of the Wnt1173 and non-canonical calcium-dependent 
Wnt5a pathway.70,71 These data suggest that surface design may be able to compensate for low 
E2 typical of osteoporosis by stimulating MSC differentiation and osteoblast maturation. 
Successful osseointegration not only requires net new bone formation but also involves 
osteoclast-mediated bone remodeling. Therefore, implants designed for osteoporotic patients 
should mitigate the effects of the altered communication among the cells responsible for bone 
remodeling. In osteoporotic patients, MSCs and osteoblasts produce factors favoring 
osteoclastogenesis unfettered by any regulatory feedback mechanisms. Increased levels of pro-
inflammatory IL-6 and decreased levels of TGFβ1 are produced by bone cells isolated from 
osteoporotic patients compared to healthy patients.77–79,262 Interestingly, both E2 treatment and 
microstructured Ti substrates are known to inhibit IL-6 production while enhancing production of 
TGFβ1 and OPG.75,80,81 It was also shown that conditioned media from MSC cultures grown on 
microstructured Ti substrates for 7 days inhibit osteoclast activity and this is correlated with 
surface-dependent production of osteoclast inhibitory factors.326 In addition to the high 
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production of negative regulators of osteoclast activity, cells produce high levels of osteocalcin 
and osteopontin.22,53 Osteocalcin has been shown to promote the chemotaxis, adhesion, and 
spreading of osteoclasts86,87 while osteopontin plays a role in anchoring osteoclasts to the 
mineralized bone matrix.88 The sequential production of these factors suggests microstructured 
Ti facilitates the production of a cascade of factors by MSCs and osteoblasts to mediate 
osteoclast recruitment while preventing their premature fusion and activity. 
Many studies have suggested a favorable effect of a nanostructured surface on osteoblast 
differentiation and maturation in vitro and new bone formation in vivo. No positive influence of 
nanostructures on implant osseointegration in OVX-induced osteoporotic animals was observed 
in this study. Moreover, the production of osteoblastic factors was impaired in primary 
osteoblasts when cultured on the hydrophobic/nanostructured SLAnano surface in vitro, an 
effect observed previously in healthy cells. Calvarial osteoblasts isolated from OVX animals 
displayed decreased osteocalcin, VEGF, BMP2, and osteopontin when cultured on SLAnano. 
The nanostructure size of the SLAnano surface was previously reported to be ~10nm22 whereas 
studies that observed positive effects of nanostructures ranged from 40 – 200nm.51,142,191 This 
suggests that osteoblastic differentiation and maturation can be altered by varying the size and 
shape of the nanostructures. Moreover, the effect of the nanostructures can be recovered and 
improved through the addition of the hydrophilicity providing the optimum conditions of 
osteoblastic differentiation and maturation. Interestingly, rOBs on all surfaces displayed 
decreased productions of OPG and increased productions of RANKL compared to TCPS. 
Previous studies have shown that aging in humans and rodents leads to an increased 
osteoblast-specific production of RANKL and decreased osteoprotegerin in osteoblasts,78,79 
which could be exacerbated by the enhanced maturation that Ti surfaces facilitate in osteoblasts. 
Conclusions 
Clinical grade Ti was successfully modified to fabricate microrough surfaces exhibiting 
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hydrophobic or hydrophilic nanostructured surfaces. Moreover, these surfaces were able to 
osseointegrate in an aged rat model of OVX-induced osteoporosis without pharmacologic 
intervention. Although modified surfaces were able to osseointegrate, a hydrophilic and micro-
/nano-structured mSLA surface had better osseointegration as indicated by higher percent BIC 
and RTVs. These values are also like what was previously observed in healthy animals receiving 
SLA implants. In vitro production of markers of osteoblastic differentiation and maturation were 
also greatest on mSLA while a hydrophobic and micro-/nano-structured SLAnano surface 
delayed the process of osteoblastogenesis. These results suggest that when the appropriate 
microstructure is present, hydrophilicity may play a greater role in stimulating differentiation of 
MSCs and osteoprogenitor cells and maturation of osteoblasts than nanostructures. 
Furthermore, when presented with the optimal surface, similar degrees of osseointegration 
between healthy and compromised patients can be achieved. Because of these differences 
observed both in vitro and in vivo, modified implant surfaces can exert their control over the 
altered bone remodeling and turnover observed in patients with osteoporosis to stimulate 
functional osseointegration. This insight is critical to the development of implants that support 
osseointegration in compromised patients. 
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Chapter 9. Conclusions and Future Perspectives 
This work has established that microstructured Ti and TiZr surfaces play significant roles in 
the bone remodeling stage of osseointegration. We have shown that Ti and TiZr can be 
successfully modified to enhance surface hydrophilicity, create microroughness, and induce 
nanostructure formation. Although all modified surfaces were able to facilitate a healthy 
osteoblastic phenotype in both MSCs and NHOsts, nanostructure size of ~11nm may delay the 
process of osteoblastogenesis. However, the effect of these nanostructures can be recovered 
with enhanced surface energy (hydrophilicity). This holds true when comparing the in vitro 
response of these cells between Ti to TiZr. Both MSCs and NHOsts responded similarly to both 
surfaces despite differences in bulk material and variations in surface nanostructure 
morphology/density. While it is tempting to definitively conclude that surface hydrophilicity 
overpowers any influence elicited by the surface chemistry (Ti vs. TiZr) or the surface 
nanoroughness, we are unable due to missing controls. Future studies would benefit from 
comparing hydrophobic/microrough Ti and TiZr as well as comparing hydrophilic/microrough 
Ti/TiZr to hydrophilic/microrough/nanorough Ti/TiZr. equivalent. 
We also showed that cellular response to surface roughness and hydrophilicity is modulated 
by nitrogen containing BPs. BPs are commonly used to combat osteoporosis by targeting OCs, 
slowing the rate and severity of bone resorption providing rationale for their use to enhance 
osseointegration. Our results indicate their use may have deleterious effects on implant success 
and patient safety contraindicating their use when implant osseointegration is the desired 
outcome. Exposure to BPs jeopardizes the pro-osteogenic response osteoblasts have to 
microstructured surfaces. Since BP treatment was more robust in cells cultured on rough and/or 
hydrophilic surfaces compared to smooth substrates, this effect may be dependent on cell 
maturation state, as well as donor sex and age. Moreover, their effects persist in vivo and 
condition osteoblasts to negatively influence their in vitro response. Because of their persistent 
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effects, clinicians may consider implementing a “drug holiday” for patients prescribed BPs, 
especially those who need a dental and/or orthopaedic implant. Future studies should assess 
the time it takes for primary osteoblasts to recover from the persistent effects of different BPs. 
Clinically, BPs could compromise peri-implant bone formation slowing the rate and quality of 
implant osseointegration. In order to assess the effects of BPs on osseointegration, an aged rat 
model with ovariectomized induced osteoporosis was employed. Our results show that 
osseointegration is decreased in osteoporotic animals compared to age-matched controls. 
Clinically relevant doses of ibandronate were able to halt the progression of the osteoporotic 
phenotype. These doses neither increased nor decreased implant osseointegration. However, 
the in vitro response of isolated osteoblasts was impaired, especially in sham ovariectomized 
animals. Interestingly, cells isolated from untreated ovariectomized animals responded more 
favorably to microstructured surfaces when compared to cells isolated from healthy controls. 
Whether implant surface properties alone were enough to stimulate peri-implant bone 
formation and osseointegration was assessed using only untreated ovariectomized rats. Clinical 
grade 4 Ti implants were successfully modified to fabricate microrough surfaces exhibiting 
hydrophobic or hydrophilic nanostructured surfaces like the grade 2 Ti disks used for in vitro 
studies. Each implant was able to osseointegrate in an aged rat model of OVX-induced 
osteoporosis without pharmacologic intervention. Unlike what was seen in vitro, the hydrophobic 
nanostructured implant surface did not impair osseointegration. Perhaps after 28d the influence 
of ~11nm nanostructures cannot be observed and instead reserves its influence over the initial 
stages. The aspect that was similar to what was observed in healthy MSC and NHOst cultures 
was the superior influence a hydrophilic and micro-/nano-structured surface had over 
osseointegration. In vitro production of osteoblastic markers from isolated primary cells were 
perpetuated on this surface as well. These results support the hypothesis that hydrophilicity may 
exert a greater influence compared to nanostructures. Whether or not it is greater than 
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microroughness remains to be determined. Regardless, these results suggest that modified 
implant surfaces exert their control over the altered bone remodeling and turnover observed in 
patients with osteoporosis to stimulate functional osseointegration. 
The question of what to do with this information now presents itself. Current research in the 
field of dental and orthopaedic implantology tends to focus on the development of novel methods 
of altering biomaterial surfaces and characterizing their effects on early stage osteogenesis. 
While these approaches are well-intentioned, it is unlikely that development of an optimal surface 
design capable of stimulating similar degrees of osseointegration between healthy and 
osteoporotic patients will manifest itself in this way. Instead, research in the field of dental and 
orthopaedic implantology should focus on knowledge gaps in bone biology and how implant 
surface features alter the dynamics of wound healing. Thus, it is of great importance to determine 
which factors regulate coupling and the influence dental implant surface features have on these 
mechanisms. 
By investigating the extent to which microstructured Ti surfaces modulate the dynamic 
interplay of multiple cell types, we are innovating the redundancy of contemporary biomaterial 
surface research. Using a newly developed system that exploits the OsteoLyse Assay Kit, we 
Figure 39. Eph/Ephrin and semaphorin system mRNAs in MSCs cultured on Ti surfaces. Groups not sharing a letter are 
statistically different at α=0.05. 
Osseointegration in Metabolically Compromised Conditions • Spring 2019 
Ethan M. Lotz • Ph.D. Dissertation • Biomedical Engineering • Virginia Commonwealth University • 160 
have shown that microstructured Ti surfaces indirectly regulate OC activity and gene expression 
After surface recognition by integrins, MSC and NHOst protein production is modulated and 
responsible for the decreased activity of existing OCs and reduced fusion of new OCs. In 
addition, OC gene expression is selectively regulate suggesting more than one pathway of 
control may be involved. Of the proteins responsible, the classic coupling mediators, TGFβ and 
OPG, do not contribute to the surface dependent regulation in vitro. Efforts should now continue 
exploring alternative mechanisms capable of regulating bone remodeling. 
Two other systems have been identified as important regulators of bone remodeling: 1) 
Eph/Ephrins and 2) Semaphorins. These two systems aid bone homeostasis and offer an 
intriguing mechanism for a reciprocal communication of the cell types involved. We have 
demonstrated that components of these signaling systems are modulated by microstructured Ti 
surfaces (Fig.39). Our research shows mRNAs for EPHB2 and SEMA3A increase on modSLA. 
Expression of the SEMA3A receptor, NRP1, is increased on SLA and modSLA. In contrast, 
Figure 40. Effects of exogenous and endogenous Sema3A on MSCs cultured on microstructured Ti surfaces. Groups not 
sharing a letter are statistically different α=0.05. 
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EPHB3, EFNB2, and SEMA3C expression in MSCs decreases in a surface-dependent manner. 
Addition of exogenous SEMA3A to surface cultured MSCs stimulates their osteoblastic 
differentiation while addition of a SEMA3A neutralizing antibody slows their osteoblastic 
differentiation (Fig.41). Moreover, conditioned media from MSC cultures stimulates SEMA3C 
expression in OCs and decreases expression of SEMA4D and PLXNA1 (Fig.41). SEMA4D 
produced by OCs can bind to PLXNB1 on the OB surface to decrease bone formation. Currently, 
SEMA3C has no known role in regulating bone homeostasis in TCPS culture. Our results 
suggest that surface-dependent modulation of MSCs and their downstream modulation of 
osteoclastic activity involve important, novel roles for semaphorin family proteins. Future 
research should focus on expanding the role semaphorins play in modulating bone remodeling 
in vitro as well as in vivo. 
A thorough understanding of how cells interact with the physical features of their 
environments has led to the development of implants that are both biocompatible and bioactive. 
By targeting the surface of the substrate, major enhancements in the performance of dental and 
orthopaedic implants have been achieved. Implant surface features are now designed to mimic 
the inherent surface roughness, surface chemistry, and surface hydrophilicity of native bone. 
Furthermore, methods to recreate the complex hierarchical features of an osteoclast resorption 
pit are now widely used to induce combinations of macroscale, microscale, mesoscale, and 
nanoscale topography. Thus, by mimicking the surface structure present on native bone tissue, 
Figure 41. Semaphorin system mRNAs in OCs treated for 2d with media collected from MSCs cultured on Ti surfaces. 
Exogenous RANKL and M-CSF was added to control for initial quantity for OC differentiation. OCPs and untreated OCs were 
used as a negative and positive control respectively. Groups not sharing a letter are statistically different α=0.05. 
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contemporary dental and orthopaedic implants can be designed to achieve rapid and optimal 
osseointegration. As research into these areas progresses, the future of implantology could see 
patient-specific implant designs that modulate different pathways, promoting healthy bone 
formation despite health issues the patient may present. 
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